













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 






The molecular function of the RNA-
binding protein NANOS2 in mouse 









Thesis presented for the degree of Doctor of Philosophy 
 
Institute for Regeneration and Repair 
Centre for Regenerative Medicine 








I declare that this thesis has been composed by myself. The work contained 
in this thesis is my own, except where stated otherwise by reference or 
acknowledgment. This work has not been submitted for any other previous 
degree or professional qualification. 
 
 Azzurra Codino 









         
 
        To my grandmother. 
 









“Consider ye the seed from which ye sprang; 
⁠Ye were not made to live like unto brutes, 
⁠But for pursuit of virtue and of knowledge”. 
 




“Considerate la vostra semenza: 
fatti non foste a viver come bruti, 
ma per seguir virtute e canoscenza”. 
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Lay summary  
 
Life is perpetuated by the reproduction of fertile organisms. Notably, adult male 
mammals are fertile throughout their life and can generate up to hundreds of 
million sperm daily. But how can they ensure such continuous sperm 
production? Which are the biological processes underlying their fertility? In 
mammals, sperm is produced after a long and highly organised developmental 
process called spermatogenesis, which starts from particular cells: 
spermatogonial stem cells (SSCs). SSCs constitute the endless source which 
fuels spermatogenesis, as they have the unique ability to both self-renew and 
differentiate. When they self-renew, they give rise to an identical SSC; 
whereas, upon differentiation, they generate more specialised cells, which 
ultimately undertake spermatogenesis and produce mature sperm. SSCs can 
be identified in adult testes by morphological features, molecular markers, as 
well as by functional assays in mouse models. However, the precise 
mechanisms underlying their self-renewal ability are poorly understood. 
During my Ph.D., I used the mouse as a model organism to investigate the 
molecular processes which occur inside SSCs. Notably, I focused on 
NANOS2, a protein which is essential for SSCs self-renewal, and male mice 
fertility. By using a genetic modified mouse which expresses a variant of 
NANOS2 (TAG-NANOS2), I was able to ‘fish’ NANOS2 protein inside SSCs 
and to characterise which are its interacting partners, at the molecular level. 
Notably, I discovered that NANOS2 strongly associates with ~1400 mRNAs. 
These are recognised by NANOS2 because they have a particular motif, which 
distinguishes them from the rest of the transcriptome. Additionally, these 
mRNAs produce proteins involved in metabolic processes. I also discovered 
that these mRNAs are rapidly degraded in SSCs. Since NANOS2 cooperates 
with other proteins, called CNOTs, their interplay might be the cause of 
mRNAs decay. Overall, these findings constitute a great advance for the 
comprehension of NANOS2 molecular function, in mouse SSCs. 
 
Importantly, also human NANOS1 was implicated in male infertility. Thus, as 
in mouse, it is possible that also human NANOS proteins repress mRNAs in 
healthy adult testes. In conclusion, my data could also pave the way for 





Spermatogonial stem cells (SSCs) are adult unipotent stem cells which are 
able to both self-renew and differentiate to support spermatogenesis 
throughout adult life. NANOS2 is a conserved RNA-binding protein, and its 
genetic deletion in adult mice leads to male infertility due to loss of SSCs. 
However, the precise mechanism underlying NANOS2 function during SSCs 
maintenance remains largely unexplored at the transcriptomic level. To 
accurately identify NANOS2 RNA-occupancy, we generated a Nanos2TAG 
mouse model, I derived and expanded SSCs in vitro and performed CRAC 
(UV-Cross-linking and Analysis of cDNA). CRAC revealed that NANOS2 
strongly and specifically interacts with RNA, despite its low abundance in cells. 
It also showed that NANOS2 mainly binds mRNAs within their 3' UTRs, which 
are enriched in the novel ‘AUNAANU’ motif. These mRNAs are involved in 
cellular metabolism, and they also include positive regulators of the mTORC 
pathway, which is known to control SSCs self-renewal. Additionally, we 
analysed the expression profile of these mRNAs throughout adult 
spermatogonia development. This revealed that one-third of NANOS2 targets 
are upregulated during the transition from self-renewing SSCs to transit-
amplifying spermatogonia. 
To further explore NANOS2 function, we performed immunoprecipitation 
followed by mass spectrometry and identified components of the CCR4-NOT 
complex amongst the strongest interactors. Since the CCR4-NOT promotes 
RNA decay, I investigated the mRNA stability of NANOS2 targets by using 
SLAM-seq, a novel technique that enables the determination of mRNA half-life 
transcriptome-wide. This analysis suggested that NANOS2 mRNA targets 
have a shorter half-life, compared to the average mRNA stability in SSCs.  
In summary, I demonstrated that NANOS2 shortens the half-life of hundreds 
of mRNAs involved in metabolism, through the recruitment of the CCR4-NOT 
RNA deadenylation complex, in SSC lines. Therefore, we speculate that 
NANOS2 promotes SSCs self-renewal by repressing active metabolism and 
 
cellular growth. This would preserve cellular quiescence and ensures the 
presence of a long-term SSCs pool in adult mice. Overall, these findings 
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Chapter 1. Introduction  
 
1.1 Mouse spermatogenesis 
 
The precursors of male germ cells originate during early embryonic 
development from Primordial Germ Cells (PGCs), which arise from the 
epiblast, as a result of inductive signals (Hayashi et al., 2007). PGCs induction 
occurs at E5.5-6.25 and requires Bmp4 signalling from the extraembryonic 
ectoderm (Lawson et al., 1999; Ohinata et al., 2009) (Figure 1.1 A). PGCs 
specification also necessitates the expression of different transcription factors, 
including Blimp1 (Ohinata et al., 2005), Prdm14 (Yamaji et al., 2008) and Ap2𝜸 
(Weber et al., 2010). After E8.5, PGCs start migrating towards the genital 
ridges, and there, at E11.5, they undergo sex determination (Saga, 2008). In 
the gonads of female embryos, gonocytes are subjected to retinoic acid (RA), 
and thus, they enter meiosis (Koubova et al., 2006) (Figure 1.1 B). On the 
contrary, male gonads express high levels of Cyp26b1, which degrades RA 
and prevents male gonocytes from entering meiosis (Saga, 2008). Thus, male 
gonocytes undergo mitotic arrest at G1/G0 and remain quiescent until birth 





Figure 1.1. Germ cell development during mouse embryogenesis, adapted from 
(Saga, 2008).  
A. The figure depicts the main stages of germ cell development between embryonic 
day (E) 6.5 and 16. Primordial germ cells (PGCs) are shown as red circles. Key genes 
involved in each phase of the process are also shown at the bottom. B. In female 
embryonic gonads (pink panel), retinoic acid (RA) induces Stra8 and triggers meiosis. 
In males (green panel), the meiotic entry of gonocytes is prevented by the expression 
of Cyp26b1. 
  
After birth, the mitotically arrested male gonocytes re-enter the cell cycle and 
migrate from the central part of the seminiferous tubules towards their 
periphery. Once they reach the basement membrane of the tubules, at post-
natal day P3-6, gonocytes become spermatogonia (Bellve et al., 1977). 






spermatogenesis (Russell et al., 1990). However, the initial round of 
spermatogenesis after birth in mouse is initiated directly from gonocytes, thus 
bypassing the spermatogonia stage (Yoshida et al., 2006).  
 
Spermatogenesis is a highly organised developmental process that results in 
the production of haploid spermatozoa, the male gametes competent for egg 
fertilisation (Phillips et al., 2010). This process takes place inside the 
seminiferous tubules of testes and involves different types of germ cells 
(Figure 1.2). These cell types arise in a sequential manner and are spatially 
arranged inside tubules (Russell et al., 1990). Male germ cells include the 
undifferentiated spermatogonia, which are initially located near the basal 
membrane of the tubules, but upon cell division and differentiation, they move 
towards the centre of the tubules, to the adluminal compartment (Figure 1.2) 
(Russell et al., 1990). Outside the seminiferous tubules, there is the interstitial 
tissue, composed of Leydig cells, which produce testosterone, blood vessels, 
and other somatic cells (Russell et al., 1990). However, inside tubules, there 
is only one type of somatic cells, the Sertoli cells. These are in close contact 
with germ cells, and they provide both mechanical and nutritional support, for 
each stage of spermatogenesis (França et al., 2016). Indeed, Sertoli are also 
called ‘nurse cells’, since they nourish germ cells by providing nutrients, such 
as lactate, cytokines, such as GDNF, and hormones (França et al., 2016). 
Moreover, adjacent Sertoli cells form tight junctions between each other, and 
this contributes to the formation of the blood-testis barrier (BTB), which 
separates two compartments within the tubules: the basal and the adluminal 
ones (Figure 1.2). This separation forms a unique microenvironment where, in 
the apical part, there are exclusively the meiotic germ cells and mature 
spermatozoa, which are completely isolated from the blood vessels (Jiang et 
al., 2014).  
 
 4 
Importantly, almost all the functions performed by Sertoli cells are under the 
control of multiple signalling pathways (Ni et al., 2019).  
 
 
Figure 1.2. Seminiferous tubules showing the spatial arrangement of different 
types of germ cells, adapted from (Hara et al., 2014).  
The figure shows the anatomy of seminiferous tubules, and the distribution of specific 
types of germ cells, in the basal compartment, and the adluminal or apical one. 
Undifferentiated spermatogonia are shown in brown and the other germ cells in grey. 
 
 
As previously said, there are different types of germ cells, depending on their 
stage during spermatogenesis. In particular, spermatogonia were initially 
divided into three categories, type A, Intermediate (In) or type B (Russell et al., 
1990) (Figure 1.3). This subdivision was based on the morphological features 
of their nuclei, which contained a different amount of heterochromatin, 
increasing from type A to type B (Phillips et al., 2010). Type A spermatogonia 
are undifferentiated cells, which also include the spermatogonial stem cells 
(SSCs) population (see below), and comprise Asingle cells, which can divide to 
give rise to another identical Asingle or generate two daughter cells called Apaired. 
These are the result of incomplete cytokinesis (Russell et al., 1990). Apaired can 
further divide and generate Aaligned cells, which contain multiple cells in the 
same ‘syncytia’. Long chains of Aaligned spermatogonia undergo differentiation 
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and continue to proliferate to give rise to Intermediate spermatogonia, and then 
to type B spermatogonia (Figure 1.3). Then spermatocytes enter the meiotic 
divisions, to reduce their chromosome numbers and become haploid cells 
(Russell et al., 1990). Importantly, during meiosis, the genetic material is 
recombined through the crossing-over, in order to produce haploid spermatids 
with a unique genetic asset (Russell et al., 1990). Then, round spermatids 
undergo an additional developmental process in order to form specialised 
spermatozoa, which are released into the lumen of seminiferous tubules 
(Russell et al., 1990; Rooij, 2017).  
The formation of long chains of germ cells implicates that cellular products are 
shared through intercellular bridges across the syncytia (Dunleavy et al., 
2019). This peculiar feature is thought to contribute to the synchronisation of 
spermatogenesis, and also to make the haploid stages ‘phenotypically diploid’ 








Figure 1.3 The different stages of mouse spermatogenesis, adapted from 
(Kanatsu-Shinohara and Shinohara, 2013). 
Spermatogenesis starts from type A spermatogonia, which are divided into 
undifferentiated and differentiated cells. The undifferentiated population includes 
Asingle spermatogonia, which can divide to produce an identical Asingle or to generate 
Apaired spermatogonia through incomplete cytokinesis. Long chains of Aaligned 
spermatogonia undergo multiple rounds of cell divisions and also differentiation. 
Intermediate spermatogonia (In) become type B spermatogonia and then 
spermatocytes, which enter meiosis. At the end of the process, spermatids undergo 
further maturation to produce spermatozoa. 
 
 
The developmental processes which allow spermatogonia to become 
spermatocytes and then spermatids, not only take place in a spatially 
organised manner, but they are also specifically timed (Russell et al., 1990). 




exactly the same sequence of events, every 8.6 days in mouse. This periodic 
process is called the spermatogenic cycle and  includes twelve stages, each 
representing a unique combination of germ cells present in a distinct area of 
the tubule (Phillips et al., 2010; Rooij, 2017). 
1.2 Spermatogonial stem cells (SSCs) and the models of self-renewal 
 
Spermatogonial stem cells (SSCs) are unique as they can both self-renew to 
produce an identical SSC, and differentiate, to give rise to other 
spermatogonia, which undergo spermatogenesis (Kanatsu-Shinohara et al., 
2008; Rooij, 2017)(Russell et al., 1990). Their self-renewal ability allows 
sustaining a long-term pool of SSCs, in the adult mouse, which fuels 
spermatogenesis throughout life. The first studies aimed at understanding 
SSCs division and self-renewal were based on the morphological features of 
spermatogonia, observed after fixation of seminiferous tubules (Chiarini-
Garcia and Russell, 2001; Rooij and Russell, 2000). By evaluating their spatial 
arrangement within the tubules as well as the morphology of their nuclei, it was 
initially postulated that the most undifferentiated spermatogonia resided within 
the Type A and that only the As (Asingle) were able to self-renew (Huckins, 1971; 
Oakberg, 1971). According to this model, later on called the ‘As model’ (Figure 
1.4 A), an As can divide to form another identical As which also has self-renewal 
capacity, or it can divide to form two daughter cells, Apr (Apaired), committed to 
differentiation (Huckins, 1971; Oakberg, 1971).  
The identification of genes expressed only in selected groups of 
undifferentiated spermatogonia allowed defining better the properties of SSCs 
(Aponte et al., 2005). One of the first markers was the transcription factor 
neurogenin3, Ngn3, which was shown to be specifically expressed in 
undifferentiated spermatogonia (c-Kit-negative cells), and in As, Apr Aal4 
(Aaligned4) cells (Yoshida et al., 2004). Moreover, the receptor for the glial cell 
line-derived neurotrophic factor (GDNF), called GFRα1, was shown to be 
expressed mainly in As (Hofmann et al., 2005), and to smaller extents also in 
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Apr Aal4 (Suzuki et al., 2009). Moreover, the RNA-binding protein NANOS2 was 
shown to be exclusively expressed in undifferentiated spermatogonia, and to 
nearly overlap with GFRα1 (Suzuki et al., 2009). The transcription factor PLZF 
was shown to be expressed in short chains of spermatogonia and to be critical 
for the maintenance of SSCs in mouse (Buaas et al., 2004; Costoya et al., 
2004). 
However, these genes were shown to be present simultaneously in As and in 
Apr, as well as to a smaller extent in longer chains, which suggested the 
existence of heterogeneity within clusters of spermatogonia having the same 
morphological features (e.g., within As) (Suzuki et al., 2009). Later on, the 
inhibitor of differentiation 4, ID4, was shown to be present almost exclusively 
in As and to be necessary for the self-renewal ability of SSCs cultures (Oatley 
et al., 2011). Lineage tracing experiments also revealed that ID4-cells could 
give rise to long-term patches, which produce the entire spermatogenic lineage 
(Sun et al., 2015). Moreover, the self-renewal potential of ID4-cells was also 
tested with transplantation. This a functional assay which is based on the 
dissociation of donor testicular tissues and its transplantation into the empty 
testes of recipient mice, which are then examined for the ability to generate 
offspring (Brinster and Zimmermann, 1994). Thus, when transplanting ID4-
cells into recipient mice, these were shown to repopulate testes, highlighting 
their self-renewal ability (Chan et al., 2014). However, not all As in testes 
express ID4, and within the ID4-cells, there is an expression gradient which 
correlates with their self-renewing ability (Helsel et al., 2017). Overall, these 
data suggested a hierarchy within the As, where only some rare As have the 
highest self-renewal ability and thus these were called ‘the ultimate’ SSCs 
(Helsel et al., 2017; Rooij, 2017). Since low levels of ID4 indicate gradual loss 
of self-renewal potential, these cells have been called ‘transitory’ SSCs (Helsel 
et al., 2017). According to this model, called the ‘hierarchical As model’ (Figure 
1.4 B), upon As division, ID4 levels decrease and these daughter cells have 
higher chance to form Apr. Moreover, cells expressing high levels of ID4 also 
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highly express BMI1, which marks a population of As with similar properties to 
ID4 (Komai et al., 2015). 
 
However, live imaging and pulse labelling experiments on the GFRα1- and 
Ngn3-positive spermatogonia supported a different model for SSCs self-
renewal, which was called the ‘fragmentation model’ (Hara et al., 2014; 
Nakagawa et al., 2010; Rooij, 2017)(Figure 1.4 C, D). According to this model, 
also Apr and Aal cells can contribute to the self-renewing pool, by fragmenting 
and forming new As cells and smaller chains (Hara et al., 2014). Previous 
studies showed that Nng3 expression was restricted to the undifferentiated 
spermatogonia (Yoshida et al., 2004, 2006). Moreover, a pulse-labelling 
system which studied the behavior of Ngn3-cells, revealed the presence of two 
stem cell populations, the actual and the potential stem cells (Nakagawa et al., 
2007). Potential stem cells normally have a rapid turnover, but upon loss of the 
actual stem cells, they are thought to switch towards self-renewal, suggesting 
a flexible behavior of spermatogonia, in contrast with the ‘hierarchical As 
model’ (Nakagawa et al., 2007). These studies were supported by further data 
afterwards. In the steady-state, GFRα1-cells, which are mainly represented by 
As, Apr, and Aal cells, are at the top of the SSCs hierarchy, as demonstrated by 
live imaging and lineage analyses (Nakagawa et al., 2010; Sada et al., 2009). 
GFRα1-cells (in pink, Figure 1.4 D) normally maintain their own population and 
they also generate the second one, marked by Ngn3 (in green, Figure 1.4 D), 
which encompasses more Aal cells. Ngn3-cells mainly give rise to the 
differentiating c-Kit-cells (in blue, Figure 1.4 D), but they also have the ability 
to fragment into shorter chains and even into As (Nakagawa et al., 2010). 
These fragmented cells also re-acquire the expression of GFRα1 (yellow 
arrows, Figure 1.4 D) and can contribute to the SSCs pool in the long-term. 
Moreover, during regeneration, the reversibility of the Ngn3 population 
becomes more accentuated, suggesting that the Ngn3-cells may act as a 
reserve for the actual stem cells, following tissue insult (Hara et al., 2014; 






Figure 1.4 Models for SSCs self-renewal and division, adapted from (Hara et al., 
2014; Rooij, 2017).  
A. According to the historical ‘As model’, the As spermatogonia were the only stem 
cells. Upon division, As could either self-renew or produce two daughter cells (Apr), 







self-renewing pool. B. In the ‘As hierarchical model’, the As population is 
heterogeneous, as it is marked by different levels of ID4 and BMI1. Their expression 
levels correlate with their self-renewal ability, as the ID4-bright cells have the highest 
self-renewal potential. C. In the ‘fragmentation model’, most of the times As generate 
Apr, which then form Aal cells. Chains of Apr and Aal can also revert to As, by 
fragmentation, thus, implicating that Apr and Aal cells are not completely committed for 
differentiation. D. Hierarchy among different subpopulations of spermatogonia, 
according to the fragmentation model. Undifferentiated spermatogonia are marked by 
GFRa1 (in pink) and Ngn3 (in green), whereas differentiating spermatogonia are c-
Kit+ (blue). In this model, GFRa1+ As, marked by the asterisk (*), are the self-renewing 
pool; the reversibility of Ngn+ spermatogonia is depicted by yellow arrows.  
 
1.3 SSCs cultures in vitro 
 
SSCs constitute a very tiny population in vivo, as they are estimated as 0.02-
0.03% of all germ cells in the mouse testes (Rooij and Russell, 2000). Their 
scarcity has hampered for decades the study of the molecular processes 
underlying their self-renewal ability. However, after identifying the cytokine 
GDNF as a critical regulator of SSCs self-renewal (Meng et al., 2000), 
scientists developed the first SSCs culture system, which allowed the 
exponential expansion of SSCs in vitro, and their long-term culture (Kanatsu-
Shinohara et al., 2003). SSCs were originally derived from neo-natal mice, at 
P0-2, a period during which testes are enriched for SSCs (Rooij, 2017). These 
cells were grown on mouse feeders (MEFs) and formed grape-like colonies, in 
the presence of four cytokines GDNF, FG2, EGF and LIF, essential for SSCs 
self-renewal (Kubota et al., 2004). Importantly, upon transplantation into 
recipient testes, SSCs from these cultures were able to start spermatogenesis 
and generate fertile offspring (Kanatsu-Shinohara, 2005). However, only 1-2% 
of these SSCs were shown to produce colonies in vivo, highlighting the 
functional heterogeneity of these cells cultures (Kanatsu-Shinohara and 
Shinohara, 2013). Another important property of SSCs cultures is to maintain 
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in the long term a stable karyotype and a correct DNA methylation pattern in 
imprinted genes, even after two years of culture (Kanatsu-Shinohara, 2005). 
Later on, SSCs cultures were also developed in feeders-free conditions as well 
as in serum-free cell media (Kanatsu-Shinohara et al., 2005, 2014).  
Moreover, subsequent studies showed that SSCs could also be derived from 
neonatal testes at P4.5-7.5 (Kubota et al., 2004), and even from 4-6 weeks old 
mice (Guan et al., 2006). Although germ cells are thought to lose their 
pluripotency during early embryonic development (Takashima and Shinohara, 
2018), it was shown that SSCs derived from neonatal testes have the ability to 
spontaneously convert into pluripotent cells in vitro (Kanatsu-Shinohara et al., 
2004). Additionally, also SSCs derived from adult testes were shown to retain 
pluripotency, when cultured under specific conditions (Guan et al., 2006).  
As previously mentioned, SSCs can divide logarithmically for a long time in 
culture, in the presence of four cytokines, among which GDNF (Takashima 
and Shinohara, 2018). Notably, GDNF mediates the activation of the 
phosphatidylinositol 3-kinase-AKT pathway (Figure 1.5), which is necessary 
for SSCs self-renewal, but when this pathway is constitutively activated, also 
independently of GDNF, SSCs can still proliferate (Lee et al., 2007; Oatley et 
al., 2007). Both GDNF and FGF2 stimulate the Src kinases, which, in turn, 
activate Ras and subsequently, the Akt and MEK pathways  (Takashima and 
Shinohara, 2018). In particular, activation of the MAP2K mediated by FGF2 
upregulates ETV5 and BCL6B, which then stimulate self-renewal (Ishii et al., 
2012; Oatley et al., 2006). Since ETV5 controls the expression of c-ret (Tyagi 
et al., 2009), a component of the GDNF receptor essential for 
spermatogenesis (Naughton et al., 2006), these pathways also use feedback 
mechanisms to support SSCs self-renewal.  
Moreover, other studies discovered that self-renewal is also promoted by 
moderate levels of ROS (reactive oxygen species) produced by two NAPDH 
oxidase, Nox1 and Nox3, which are also positively regulated by the AKT and 






Figure 1.5. The main signalling pathways involved in SSC self-renewal, adapted 
from (Kanatsu-Shinohara and Shinohara, 2013).  
On SSCs membrane, GDNF and FGF2 bind to the FGFR and GFRa1/c-ret receptors 
respectively and trigger signalling cascades which sustain SSC self-renewal.  
 
 
1.4 Post-transcriptional gene regulation (PTGR)  
 
Post-transcriptional gene regulation (PTGR) is an efficient way to modify the 
level of transcripts in response to cellular or extra-cellular stimuli. In contrast 
with the transcriptional regulation of gene expression, PTGR acts rapidly since 
it uses existing RNAs, which are already transcribed. This type of regulation 
occurs in every type of mRNA although to different extents, and takes place 
also as a quality control process, from the very early phases of an mRNA life 
until its end.  
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During transcription, nascent mRNAs are processed, to ensure their correct 
maturation. These co-transcriptional events include the addition of the 5’-cap 
to form a 7-methylguanosine, the splicing, and the 3’-end maturation, which 
includes cleavage and polyadenylation. If any of these early events do not 
occur, mRNAs are degraded, without even being exported from the nucleus to 
the cytoplasm (Corbett, 2018; Singh et al., 2015). Following nuclear export, 
mRNAs are subjected to additional quality-control processes, to ensure that 
only ‘healthy’ mRNAs are translated, thus optimising cellular energy. For 
instance, the Non-sense mediated decay (NMD) pathway induces the 
degradation of mRNAs with premature stop codons, thus preventing the 
production of aberrant proteins (Lykke-Andersen and Jensen, 2015). 
From the birth to the end of their life, mRNAs are accompanied by other factors 
which assemble along their body length. It is estimated that on average, 14 
RNA-binding proteins (RBPs) bind to the 3' UTR of each mRNA (Plass et al., 
2017). The combination of mRNAs, RBPs as well as other factors, such as 
miRNAs, form the messenger ribonucleoprotein particles (mRNPs). mRNPs 
can have variable composition depending on the specific phase of the mRNA 
lifecycle or simply on the localisation of the mRNA. The exact array of factors 
included in a specific mRNP decides the fate of a given mRNA, its expression 
level and in general they are the major determinant of PTGR (Kuersten and 
Goodwin, 2003). 
RBPs in mRNPs can be either general or specific. Examples of general RBPs 
which bind to regions shared among all mRNAs, are: the nuclear cap-binding 
complex, CBC20/80, which binds to the 5’ cap of mRNAs, the Exon junction 
complex, (EJC), which binds to the exon-exon junctions, and the Cytoplasmic 
poly(A) binding protein, (PABPC), which binds to the poly(A) tail of every 
mRNA (Moore, 2005).  
RBPs can associate along the entire length of the mRNA body without 
sequence specificity, such as the Y-box proteins, which are useful for the 
packaging of mRNPs. However, RBPs can also bind with sequence specificity 
to certain regions of mRNAs, enclosed in the 5' and 3' UTRs (Moore, 2005). 
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For instance, 3' UTRs with AU-rich elements (ARE) are bound by the TTP 
(tristetraprolin) proteins, which trigger RNA degradation (Carballo et al., 
1998a). In other cases, mRNAs have specific miRNA-recognition elements, 
which are bound by miRNAs. These, in turn, associate with the RBPs 
Argonaute and induce mRNA repression (Mayya and Duchaine, 2019).  
Therefore, the nucleotide sequence of mRNAs is critical to determine the fate 
of transcripts.  
Moreover, the promoter sequence of a gene can also affect the decay of the 
corresponding transcripts (Haimovich et al., 2013). Since this strategy is 
adopted by yeast and mammalian cells, it suggests that coordination between 
transcription and mRNA decay is a highly conserved process which might also 
have helped the evolution of living organisms (Haimovich et al., 2013). 
Another element that affects PTGR is the 3' UTR structure, which has been 
recently defined as a new level of genetic code (Bevilacqua et al., 2016; Mayya 
and Duchaine, 2019). In contrast to DNA, single-stranded RNA can fold into a 
myriad of secondary and tertiary structures, which also contribute to the variety 
of RNA functions. Secondary structures are based on canonical (G-C and A-
U) and noncanonical base pairs, such as the G · U wobble, but also include 
unpaired nucleotides. Altogether, these give rise to hairpins, which are 
composed of stem and loops, bulges, and 3-way junctions. Then, secondary 
structures fold into complex tertiary structures, which can include pseudoknots 
and G-quadruplexes.  
This knowledge is used to predict the RNA structure with free energy 
minimization, in traditional, thermodynamics-based approaches. However, 
these in silico predictions are not sufficient to grab the complexity of RNA 
structures in cells. RNA structure is also affected by RBPs and other factors 
(like lncRNAs and miRNAs) existing in vivo, which modify the accessibility of 
certain regions in the mRNA. Thus, to capture the complexity of the RNA 
structure in cellular systems, existiting methods have been recently coupled to 
next-generation sequencing and applied to various organisms. For instance, 
new insight into the ‘RNA structurome’ concerns stress-related mRNAs. These 
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were shown to have more single-stranded regions than previously predicted 
with traditional methods. Notably, these mRNAs are thought to be very 
dynamic in vivo, a property that could confer them the necessary flexibility to 
respond to stress and to adapt to other regulatory processes in cells 
(Bevilacqua et al., 2016; Jacobs et al., 2012; Kwok et al., 2015).  
 
1.5 The role of RNA-binding proteins (RBPs) in PTGR 
RBPs greatly participate in the PTGR. They associate with mRNAs throughout 
their lifecycle and thus are major determinants of mRNA fate. Importantly, also 
the ‘history’ of RBPs bound to a specific transcript can greatly influence its fate. 
One example is represented by the EJCs which are deposited on mRNAs in 
the nucleus. Although this deposition occurs at the beginning of mRNA life, it 
can have downstream effects in the cytoplasm, when, in some cases, it 
triggers the NMD pathway and determine RNA degradation (Dreyfuss et al., 
2002).  
RBPs are widely employed by cells, in all organisms studied. RBPs are 
remarkably conserved across evolution, in particular, compared to TFs. 
Notably, 50% of human RBPs are also found in S. cerevisiae, whereas only 
14% of human TFs are also found in S. cerevisiae. This highlights the fact that 
RBPs diversified very early in evolution compared to TFs. Thus, if TFs 
expansion reflects better the complexity of organisms during evolution, RBPs 
indicate highly conserved metabolic processes shared in all living organisms 
(Gerstberger et al., 2014). 
On average, human tissues express RBPs at higher levels than any other 
category of proteins. Moreover, although similar numbers of genes encode 
RBPs and TFs, RBPs constitute 20% of protein-coding transcripts and TFs, 
only 3% (Gerstberger et al., 2014).  
Furthermore, although the majority of human RBPs has no tissue-specificity, 
90% of the tissue-specific RBPs reside in the germline, brain, muscle, bone 
marrow, and liver cells (Gerstberger et al., 2014). Moreover, ~50% of these 
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specialised RBPs is enriched in adult testis (Gerstberger et al., 2014). This is 
not surprising, given that RBPs have essential roles during spermatogenesis, 
where they are involved in splicing, in the 3' end formation of mRNAs, in 
translation, and RNA decay (Elliott, 2003). 
 
RBPs function greatly depends on their ability to bind and select their RNA 
targets. The interaction between proteins and RNAs is mediated by RNA-
binding domains (RBDs), which include RRM, KH, and zinc fingers, among 
others. In general, target specificity is achieved by the particular features of 
each domain (described below), but also by the presence of multiple repeats 
of the same domain or by the combination of different domains. Overall, 
multiple domains increase the sequence specificity of an RBP, although RNA-
binding can also be greatly influenced by either synergy or competition among 
different RBPs (Lunde et al., 2007). 
 
The most common module used by RBPs is the RNA recognition motif (RRM). 
This usually contacts ~4-8 nucleotides of RNA, through an Arg or Lys and two 
aromatic amino acids present on the surface of a beta-sheet (Lunde et al., 
2007). The hnRNP K homology (KH) can bind to RNA by recognising ~4 
nucleotides, through hydrogen bonds and electrostatic interactions formed in 
a cleft of the KH domain. Zinc fingers include several types of domains, which 
are classified depending on the number and order of cysteine (C) and histidine 
(H) residues which coordinate zinc. Thus, there are C2H2, CCCH, and CCHC 
domains, which use slightly different ways to achieve target recognition. 
Other domains include the S1 domain, which binds to RNA similarly to the 
RRM, and the PAZ and PIWI domains which are specifically present in small 
non-coding RNA-binding proteins (Lunde et al., 2007). RBPs can also have 
double-stranded RNA-binding domains (dsRBD) such as the RNA editing 
enzyme ADAR as well as DICER (Saunders and Barber, 2003). However, the 
dsRBDs generally bind to RNA without sequence specificity, by contacting the 
phosphate backbone and the 2'-OH groups of RNAs.  
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Interestingly, it has been recently discovered that also many proteins with 
unconventional domains can bind to RNA. Notably, these domains include 
intrinsically disordered regions (IDRs), the enzymatic cores of metabolic 
proteins, as well as protein-protein interfaces (Dreyfuss et al., 2002; Hentze et 
al., 2018).  
 
1.6 Cytoplasmic mRNA degradation  
 
Cells do not accumulate as much RNA as they transcribe it, indicating that they 
actively employ RNA degradation pathways.  
By default, mRNAs are unstable molecules, prone to decay, whose life is 
constantly threatened by the action of RNases, ubiquitously present in cells. 
However, their instability also makes them an ideal means to control gene 
expression. 
Indeed, mRNAs are degraded for various reasons in cells. First of all, to 
prevent their permanent expression throughout time, which would promote the 
wrong cellular program. Then, mRNA decay is used to respond to changes in 
the microenvironment rapidly. Moreover, it is also employed to perform quality 
control, as defective mRNAs are promptly removed in cells, to prevent the 
production of aberrant proteins.  
In general, an abnormal accumulation of RNA in cells would be detrimental, 
because free and random RNAs molecules could sequester RBPs, and impair 
their functions. Furthermore, free nuclear RNA fragments could form RNA-
DNA hybrids, which would negatively impact DNA replication (Houseley and 
Tollervey, 2009).  
 
mRNA decay is mediated mainly by exonucleases, which degrade RNAs from 
the two extremities, the 5' and 3' ends. This is the main reason why every 
mRNA has to be protected by the 7-methylguanosine cap at the 5’, and by the 
poly(A) tail at the 3' end.  
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The prevalence of exonucleases, rather than endonucleases, in RNA decay 
pathways, seems to have evolved in order to protect cells from an excess of 
free RNA fragments. Since small noncoding RNAs are extensively used to 
regulate gene expression, increased production of random small RNAs in cells 
could cause their inappropriate entry into the RNA processing pathways 
(Bühler et al., 2008; Houseley and Tollervey, 2009).  
 
Since every mRNA is capped and polyadenylated, and the removal of these 
two terminal structures is considered the most rate-limiting step in RNA decay 
(Meyer et al., 2004).  
In general, mRNA degradation is initiated by the shortening of the poly(A) tail 
catalysed by the conserved PAN2/3 and CCR4-NOT (CNOT) complexes. This 
occurs via a ‘biphasic model’ where PAN2/3 start to trim the poly(A) tail, and 
then CNOT completes the deadenylation, with its two catalytic subunits, CCR4 




Figure 1.6. Models for the cytoplasmic mRNA degradation (Bresson and 
Tollervey, 2018).  
A. CAF1 (CNOT7/8 in mammals) and CCR4 (CNOT6/6L in mammals) alternate on 
the poly(A) tail of mRNAs. CCR4 preferentially binds to tails covered by PAB, which 
stimulates its deadenylation activity, whereas CAF1 prefers trimming free poly(A) 
tails. B. In the first phase of deadenylation, PAN2/3 deadenylate long polyA tails (> 
150 nt), rapidly. Then, once tails become shorter than 150 nt, CAF1 and CCR4 
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replace PAN2/3 and catalyse a slower deadenylation. mRNAs with short poly(A) tails 
are degraded from the 5' end by XRN1, after removal of the 5' end cap. In some 
cases, very short tails are targeted for uridylation by the TUT enzymes, which then 
recruit DIS3L2 to complete the degradation, (3'-5' direction).  
 
 
After deadenylation, short poly(A) tails are degraded from the 5' end, by the 
action of the Xrn1 exonuclease, which acts after decapping (Bresson and 
Tollervey, 2018; Wahle and Winkler, 2013).  
More recently, two studies in yeast and human cells have enlarged our 
knowledge about the ‘biphasic model’ and the relationship between the 
cytoplasmic deadenylases and the poly(A) binding proteins, called PAB1 in 
yeast, and PABPC1 in human (Webster et al., 2018; Yi et al., 2018).  
In yeast, PAB1 was shown to physically interact with CNOT and to accelerate 
the deadenylation process. In particular, PAB1 stimulates CCR4 and inhibits 
CAF1. This would cause the alternation of CCR4 and CAF1 on the poly(A) 
tails, with CCR4 binding to tails still covered by the PAB1, and CAF1 binding 
only to free tails (Figure 1.6 A) (Webster et al., 2018). Moreover, by measuring 
the length of the poly(A) tail by TAIL-seq, Yi and colleagues discovered that 
deadenylation occurs as discrete steps, by removing 27 adenine residues in 
each cycle, a length that corresponds to the PABPC1 footprint (Yi et al., 2018).  
Additionally, the first phase of deadenylation, mediated by PAN2/3, occurs 
very rapidly, on tails longer than 150 nt. In contrast, the second phase, 
mediated by CNOT, is slower and occurs on tails shorter than 150 nt (Figure 
1.6 B).  
Importantly, in both yeast and human, PAB1 and PABPC1 activate 
deadenylation. Notably, PABPC1 promotes mRNA decay exclusively through 
CCR4, thereby protecting mRNAs from over-deadenylation. Thus, although on 
one hand PABPC1 coats poly(A) tails and increases translation efficiency of 
mRNAs, on the other hand, it also stimulates mRNA decay (Bresson and 




mRNAs degradation is also regulated by cis-elements, present in the 3' UTR. 
The most characterised and widespread sequences are the AU-rich elements 
(AREs) (Otsuka et al., 2019). These are constituted by the nonamer 
‘UAAAUAUU’  (Worthington et al., 2002) and are recognised by several RBPs, 
which can have both stabilising and destabilising functions. For instance, upon 
binding to ARE-mRNAs, TTPs (Carballo et al., 1998b) and BRF1 (Stoecklin et 
al., 2002) decrease their half-life through the recruitment of other proteins, 
such as CNOT, involved in the RNA decay pathways (Mayya and Duchaine, 
2019). However, when HuR proteins bind to AU-rich sequences, they can elicit 
opposing effect, by impairing mRNAs deadenylation and thus slowing their 
decay (Peng et al., 1998).  
Thus, only a complex combination of multiple factors contributes to the fine 
regulation of ARE-mRNAs. ARE-RBPs can compete with each other by 
binding to closely related ARE sequences. Moreover, ARE-RBPs are post-
translationally modified, and this constitutes an additional layer of regulation. 
Eventually, RNA secondary structures in the proximity of the ARE elements as 
well as other unknown cis-elements in the 3' UTRs, could contribute to the final 
mRNA stability of ARE-mRNAs (Mayya and Duchaine, 2019; Otsuka et al., 
2019). 
 
Apart from the ARE elements, which are an integral part of some mRNAs and 
reflect the original DNA sequence, also other types of elements present in the 
poly(A) tail can affect mRNA stability. These modifications are called ‘RNA 
tailing’ and are the result of non-templated nucleotides addition mediated by 
different enzymes, at the posttranscriptional level (Lee et al., 2014; Norbury, 
2013). In particular, the oligo-uridylation of short poly(A) tails (< 25 nt) 
mediated by the TUT proteins stimulates mRNA decay (Chang et al., 2014; 
Rissland and Norbury, 2009; Lim et al., 2014; Morgan et al., 2017). Moreover, 
mRNAs longer than 25 nt can also be guanylated. Guanosine is added by the 
TENT4A and TENT4B enzymes as single residues, at the very last position of 
 
 22 
the poly(A) tails or penultimate positions. These modifications have been 
shown to protect mRNAs from deadenylation mediated by the CNOT complex 
(Lim et al., 2018). 
 
In summary, cis-elements in the 3' UTR, specific RBPs, and RNA tailing 
explain the complex mechanisms underlying mRNA instability, and the 
variability of mRNAs half-life which, in mammals, ranges from 15 minutes to 
24 hours (Meyer et al., 2004).  
 
1.7 Structure and functions of the CCR4-NOT (CNOT) complex  
 
The CCR4-NOT complex (CNOT) is the most important cytoplasmic 
deadenylase, in all the organisms analysed so far. Although this complex is 
also known to have additional functions in the nucleus related to transcription 
and nuclear surveillance (Inada and Makino, 2014), I will focus on the 
cytoplasmic roles of its subunits and in particular on deadenylation.   
The complex is composed of multiple subunits with different structures and 




Figure 1.7 Components of the CCR4-NOT complex, from (Shirai et al., 2014).  
The CCR4-NOT complex is the major cytoplasmic deadenylase and is composed of 
many subunits. CNOT1 is the largest one and serves as a scaffold for all the 
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remaining components. CNOT7/8 (CAF1 in yeast) and CNOT6/6L (CCR4 in yeast) 
are the only subunits with deadenylase activity, which results in the removal of the 
poly(A) tails from mRNAs. Importantly, CNOT6 and CNOT6L do not directly interact 
with CNOT1, but they are recruited by CNOT7/8 into the CCR4-NOT complex. 
 
 
The NOT1 subunit is the largest one and serves as a scaffold to assemble all 
the other components of the complex. Importantly, the middle region of NOT1 
directly interacts with CNOT7 or CNOT8 (CAF1 in yeast), which are two 
catalytic components. Additionally, the same part of the protein also associates 
with CNOT9. The N-terminal part of CNOT1 interacts with CNOT11 which, in 
turn, recruits CNOT10 into the complex. The C-terminal region interacts with 
CNOT2 and CNOT3 (Bawankar et al., 2013; Shirai et al., 2014). Although 
CNOT1 has no catalytic domain, it is essential for the deadenylase activity of 
the entire complex and for its correct assembly (Ito et al., 2011). Importantly, 
CNOT1 also mediates protein-protein interactions with RBPs, which recruit 
CNOT to specific mRNAs (Shirai et al., 2014). 
 
CNOT2 and CNOT3 are two structural components of the CNOT complex, as 
they do not have any catalytic activity. They share a NOT-box domain in their 
C-terminal region (Zwartjes et al., 2004) and CNOT2 serves as a molecular 
bridge between CNOT1 and CNOT3. Both subunits positively regulate the 
deadenylation activity of the complex and, importantly, Cnot3-/- mice are 
embryonic lethal (Neely et al., 2010; Shirai et al., 2014). 
 
CNOT9 is another structural subunit of the complex, which interacts with 
CNOT1 with the ARM (armadillo) repeat domain. Interestingly, the same 
domain is also able to bind to ssDNA polymers, apart from poly(dA). CNOT9 
is expressed at very low levels in human tissues, apart from testis and in 
mouse it is expressed in various organs, including testis (Chen et al., 2001; 




CNOT4 is an E3 ubiquitin ligase, which is not constitutively present in the 
human CNOT complex and indeed is not essential for its deadenylase 
function. However, in yeast, it is involved in the co-translational degradation of 
aberrant proteins stalled at the ribosomes (Collart and Panasenko, 2012). 
Recently, it has been shown that the C-terminus of CNOT4 contains a 
conserved motif, both in Drosophila and human. This region binds to the 
CNOT9 subunit in order to recruit CNOT4 into the CNOT complex (Keskeny 
et al., 2019).  
 
CCR4 and CAF1/POP2 are the catalytic subunits of the CNOT complex 
(Wahle and Winkler, 2013). In mammals, the yeast CCR4 has two orthologs, 
CNOT6 and CNOT6L. All the CCR4 orthologs share two evolutionary 
conserved domains: the exonuclease/endonuclease/phosphates (EEP) 
domain, located in the C-terminal region, and the leucine-rich repeat (LRR) 
domain in the N-terminus. The EEP domain has deadenylase activity, whereas 
the LRR allows CCR4 to physically interact with CAF1 (Winkler and Balacco, 
2013). The crystal structure of the human CNOT6L showed that this protein 
exclusively binds to poly(A) substrates and that it prefers RNA to DNA (Wang 
et al., 2010). In human cells, CNOT6 and CNOT6L do not co-exist in the same 
CNOT complex, suggesting that they might be redundant (Lau et al., 2009). 
Interestingly, it was recently shown that the genetic deletion of Cnot6l causes 
female infertility, due to accumulation of the maternal mRNAs, in mouse 
oocytes (Sha et al., 2018). 
 
The other catalytic subunit of the CNOT complex is CAF1 (in yeast), which has 
two orthologs in mammals, CNOT7 and CNOT8. These proteins belong to the 
conserved class of DEDD exonucleases, as they share the ribonuclease D 
domain. This domain spans most of the length of the proteins (Collart and 
Panasenko, 2012; Shirai et al., 2014; Winkler and Balacco, 2013). CNOT7 and 
CNOT8 directly bind to CNOT6 and are essential for the recruitment of 
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CNOT6/6L to the CNOT complex. Importantly, Cnot7 null mice display severe 
impairment of their fertility (Berthet et al., 2004; Nakamura et al., 2004). 
 
1.8 The evolutionarily conserved family of RNA-binding proteins NANOS 
 
1.8.1 Nanos genes family  
 
Nanos genes are characterised by a highly conserved sequence which 
encodes two CCHC zinc finger motifs, usually positioned at the C-terminus of 
NANOS proteins (Figure 1.8) (e.g., in Drosophila NANOS is 401 aa long, and 
the zinc fingers (ZFs) are included between 318-372 aa; in mouse, NANOS2 
is 136 aa long, and its ZFs are between 60-114 aa; in human NANOS1 is 292 
aa long, and its ZFs are positioned between 213-267 aa). Another conserved 
region present in most of Nanos genes encodes the NOT1 interacting motif 
(NIM) at NANOS N-terminus. Although the NIM region is shared among all 
vertebrates and some invertebrates, it is not as conserved as the zinc finger 
domain. Thus, the Zinc fingers have been used to draw a nanos phylogenetic 
tree, which showed that nanos genes are present in all animals  (De 
Keuckelaere et al., 2018). These include the ancestral Non-bilaterian animals, 
like Ctenophora, Porifera and Cnidaria as well as Protostomes, with 
Drosophila and C. elegans among others.  
Moreover, nanos genes are also present in Deuterostomes including Fish (e.g. 
Danio rerio), Amphibia (Xenopus tropicalis), Rodents and Primates. The 
number of nanos genes per animal can vary from one to four. Only one gene 
is present in Drosophila, whereas two genes are found in Cnidaria (e.g. Hydra 
vulgaris), and three genes are present in C. elegans and most of the 
vertebrates, including mouse and human. Eventually, four genes can be found 
rarely, as in Fish.  
Interestingly, among vertebrates, NANOS paralogs (like NANOS1, NANOS2, 
and NANOS3) are not as conserved as NANOS orthologs, found in different 
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species. This suggests that the original nanos gene underwent duplication 
events, which generated paralogs with probable distinct functions.  
Moreover, although the zinc finger domain is highly conserved, the sequence 
encoding for it is highly variable in length. For instance, in Drosophila, the only 
nanos gene present encodes a large protein of 401 amino acids (aa). In 
contrast, mouse and human nanos genes produce small proteins, such as 
NANOS2 (136 and 138 aa respectively) or bigger ones like NANOS1 (267 and 




Figure 1.8. Schematic representation of the Nanos proteins, adapted from 
(Hashimoto et al., 2010b).  
A. The figure shows the architecture of zebrafish Nanos protein, which is 
representative of Nanos orthologs. In particular, in their C-terminal region, there are 
two conserved zinc fingers, ZF1 and ZF2. B. The figure shows the amino acid 
sequence alignment of the C-terminal portion of different Nanos proteins. zNanos is 
zebrafish Nanos, mNanos1, -2, -3 are mouse Nanos, dmNanos is Drosophila Nanos. 
Amino acid residues in pink are present in the ZF1, whereas residues in violet are the 
ones in ZF2. 
 
 
1.8.2 Functions of Nanos genes 
 
NANOS proteins share the evolutionary conserved zinc fingers domain as well 
as similar functions in germ cell development. 
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In particular, this role is conserved in Protostomes, like Drosophila (Kobayashi 
et al., 1996; Lehmann and Nusslein-Volhard, 1991), and C. elegans 
(Subramaniam and Seydoux, 1999), and, among Vertebrates, in Xenopus 
(MacArthur et al., 1999), zebrafish (Köprunner et al., 2001), and mouse (Tsuda 
et al., 2003).  
In Drosophila, nanos was shown to be essential for the migration of pole cells 
towards the gonads, and the formation of functional germ cells. Upon nanos 
loss, pole cells activate prematurely the germline expression program, that 
usually is switched on only after gonad colonisation (Forbes and Lehmann; 
Kobayashi et al., 1996).  
Notably, Nanos and Pumilio are involved in the mitotic quiescence of pole 
cells, by binding to a nanos response element (NRE) (Wharton and Struhl, 
1991) in the 3' UTR of cyclin B mRNA (Asaoka-Taguchi et al., 1999; Dalby and 
Glover, 1993). First, Pumilio recruits Nanos to the NRE, and then Nanos 
recruits the entire CCR4-NOT complex to cyclin B. This is achieved through a 
direct interaction between Nanos and the NOT4 subunit, which eventually 
stimulates the translational repression of cyclin B (Kadyrova et al., 2007).  
Nanos regulates pole cells also by suppressing apoptosis (Hayashi et al., 
2004). Similar to the repression of cyclin B in the migrating germ cells, Nanos 
also inhibits the pro-apoptotic hid mRNA at the translational level (Sato et al., 
2007).  
 
Additionally, Nanos was shown to be involved in germline self-renewal. In 
nanos mutants, there is a loss of germline stem cells (GSCs), which leads to 
empty ovaries (Wang and Lin, 2004). In particular, in the absence of the 
Nanos-Pumilio complexes, GSCs do not self-renew because there is a de-
repression of the germline differentiation program (Gilboa and Lehmann, 2004; 
Wang and Lin, 2004). This process is thought to occur by controlling mei-P26 
mRNA. Again,  the Nanos-Pumilio-CCR4-NOT complex promotes the 
translational repression of this mRNA, thus preserving germline self-renewal 




Also in C.elegans, nos-1 and nos-2 genes have been implicated in primordial 
germ cells (PGCs) development  (Subramaniam and Seydoux, 1999). In 
particular, loss of nos-1 and nos-2 prevents germ cell proliferation during larval 
development. Similar to Drosophila nanos, nos-2 is essential for PGCs 
colonisation of gonads, and nos-1 is required for the viability of germ cells.  
 
In Xenopus, one of the nanos genes, called Xcat2, was also shown to be 
involved in PGCs development. Indeed, Xcat2 produces a protein which 
accumulates in the germplasm during PGCs formation (MacArthur et al., 
1999). Interestingly, also in Xenopus, Xcat2 is thought to promote the mitotic 
quiescence of germ cells, as in Drosophila. Xcat2 (also called Nanos1) 
associates with the cyclin B mRNA in vivo and is thought to promote its 
translational repression in Xenopus germline (Lai et al., 2011).  
 
In zebrafish, nanos1 has also been shown to localise in the germplasm, and 
to be critical for the migration and viability of PGCs (Köprunner et al., 2001). 
Moreover, nanos2 specifically labels germline stem cells (GSCs) in medaka 
fish ovaries (Nakamura et al., 2010), and is involved in ovary regeneration in 
zebrafish (Cao et al., 2019). 
 
Therefore, Nanos genes have conserved functions during germ cell 
development, and interestingly, they often act as translational repressors of 
mRNAs, in order to promote mitotic quiescence (e.g., cyclin B) or suppression 
of apoptosis (e.g., hid).  
 
Another critical function of nanos is the formation of embryonic polarity in 
Drosophila (Irish et al., 1989) (Figure 1.9). Although this role is not conserved 
in other organisms, it represents an established example of PTGR mediated 




Notably, nanos mRNA is a maternal factor deposited during oogenesis in the 
posterior part of the egg. Different RBPs, among which Rump and Aub, bind 
to specific sequences present in nanos 3' UTR (Bergsten and Gavis, 1999; 
Gavis and Lehmann, 1992, 1994), and allow nanos transcript localisation in 
the posterior pole of the egg (Becalska et al., 2011; Jain and Gavis, 2008). 
After fertilisation, nanos mRNA is translated and becomes expressed as a 
gradient, which increases from the anterior to the posterior pole. Then, Nanos, 
together with other two RBPs, Pumilio and Brat, recognise NREs in the 3' UTR 
of hunchback mRNA and repress it exclusively in the posterior pole (Hülskamp 
et al., 1989; Wharton and Struhl, 1991). In particular, Pumilio and Brat are the 
first to bind to the NREs of hunchback, and subsequently, Nanos joins the 
complex (Loedige et al., 2014; Sonoda and Wharton, 1999). Then, Nanos 
recruits CCR4-NOT, which promotes the deadenylation of hunchback mRNA 
(Wreden et al., 1997). Additionally, Brat recruits d4EHP to the 5’ cap of 
hunchback, and prevents the binding of eIF4E, thus inhibiting its translation 
(Cho et al., 2006).  
In summary, an intricate network of RBPs and mRNAs, are responsible for the 






Figure 1.9. Example of PTGR mediated by Nanos in Drosophila embryos, 
adapted from (De Keuckelaere et al., 2018).  
In the posterior pole of Drosophila embryos, Nanos binds to the RBP Pumilio and 
recognise hunchback mRNA, through the nanos response elements (NRE) present 
in the 3' UTR. Nanos and Pumilio, together with the RBP Brat, mediate the 




1.8.3 The structure of NANOS proteins and its functional implications 
As previously described, Nanos proteins have two conserved zinc fingers, 
(CCHC)2, within their C-terminal region. The first physical and chemical 
characterisations of this domain were performed by NMR and absorption 
spectroscopy, which determined that each CCHC motif in Drosophila Nanos 
bound to one zinc ion (Curtis et al., 1997). In particular, these data showed 
that Nanos is composed by two consecutive zinc finger motifs, C-X2-C-X12-H-
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X10-C and C-X2-C-X7-H-X4-C, linked by a spacer, whose length (7 amino acids) 
is also highly conserved among Nanos orthologs. Moreover, the spacing 
between the zinc ligands in each motif seemed different from any other known 
zinc finger. Thus, Nanos domain seems to be a novel one, even distinct from 
the most similar retroviral CCHC domain. 
Importantly, Curtis and colleagues also proved for the first time that the two 
zinc fingers were essential for Nanos function in vivo (Curtis et al., 1997). In 
particular, they showed that the cysteine residues (C) inside the zinc fingers 
were critical to rescue defects in nanos mutant embryos.  
Moreover, they showed that Nanos was able to bind to RNA with high affinity 
in vitro, and this ability was dependent on the zinc fingers. However, the RNA-
binding ability was not sequence-specific. Indeed, filter binding assays showed 
that mutations in the NRE sequence of hunchback mRNA did not significantly 
decrease Nanos binding.  
Next, by performing a genetic screening aimed at identifying new nanos 
mutants, other authors showed that the zinc fingers were indeed necessary to 
support all nanos functions (Arrizabalaga and Lehmann, 1999). Moreover, in 
the same study, they discovered that another region, present after the zinc 
fingers (tail region) was also critical for at least two functions in Drosophila: 
migration of germ cells and embryonic polarity.  
As previously mentioned, Nanos has a particular spacing between the cysteine 
(C) and histidine (H) residues inside each zinc finger. This feature makes 
Nanos zinc finger domain unique and led Hashimoto and colleagues to solve 
the crystal structure of the C-terminal region of zebrafish Nanos (Hashimoto et 
al., 2010a) (Figure 1.10). This revealed that Nanos zinc finger domain is 
composed of two independent lobes (motifs), which form a large cleft, and 
which are linked by a helix (constituted by the 7 amino acids spacer). In each 
lobe, three C and one H residues bind to one zinc ion, by tetrahedral 
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coordination. Importantly, this structure did not overlap with any other 
homologous domains, confirming that Nanos domain adopts a new structure 
(Hashimoto et al., 2010a). However, more recently, other structural studies 
revealed that the second zinc finger motif present in dNanos is homologous to 
the zinc knuckle structure of the HIV nucleocapsid protein (Weidmann et al., 
2016) (Figure 1.10 E). Thus, Nanos zinc fingers might not be as unique as 





Figure 1.10. Structure of the zebrafish Nanos zinc-fingers and Zn knuckle (ZK) 
structure of the HIV nucleocapsid protein, adapted from (Hashimoto et al., 2010; 
Weidmann et al., 2016).  
A. Ribbon diagrams of the zinc-fingers (ZFs) present in zebrafish Nanos (zNanos). 
Four molecules of zNanos are shown; zinc ions are grey and white spheres. B. Core 







spheres) are depicted by stick representation. C. The interaction between key amino 
acid residues (CCHC) of the ZF and the zinc ion is shown as white dots. Bond lengths 
are expressed in Ångström (Å). On the left it is shown ZF1, on the right ZF2. C is 
Cysteine, H is Histidine. D. Ribbon diagrams of the two ZFs. N and C are N- and C-
terminal respectively. E. On the left, the Zn knuckle (ZK) structure of the HIV 
nucleocapsid protein (HIVnc) is shown. On the right, superimposition of the Nanos 
ZF2 and the HIVnc ZK. 
 
Interestingly, several conserved amino acid residues in zebrafish Nanos 
crystal were found to be part of a large basic area, present on the surface of 
the two lobes (Hashimoto et al., 2010a). By mutating two aromatic residues 
included in this surface, Nanos zinc finger domain was shown to lose its RNA 
binding ability substantially, by EMSA. Moreover, the same mutations were 
previously found to cause strong nanos phenotype in Drosophila, suggesting 
an important link between nanos function and its RNA-binding ability.  
Overall, these results also indicated, for the first time, that Nanos-RNA 
interaction was also mediated by electrostatic interactions between conserved 
basic amino acids and the phosphate blackbone of RNA.  
Moreover, these authors confirmed by EMSA that Nanos zinc finger domain 
binds to RNA independently of the NRE sequences, as previously shown in 
1997 by Curtis and colleagues. Thus, Drosophila Nanos binds to RNA with no 
sequence specificity.  
As previously explained, Nanos binds to RNA together with Pumilio in 
Drosophila. To gain insight into the molecular basis of Nanos-Pumilio 
interaction with RNA, a new crystal structure was determined for the complex 
dNanos-Pumilio-RNA (Weidmann et al., 2016). In this crystal, dNanos zinc 
fingers were shown to enclose RNA, and both the zinc fingers and the C-
terminal region of dNanos enveloped Pumilio.  
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Moreover, the addition of dNanos to the Pumilio-RNA complexes, induced 
conformational changes into Pumilio C-terminus, which resulted in the 
establishment of new interactions between Pumilio and RNA. In particular, in 
the presence of dNanos, Pumilio does not recognise a perfect Pumilio 
Response Element (PRE) anymore, but also contacts few nucleotides 
upstream. This was also confirmed by in vitro selection assays, which showed 
that dNanos could change the RNA motif bound by Pumilio, by enriching for 
A/U nucleotides, upstream of the PRE (Figure 1.11) (Weidmann et al., 2016).  
 
 
Figure 1.11. RNA-binding motifs of Pumilio (Pum) and Nanos-Pumilio (Nos-
Pum) in Drosophila, adapted from (Weidmann et al., 2016).  
The figure shows results from SEQRS (in vitro selection, high-throughput sequencing 
of RNA, and sequence specificity landscapes) analysis performed with Pumilio (top) 
and Nanos-Pumilio (bottom). When Nanos protein is added to Pumilio, A/U-rich 
sequences are enriched upstream of the Pumilio response element. 
Weidmann and colleagues also showed for the first time that dNanos mediates 
sequence-specific interactions with RNA, at the atomic level. In particular, this 
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interaction occurs between three amino acids present in a hydrophobic binding 
pocket in dNanos and the third nucleotide of the ‘AAU’ Nanos binding site 
(NBS) (which is upstream of the PRE). Importantly, the same three amino 
acids are also essential to repress a luciferase reporter containing the NRE 
sequence (Weidmann et al., 2016), thus highlighting the link between Nanos 
repressive function and its RNA-binding ability. 
Additionally, when dNanos RNA-binding ability was assessed by EMSA, 
dNanos could shift RNA only when in complex with Pumilio, but not alone 
(Weidmann et al., 2016). This result suggested that dNanos does not bind to 
RNA independently, but only together with other RBPs.  
Besides the zinc finger, Nanos proteins also have another conserved region, 
which is used to interact with the CCR4-NOT (CNOT) complex, in order to 
recruit it to various RNAs (Suzuki et al., 2012; Wreden et al., 1997). In 
vertebrates, Nanos proteins interact with CNOT through the Nanos Interacting 
Motif, NIM, which is only 17 aa long, and is located within a disordered region 
of Nanos N-terminus (Bhandari et al., 2014). The NIM directly interacts with 
the C-terminal SHD domain in CNOT1. Importantly, when key aromatic 
residues are mutated inside the NIM, Nanos cannot repress RNA anymore in 
vitro.  
In contrast, invertebrates do not have a NIM sequence. For instance, 
Drosophila Nanos has the Nanos effector domain (NED), which is responsible 
for the interaction with CNOT (Raisch et al., 2016). The NED is significantly 
longer than the NIM (187 aa) and seems to contact the C-terminal region of 
CNOT1-3 multiple times. Importantly, also in Drosophila, this domain was 
shown to be essential for Nanos repressive activity on RNA.  
In summary, these structural studies illustrated the molecular basis of the 
interaction between Nanos and RNA, and also between Nanos and its protein 
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partners. Moreover, they clarified the molecular basis of various Nanos 
phenotypes.  
 
1.8.4 Nanos2 in male gonocytes 
 
The first Nanos gene identified and studied in mouse was called Nanos1. 
Similar to its orthologs, Nanos1 was shown to be present in mouse oocytes 
and to be maternally supplied (Haraguchi et al., 2003). However, in contrast 
with the restricted expression pattern of other Nanos orthologs, Nanos1 is 
evenly localised in the cytoplasm of mouse oocytes and, after fertilisation, the 
maternal copy is rapidly replaced with the zygotic one. Moreover, Nanos1 is 
not expressed in PGCs, but in adult mice, it is present during oocyte maturation 
and in spermatids. However, Nanos1-/- mice are completely fertile, indicating 
that, in contrast with its orthologs, Nanos1 is dispensable for germ cell 
development. Interestingly, Nanos1 expression was also detected in the 
central nervous system, although its loss does not cause morphological or 
behavioral defects (Haraguchi et al., 2003).  
Next, other two Nanos paralogs were identified in mouse and called Nanos2 
and Nanos3. These are two zygotic genes which were found to be essential 
for germ cell development (Tsuda et al., 2003). Thus, although PGCs 
specification significantly differs among different organisms (with Drosophila, 
Xenopus, and zebrafish relying on maternal determinants, whereas the mouse 
does not), Nanos family has a conserved evolutionary function in germ cells.  
Both Nanos2 and Nanos3 are present in mouse gonocytes, although they have 
different expression profiles and thus distinct phenotypes (Tsuda et al., 2003). 
Nanos2 mRNA is restricted to male gonocytes, from E13.5 to E.16.5 (see 
Figure 1.1 A), and the genetic deletion of both copies of Nanos2 causes 
exclusively male infertility.  
In contrast, Nanos3 mRNA is expressed earlier than Nanos2 in PGCs, from 
E9.5, when PGCs have not undergone sex determination (Figure 1.1 A). Also, 
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Nanos3 is detected until E14.5 in male gonocytes, but only until E13.5 in 
females, and the genetic deletion of Nanos3 causes both male and female 
infertility.  
The phenotype of Nanos2-/- mice is already detectable at E15.5, as some germ 
cells are mislocalised outside of the tubules at this stage. Additionally, at 
E18.5, the number of germ cells is significantly reduced in Nanos2-/- testes, 
and these become devoid of germ cells in 4-weeks old mice. Indeed, these 
mice showed a decrease in testicular weight by a factor of 70%. Importantly, 
from E15.5 onwards Nanos2-/- germ cells were found to be apoptotic, 
suggesting that Nanos2 in mouse has a conserved function in the suppression 
of apoptosis, like in Drosophila. 
In contrast, in Nanos3-/- mice, both ovaries and testis do not contain germ cells 
already at E15.5. This is due to a defect in PGCs maintenance during their 
migration towards the gonads, rather than to a defect in PGC specification 
(Tsuda et al., 2003).  
 
Although the loss of Nanos2 or Nanos3 causes different phenotypes, it was 
also shown that NANOS2 and NANOS3 proteins cross-talk with each other, 
and they also have partially redundant functions (Suzuki et al., 2007). Indeed, 
NANOS2 and NANOS3 expression overlap in a narrow window of time. 
NANOS3 protein is mainly expressed between E12.5-E13.5, but greatly 
decreases from E14.5 and is almost non-detectable in E15.5. However, 
NANOS2 is expressed from E13.5, and its level remains constant until E17.5. 
Thus, NANOS2 overlaps with NANOS3 between E13.5 and E14.5. 
Interestingly, in Nanos2-/- germ cells, NANOS3 expression is upregulated from 
E13.5, both at the protein and mRNA level. This suggests a feedback 
mechanism, where, in the absence of NANOS2, some putative positive 
regulators of NANOS3 would be expressed at higher levels, thus enabling 
NANOS3 expression (Suzuki et al., 2007).  
Interestingly, another type of feedback mechanism was also observed for 
NANOS2 itself, which seems to control its own expression level. Indeed, in 
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Nanos2-overexpressing mice, NANOS2 endogenous level decreases, 
probably due to a regulation occurring at the post-transcriptional level, through 
Nanos2 3' UTR (Suzuki et al., 2007).  
The redundancy of Nanos2 and Nanos3 genes was investigated by performing 
rescue experiments in mouse (Suzuki et al., 2007). Importantly, Nanos2 was 
shown to rescue defects in Nanos3-/- mice, although Nanos3 could not 
substitute for Nanos2 (Suzuki et al., 2007). 
Indeed, following Nanos3 expression in Nanos2-/- mice, the embryonic gonads 
still display mislocalised germ cells and many apoptotic cells. Moreover, 4-
weeks old mice have no germ cells left in testes. Overall, these findings 
highlighted that Nanos2 also has additional and specific functions independent 
of Nanos3, throughout male germ cell development. 
 
The precise functions of Nanos2 were further investigated also by other 
groups. For instance, it was shown that Nanos2 is required to maintain the 
mitotic quiescence of male germ cells (Suzuki and Saga, 2008), although it is 
not essential for quiescence initiation (Saba et al., 2014). Indeed, male germ 
cells typically enter G0/G1 quiescence at E14.5, but, in Nanos2-/- mice, male 
gonocytes abnormally resume proliferation from E15.5.  
Moreover, NANOS2 was shown to have other two functions. First of all, 
Nanos2  is essential to prevent male gonocytes from entering meiosis (Suzuki 
and Saga, 2008). It was shown that Nanos2-/- germ cells up-regulate Stra8 
from E14.5, which might be the cause of premature meiosis induction.  
Moreover, Nanos2 is also required to induce the male gene expression 
program in male germ cells, which otherwise retain an undifferentiated gene 
expression profile, similar to PGCs (Saba et al., 2014). Importantly, this 
function was shown to be independent of meiosis suppression. 
 
Furthermore, scientists sought to investigate the molecular mechanism 
underlying Nanos2 functions. Notably, it was proposed that NANOS2 
suppresses meiosis through the post-transcriptional repression of few 
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transcripts (Suzuki et al., 2010). This is thought to be mediated by direct 
recruitment of CNOT to NANOS2 mRNAs targets, which subsequently would 
cause RNA degradation. This model is supported by experimental data, 
showing that NANOS2 physically interacts with CNOT1 in male gonads and 
colocalises with the CNOT complex in processing bodies (PBs) (Suzuki et al., 
2010). Additionally, native RIP experiments revealed that NANOS2 interacts 
with some mRNAs involved in meiosis, such as Sycp3, Stra8, Taf7l, Dazl, and 
Meisetz, which are also up-regulated in Nanos2-/- gonads. Importantly, the 
direct interaction between the first ten amino acids of NANOS2 with the C-
terminal of NOT1 is essential for NANOS2 function in male gonocytes (Suzuki 
et al., 2012a).  
 
Moreover, NANOS2 was suggested to inhibit the meiotic entry of male germ 
cells by antagonising DAZL expression in male gonocytes (Kato et al., 2016). 
Notably, NANOS2 was shown to bind to Dazl 3' UTR and to stimulate its 
repression.  
 
Furthermore, similarly to Drosophila NANOS, which works together with the 
RBP PUMILIO, NANOS2 was shown to cooperate with DND1, another RBP, 
in mouse gonocytes (Suzuki et al., 2016). In particular, NANOS2 interacts 
directly with DND1 in male gonocytes, through its zinc finger domain, which 
surprisingly, was shown to mediate protein-protein interactions and not only 
RNA-binding. Thus, in the male gonad, NANOS2 is thought to achieve targets’ 
selection, by binding to only a subset of mRNAs, such as Sycp3, Dazl, and 
Nanog, in presence of DND1. This interaction would then trigger their 
degradation through the action of the CNOT complex (Suzuki et al., 2016). 
 
1.8.5 Nanos2 in adult SSCs 
 
As previously explained, Nanos2 is essential for male germ cells development 
in the embryonic gonad (Tsuda et al., 2003). However, Nanos2 has also a 
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separate function in the maintenance of adult SSCs (Sada et al., 2009). 
NANOS2 was shown to be expressed in the undifferentiated spermatogonia 
compartment, mainly in the As and Apr cells, marked by the self-renewing 
marker GFRα1 (Sada et al., 2009; Suzuki et al., 2009). Importantly, conditional 
deletion of the Nanos2 gene in post-natal SSCs revealed that germ cells were 
gradually lost in the adult testis (Figure 1.12). Notably, 8-weeks-old mice 
displayed a great reduction of germ cells in the testes, and 12-weeks-old mice 







Figure 1.12. Histological analysis of post-natal mouse testes lacking Nanos2, 
adapted from (Sada et al., 2009).  
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6-, 8- and 12-weeks-old testes of Control and Nanos2 cKO (conditional knockout) 
mice were analysed by immunostaining of testicular cross-sections with Hematoxylin 
and Eosin. In 8-weeks-old-Nanos2 cKO testes (E.) many tubules do not have 
spermatogonia (arrowheads), and some of them have only elongated spermatids 
(arrow). By 12 weeks (G.), tubules lack all germ cells (asterisks). 
 
 
 In particular, following Nanos2 deletion, GFRα1 SSCs were depleted, 
indicating that the SSCs pool was the main one affected among the 
spermatogonia populations and that it caused germ cell loss over time.  
Additionally, lineage-tracing experiments revealed that Nanos2-expressing 
cells can give rise to long-term patches containing all the spermatogenic 
lineages (Sada et al., 2009). Importantly, the number of these patches are ten 
times higher than those formed by Ngn3-expressing cells, which are a transit-
amplifying population (Nakagawa et al., 2007, 2010; Yoshida et al., 2007). 
Thus, Nanos2-expressing cells are able to self-renew in the long term as well 
as to differentiate, in order to produce all the different stages of 
spermatogenesis. Thus, Nanos2-expressing cells might be more enriched for 
the actual stem cell population, (as GFRα1). Moreover, when Nanos2 is 
overexpressed in mouse, undifferentiated spermatogonia greatly increase in 
number, at the expense of the differentiating pool. This accumulation is due to 
a block in SSCs differentiation and not to increased proliferation rates of SSCs.  
 
Despite this extensive characterization of Nanos2 function in adult testes, the 
mechanism through which NANOS2 maintains SSCs has not been widely 
studied. However, some insight comes from Zhou and colleagues (Zhou et al., 
2015). NANOS2 was shown to localise to PBs in male gonocytes (Suzuki et 
al., 2010) and similarly, it also co-localises with Rck, a marker for PBs and 
stress granules, in post-natal SSCs in vivo (Zhou et al., 2015). Additionally, by 
promoting mRNPs assembly in SSC lines, NANOS2 is thought to indirectly 
repress various differentiation genes, such as Sohlh1, -2, Ngn3, and c-Kit, 
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which would be trapped and stored in these granules, thus allowing SSCs self-
renewal.  
It was also proposed that NANOS2 directly represses other mRNAs involved 
in SSCs differentiation, such as Sohlh2, Dazl, and Dmrt1, also by stimulating 
their degradation (Zhou et al., 2015). Although his mechanism was never fully 
demonstrated, other data previously showed that NANOS2 has deadenylase 
activity in vitro, when it is co-immunoprecipitated with CNOT, from NANOS2-
overexpressing adult testis (Suzuki et al., 2010).  
Moreover, NANOS2 was shown to sequester mTOR (Zhou et al., 2015), the 
catalytic subunit of the mTORC1 complex, in mRNPs in SSC lines. mTORC1 
is known to be activated by retinoic acid (Lal et al., 2005) and to promote SSCs 
differentiation (Hobbs et al., 2010). Thus, the authors suggested that NANOS2 
represses SSCs differentiation also by relegating mTOR to mRNPs. Moreover, 
mTORC1 signaling stimulates cell growth and protein translation (Laplante 
and Sabatini, 2012). Since NANOS2 targets are thought to be repressed post-
transcriptionally, NANOS2 would ensure the translational repression of 
differentiation genes, also by repressing the mTORC1 pathway (Zhou et al., 
2015). 
 
Furthermore, it was recently shown that the transition from self-renewing to 
differentiating SSCs is controlled by modulating NANOS2 expression at the 
protein level (Zhou et al., 2017). Upon exposure to differentiating signals, such 
as retinoic acid, SSCs induce NDFIP2 expression, an activator of the E3 
ubiquitin ligase, NEDD4. NDFIP2 stimulates the NEDD4-dependent 
ubiquitylation of NANOS2, which results in NANOS2 degradation and allows 
SSCs differentiation. Interestingly, NEDD4 was also shown to protect SSCs 
under heat-stress conditions, by controlling mRNPs clearance and an 
excessive accumulation of misfolded proteins and stress granules in SSCs. 
Therefore, a single protein, NEDD4, can promote SSCs differentiation by 
removing NANOS2 under homeostatic conditions, and at the same time 




1.9 Methods to detect RNA-protein interactions 
 
In the past decade, hundreds of new RBPs have been identified by genome-
wide approaches in yeast, mouse, and human cell lines (Baltz et al., 2012; 
Beckmann and Granneman, 2019; Beckmann et al., 2015; Castello et al., 
2012; He et al., 2016; Shchepachev et al., 2019; Urdaneta et al., 2019). These 
studies revealed that many of the new RBPs were well-studied metabolic 
enzymes (Beckmann et al., 2015), or chromatin-associated factors (He et al., 
2016). Overall, this suggests that the biological importance of RBPs might 
have been underestimated for a long time. Therefore, a detailed 
characterisation of both known and newly identified RBPs might reveal 
unprecedented connections among different and unrelated biological 
processes.  
The first step towards the understanding of RBPs’ function necessarily 
implicates the investigation of their RNA-protein interactions. Thus, 
approximately thirty biochemical methods have been developed during the 
past twenty years to detect RBP-RNA interactions, and these are reviewed in 
(Lee and Ule, 2018). Additionally, to gather the knowledge accumulated on 
RBPs-RNA interactions, thanks to the application of these techniques, a new 
database was created, and this was called ‘ATtRACT’ (Giudice et al., 2016).  
One of the first attempts to characterise RNA-protein interactions was aimed 
at identifying the RNAs bound to the spliceosomal proteins, from patients’ 
samples with the lupus erythematosus disease (Lerner and Steitz, 1979). To 
this end, the protein of interest was pulled down with antibodies, and the bound 
RNAs were characterised. The particular abundance of the splicing protein 
studied allowed the identification of its targets with such a non-sensitive 
method. This type of approach, known as RIP (RNA and Immunoprecipitation), 
is performed under native conditions, which means that RNA-protein 
complexes are not stabilised by any strong covalent bond, before the cell lysis. 
However, there are major concerns regarding the specificity of the RNAs 
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retrieved in this way. Indeed, non-physiological interactions can also occur 
during and after the lysis, when all the different cellular compartments are 
mixed, and RBPs can potentially re-assemble in new complexes, with non-
physiological targets (Mili and Steitz, 2004). Thus, other methods have been 
developed to stabilise RBPs-RNA complexes before the cell lysis, by taking 
advantage of the cross-linking (Niranjanakumari et al., 2002). However, the 
use of formaldehyde to induce the cross-linking might also lead to false-
positive RNA-protein interactions. Indeed, formaldehyde not only cross-links 
nucleic acids to proteins, but it also induces covalent bonds between different 
proteins. This results in the purification of RNA potentially associated with 
multiple RBPs, leading to possible misleading conclusions regarding the 
interaction between a single RBP and its targets. 
In order to study direct protein-RNA interactions, scientists developed the UV 
cross-linking and immunoprecipitation, CLIP, where they employed the UV-C 
light as a cross-linking agent (Ule et al., 2003, 2005; Urlaub et al., 2000). The 
advantage of the UV-C light (254 nm) is that it mainly cross-links RNA to 
proteins and that it only cross-links amino acids and nucleotides which are at 
‘zero-distance’ (order of Ångströms apart) (Greenberg, 1979). Importantly, this 
greatly increases the sensitivity of the method, as also transient, but 
physiological, RNA-protein interactions are captured, and not only the most 
abundant RNA species are precipitated. Additionally, the presence of 
irreversible covalent bonds between RNA and proteins enables their 
purification under semi-denaturing conditions. This significantly decreases the 
RNA background and the possibility of co-purifying other RBPs, thus 
increasing the specificity of the technique.  
After immunopurifiying the RBP of interest, RT-qPCR was initially employed to 
determine the identity of the RNAs cross-linked to the protein. However, this 
impaired the characterisation of RNA occupancy at the transcriptomic level. 
Thus, scientists started to couple RIPs with microarrays and then with 
sequencing, (RIP-Chip and RIP-seq) (Keene et al., 2006; Tenenbaum et al., 
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2000; Zhao et al., 2010), whereas CLIP was coupled directly to high-
throughput sequencing, (HITS-CLIP) (Licatalosi et al., 2008). 
Although CLIP greatly improved the characterisation of RBP-RNA interactions, 
it also has some drawbacks. For instance, RNA-proteins complexes can be 
purified only under semi-denaturing conditions and it relies on the existence of 
specific antibodies towards the protein of interest. Even when these are 
available, they can still lead to the isolation of many false-positive RNAs. In 
order to limit these problems, an alternative approach was developed, the UV-
Cross-linking and Analysis of cDNA (CRAC) (Granneman et al., 2009a). Here, 
the RBP of interest is modified in order to be fused to a complex tag, which 
includes at least three parts: an epitope tag, a cleavage site, and a 6xHis 
sequence. First, the epitope tag is used for the immunopurification of the 
protein with an antibody. Next, a cleavage site allows the enzymatic removal 
of the previous tag and the bound antibody, after immunoprecipitation. Then, 
a 6xHis affinity tag allows stringent purification of the RNA-protein complexes 
on Nickel columns, under denaturing conditions. Overall, this method greatly 
reduces the number of false-positive RNA-protein interactions. However, the 
addition of such a tag can potentially affect the biology of the RBP. Thus, 
appropriate analyses need to be done before performing CRAC, to ensure that 





Figure 1.13. Schematic representation of the CRAC protocol, adapted from 
(Granneman et al., 2009a).  
A. Recombinant proteins are used for CRAC. The tag is fused to the N- or C-terminal 
of the protein of interest and includes an epitope for immunopurification, a PreScission 
site for protease cleavage and a 6xHis tag for affinity purification on nickel beads. 
Proteins are permanently cross-linked to RNA by 254 nm UV-light and cells are lysed. 
RNA-protein complexes are immunopurified by using an antibody against the tagged-
protein. The antibody is removed through protease cleavage (TEV), which cleaves 
the PreScission-tagged protein. RNA-protein complexes are then purified through 
nickel affinity purification thanks to the 6xHis tag present in the recombinant protein. 
Denaturing washes are applied to reduce the RNA background. After chemical 
modification of the cross-linked RNA (see B.), proteins are digested by Proteinase K 





from nickel columns, a fraction of the eluate can also be used for protein precipitation 
and analysis by western-blot (WB). B. After protease cleavage, cross-linked RNA is 
partially digested by RNase A and T1. Denaturing washes are applied, while RNA-
protein complexes are still immobilised on nickel beads. RNAs is treated with 
phosphates, to remove the phosphates left by RNase. A 3' adapter (shown in light 
blue) is ligated to RNA, which is also radio-labelled with 32P-γ-ATP. C. A 5' adapter 
(in green) is ligated to RNA and RNA-protein complexes are eluted from beads by 
using imidazole. After resolving RNA-protein complexes by using SDS-PAGE, they 
are transferred to a membrane, which is analysed by autoradiography. Areas 
corresponding to the mass of the radio-labelled protein are excised from the 
membrane and subjected to Proteinase K treatment. RNA is extracted and reverse 
transcribed. Readthrough cDNAs with deletions (asterisks), which correspond to 
cross-linking sites, are amplified by PCR and libraries are sequenced. 
 
 
In Figure 1.13, detailed steps of the CRAC protocol are shown. Proteins are 
permanently cross-linked to RNA by using UV-C light on live cells. After cell 
lysis, RNA-protein complexes are immunoprecipitated (IP) with an antibody 
against a tag (Figure 1.13 A). To further purify the cross-linked RNA-protein 
complexes, the tag used for the IP is enzymatically removed by using a 
protease (TEV or 3C). This enzyme specifically cleaves between glutamine 
and glycine residues present in the PreScission sequence of the PreScission-
tagged RBP. By removing the IP tag, also the bound antibody is displaced, 
which is important in order to reduce non-specific protein and RNA 
contaminants which might associate with IgG.  
Afterwards, the cross-linked RNAs are partially digested with RNase A and T1. 
RNA digestion decreases the chances of co-purifying additional RBPs, which 
might reside on the same RNA molecule, and also provides RNA with a size 
compatible for sequencing.  
To allow very stringent purification of the RNA-protein complexes, 6xHis-
tagged RBPs are immobilised on nickel beads, thanks to the strong affinity 
between nickel and His residues. Non-specifically bound RNAs are not cross-
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linked to the RBPs and thus are washed away from the immobilised RBP by 
applying denaturing buffers. This is a critical step which greatly decreases the 
RNA background. 
While being on nickel beads, RNase-digested RNAs are chemically modified 
to allow incorporation of the 3' adapter, radiolabelling, and ligation of the 5' 
adapter. First, RNAs are 3' dephosphorylated to remove the phosphate group 
previously left by RNase. Then, RNAs are ligated to the 3' adenylated adapter, 
which is complementary to the reverse transcription primer used later on. 
Afterwards, RNAs are radio-labelled with 32P-γ-ATP and a 5' adapter is ligated 
to the RNAs. The 5' adapter includes an experimental barcode which has a 
variable sequence length (2-6 bases) and composition. Since each sample is 
labelled with a different experimental barcode, different libraries can be pooled 
and sequenced together. The 5' adapter contains also a 3-bases UMI (unique 
molecular identifiers), to allow identification of PCR duplicates by bioinformatic 
analysis, at a later stage. A schematic representation of the adapters and 
primers used in CRAC is shown in Figure 1.14. 
After modifying the RNAs, RNA-protein complexes are eluted from nickel 
beads by using imidazole, which competes with the imidazole ring of His (in 
the 6xHis-tagged protein) for the binding to nickel beads. 
Eluted RNA-protein complexes are resolved on a gel through SDS-PAGE 
separation. and transferred on a membrane. During this step free and non-
specific RNAs are further removed, since they cannot migrate on the 
membrane. Visualisation of the radiolabelled-RBP is crucial to verify whether 
the RNA fragmentation was successful, and also the correct size of the purified 
protein-RNA complexes, which should migrate above the free protein. This 
step is critical also to exclude the presence of other bands at different sizes, 
which would correspond to other RBPs.  
Then, RNA-protein complexes are excised from the membrane, and proteins 
are digested by Proteinase K to isolate RNA and perform reverse transcription 
(RT). Importantly, the amino acid residue that was originally cross-linked to the 
interacting RNA by UV light cannot be digested due to the covalent bond with 
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a ribonucleotide. Therefore, this residue remains attached to RNA and 
obstructs the transition of the enzyme during RT. If the enzyme overcomes the 
cross-linked residue on the RNA fragment, it generates a readthrough cDNA 
which often has mutations at these cross-linking sites.  
After reverse transcription, a library is generated from the cDNA by PCR 
amplification and purified libraries are eventually sequenced. 
 
Sequencing reads containing mutations can be used to map the original 
protein binding site on RNA. Importantly, substitutions and deletions seem to 
be the direct consequence of the reverse transcriptase acting at the cross-
linking site, rather than sequencing or alignment errors (Granneman et al., 
2009a). Moreover, the identification of the binding site in readthrough cDNAs 








Figure 1.14. Schematic representation of the adapters and primers used to 
generate CRAC libraries.  
CRAC libraries are ~ 130-190 bases in size. The RNA insert included between the 
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treatment. 5' and 3' adapters are ligated before reverse transcription. The 5' adapter 
carries a particular sequence, the experimental barcode (‘B’, in red), which is 2-6 
bases long. It also includes a 3-bases UMI (unique molecular identifiers). RNA is 
reverse transcribed by using a primer complementary to the 3' adapter. For library 
generation, cDNA is amplified by PCR by using primers which anneal to the 5' and 3' 
adapters. Since only the 5' ‘PE Read1 Sequencing Primer’ anneals perfectly to the 
library, CRAC libraries are sequenced from the 5' end (single end sequencing). 
 
 
Like CRAC, CLIP allows detecting the protein binding site on RNA at single-
nucleotide resolution, by using mutations (deletions) present in readthrough 
cDNAs (Lee and Ule, 2018; Ule et al., 2003).  
Interestingly, a variant of CLIP called individual-nucleotide resolution UV 
cross-linking and immunoprecipitation (iCLIP) was developed to enable 
mapping of protein binding sites by using both truncated and readthrough 
cDNAs (König et al., 2010). Truncated cDNAs are produced whenever the 
reverse transcriptase stops at cross-linking sites (Figure 1.15, step 8). At these 
positions, the cross-linked amino acid residue constitutes an obstacle for the 
enzyme, which can frequently fall off the cDNA thus generating a truncated 
molecule. Truncated cDNAs are therefore indicative of the cross-linking sites. 
However, they are not retrieved in CLIP and CRAC protocols because they 
lack the SeqFw adapter at the 5' end, which was incorporated before reverse 
transcription (RT). Therefore, only full-length (readthrough) cDNAs have the 
adapter and can be further amplified and sequenced. 
Differently from CRAC and CLIP, in iCLIP truncated cDNAs can be retrieved 
because the SeqFw adapter is incorporated at the 3' end, during RT through 
the RT primer. Therefore, despite truncated cDNAs are shorter than 
readthrough cDNAs, they still have both adapters at the 3’ end and this allows 
their amplification later on. After RT, purified cDNAs are circularised through 
an enzymatic reaction, and circular cDNAs are linearised to generate libraries 









Figure 1.15. Schematic representation of the main steps performed in iCLIP 
(Lee and Ule, 2018).  
The first part of iCLIP (1-4) is performed as in CLIP. However, other steps have been 
modified to map the protein binding site through the analysis of truncated cDNA 
molecules. In iCLIP, truncated cDNAs are retrieved because they contain the SeqFW 
adapter, which is incorporated during RT through the RT primer, at the 3' end (8). The 
RT primer also includes unique molecular identifiers (UMI) and an experimental 
barcode. After purification (9), the cDNA is circularised by using the circligase and 
then linearised thanks to a restriction site (10). cDNA is amplified by PCR to generate 





Alternative ways to cross-link proteins to RNA have also been employed and 
rely on the incorporation of nucleoside analogues (s4U) into RNA. These 
analogues are then covalently linked to proteins, upon exposure of cells to the 
UV-A light (365 nm) (Hafner et al., 2010). Interestingly, this wavelength seems 
to capture better certain RBPs-RNA interactions than the UV-C light at 254 nm 
(Lee and Ule, 2018). However, these methods are partially limited by the 
incorporation rate of the nucleoside analogues in cells and tissues, and by the 
cytotoxicity of the same compounds.  
As in CLIP and CRAC, also in PAR-CLIP readthrough cDNAs are used to 
detect the protein binding site on RNA (Hafner et al., 2010). Notably, in PAR-
CLIP the identification of thymidine to cytidine mutations present in the 
readthrough cDNA can determine the initial s4U positions, which represent the 
the cross-linking sites. 
 
More recently, another category of methods has been developed to detect 
RNA-proteins interactions in vivo, and these are RNA tagging (Lapointe et al., 
2015) and TRIBE (McMahon et al., 2016). The approach used is similar to 
DamID (Steensel and Henikoff, 2000), which allows determining the genomic 
occupancy of transcription factors in vivo. In RNA tagging and TRIBE, the RBP 
of interest is engineered in order to be fused to the catalytic domain of an RNA 
editing enzyme. In this way, the enzyme is recruited by the RBP to its RNA 
targets and edits them with permanent chemical modification. Thus, RNA 
editing substitutes for the UV-cross-linking, which is used in CLIP for the same 
purpose. This represents a great advantage since RNA editing occurs in vivo 
and significantly reduces the input material of the experiment. Thus, RNA-
protein interactions can also be captured in rare populations of cells, such as 




Notably, RNA tagging was developed in yeast, and it is based on the addition 
of the catalytic subunit of an oligo(U) enzyme to the RBP of interest (Lapointe 
et al., 2015). TRIBE was developed in Drosophila, and it combines the catalytic 
domain (cd) of another RNA-editing enzyme, cdADAR, to RBPs, in order to 
mark their RNA targets (McMahon et al., 2016). When TRIBE was compared 
to CLIP, it showed lower sensitivity, as it seems to detect by far fewer targets. 
This aspect was improved by incorporating a mutation in the cdADAR to 
enhance the RNA editing efficiency and at the same time to reduce the 
sequence bias of the enzyme for certain nucleotides (HyperTRIBE) (Rahman 
et al., 2018; Xu et al., 2018).  
 
However, these in vivo methods have some limitations. First of all, they do not 
allow to detect the exact binding site of RBPs on RNA, whereas CLIP enables 
its detection at single-nucleotide resolution. Moreover, the function of the 
fusion protein needs to be assessed before performing the experiment, to 
exclude that the enzyme does not negatively impact the RBP. 
Importantly, RNA editing enzymes might exert toxic effects in specific cell 
types or during certain developmental stages. Thus, to achieve the 
appropriate, non-toxic, expression levels, it might be necessary to use 
conditional genetics, and this can be complicated when applied to mammalian 
systems in vivo.  
In summary, future refinements of these sophisticated ‘in vivo methods’, might 





Aims of the thesis 
 
In this thesis, I dissected the molecular function of the RNA-binding protein 
(RBP) NANOS2 in mouse SSCs. In order to understand the biology of any 
RBP, it is imperative to define its actual RNA interactome. Other scientists 
have previously sought to determine the molecular mechanism underlying 
NANOS2 function and, notably, they attempted to characterise its targets in 
SSC lines, by using native RNA immunoprecipitation (Zhou et al., 2015). 
However, this technique has some disadvantages, which do not allow 
identifying the RNA occupancy of an RBP unambiguously (Lee and Ule, 2018; 
Mili and Steitz, 2004). Thus, the first aim of this work was to characterise 
NANOS2 RNA targets transcriptome-wide, in SSC lines. To do so, we 
employed one of the most rigorous methods, called CRAC (Granneman et al., 
2009b). Hence, we engineered a Nanos2TAG mouse allele, which we used to 
derive SSC lines and to perform CRAC. Therefore, we addressed whether 
NANOS2-RNAs interaction is direct and which types of RNAs are bound by 
NANOS2. Moreover, we precisely defined NANOS2 binding site on RNA, at 
the single-nucleotide resolution. After identifying the biological processes 
where NANOS2 targets are involved in, we also sought to determine their 
expression profile throughout adult spermatogonia development. 
Next, this thesis aimed to characterise NANOS2 molecular function in mouse 
SSCs by identifying its protein interactor. To address this, we performed 
immunoprecipitation followed by mass spectrometry in SSC lines, which 
revealed that many subunits of the CCR4-NOT complex were the most 
confident NANOS2 interactors. 
The third objective of this work was to determine the molecular consequences 
of CNOT-NANOS2 interaction. Since CNOT is the major deadenylase in 
eukaryotic cells and it promotes RNA decay (Collart and Panasenko, 2012; 
Shirai et al., 2014), my work aimed to investigate the stability of NANOS2 
mRNA targets in SSC lines, by using a novel technique called SLAM-seq 
(Herzog et al., 2017).  
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Overall, these findings significantly expanded our knowledge on how the 
evolutionarily conserved RBP NANOS2 works at the molecular level and 




Chapter 2. Materials and methods 
 
2.1 Mouse generation and maintenance 
 
2.1.1 Mouse strains/backgrounds and diet 
 
All mice were maintained on the C57BL/6 genetic background. Mice from 
Nanos2TAG line were also bred into DBA/2J genetic background (purchased 
from the Charles River Laboratories) to generate F1 hybrid mice with a mixed 
C57Bl/6 x DBA/2J genetic background and used for SSCs derivation.  
Mice were fed with a standard chow diet and acidified water ad libitum. Mice 
were exposed to a 12 hours light and dark cycle, in rooms at standard 
temperatures.  
Mice were bred and maintained both at the EMBL Mouse Biology Unit, 
Monterotondo, and at the Scottish Centre for Regenerative Medicine, in 
Edinburgh, and all experiments were performed under UK Home Office 
authorisation.  
 
2.1.2 Mice generation using homologous recombination in mouse ESCs  
 
Mice were generated at the EMBL Mouse Biology Unit, Monterotondo, in 
accordance with the Italian legislation, under license from the Italian Health 
Ministry. 
The construct pDTA-Tag-Frt-Neo-Frt used for targeting the Nanos2 locus in 
ESCs was designed by Dónal O’Carroll and realised with the technical support 
of Dr. Philip Hublitz, from the EMBL Monterotondo Gene Expression Facility. 
For the generation of the Nanos2TAG mice, embryos were injected at the 
morula stages, using the Nanos2TAG/+ ESCs clones, as described in Chapter 




2.2 Assessment of the fertility of transgenic animals 
 
To validate Nanos2TAG males’ fertility, both heterozygous and homozygous 
animals were mated with wild type C57Bl/6 females. 2 months old animals 
were used to set-up matings and litter size was analysed for the following 3-4 
months, at pups’ weaning age.  
 
Testicular weight analysis was performed to assess Nanos2TAG and Nanos2Fl 
males’ fertility. Both heterozygous and homozygous animals were sacrificed 
when they were 2, 4, 6 months old. 
 
2.3 Genomic DNA extraction for Southern Blotting  
 
A ‘Tail digestion buffer’ was used for all DNA extraction protocols. 
Composition of the tail digestion buffer: 50 mM tris-HCl pH 8; 100 mM EDTA 
(03609, Sigma); 100 mM NaCl; 1% SDS (L4509, Sigma); 3 mg/ml Proteinase 
K (3115852001, Sigma Aldrich) to be added fresh.  
 
Tail biopsies or cell suspensions were digested by incubation with 500 µl of 
Tail Buffer supplied with fresh Proteinase K, at 55 °C, by shaking tubes at 750 
rpm overnight. To discard the undigested coat, tubes were centrifuged at 
maximum speed for 5 minutes at R.T. and supernatants were transferred into 
a new safe-lock tube (to avoid phenol vapors leakage later on). From this step 
onwards, DNA isolation was performed under a fume hood. To purify DNA 
from the organic phase, 1 volume of PCI (Phenol:Chloroform:Isoamyl alcohol) 
(77617, Sigma) (eg. 500 µl) was added to each tube and samples were mixed 
by inverting tubes vigorously or vortexing for 20 seconds. Samples were 
centrifuged at 10 000 rpm, for 5 minutes, at R.T and the upper aqueous phase 
was collected and transferred into a new tube, without disturbing the white 
protein interphase. PCI addition and aqueous phase collection was repeated 
again twice, to achieve high DNA purity. Then, to remove traces of phenol from 
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the aqueous phase,1:1 volume of Chloroform (32211, SLS) was added. 
Samples were mixed by inverting tubes and centrifuged as previously 
described. The aqueous phase was collected and transferred into a new tube. 
DNA precipitation was achieved by adding 1 volume of Isopropanol and 1:10 
Volume of 3 M NaOAc (AM9740, Thermo Fisher). Tubes were inverted 
vigorously and centrifuged at maximum speed for 5 minutes. After discarding 
the supernatant, DNA pellets were washed by adding 1 ml of 70% EtOH to 
remove salt traces. Samples were centrifuged at maximum speed for 5 
minutes ad pellets were air-dried for 5 minutes at R.T. DNA pellets were 
resuspended in 50 -100 µl of ddH20. DNA yield and purity were analysed with 
a Nanodrop ND-1000 spectrophotometer (Thermo Scientific) and DNA stored 
at 4 °C.  
 
2.4 Southern blotting 
10 µg of genomic DNA, extracted as described before, was digested at 37 °C 
overnight with 40 U of NheI enzyme (NEB, R0131S). DNA fragments were 
separated by electrophoresis in a 0.8% Agarose gel and run for 4 hours at 120 
Volts. DNA was then transferred to a Hybond Nylon membrane (GE 
healthcare, RPN203B), using an alkaline solution (1.5 M NaCl, 0.4 M NaOH). 
The membrane was rinsed twice, dried for 20 minutes at 37 °C, and cross-
linked with UV-light at 150 mJ/cm2. 
The NANOS2-DNA probe used was complementary to a region enclosed 
between the last two NheI sites, in Nanos2 locus. 30 ng of this probe were 
marked by using the Random primers labelling kit (18187-013, Invitrogen) with 
α[32P]-dGTP. The membrane was incubated at 65 °C for 2 hours with the 
hybridization buffer (0.5M Na-Phosphate buffer pH 7.2; 1mM EDTA, (Sigma, 
03609); 3% BSA; 
5% SDS (Sigma, L4509)), and then with the labelled probe overnight. The 
membrane was washed for 20 minutes at 65°C, using the pre-heated washing 
solution (40mM Na-Phosphate buffer pH 7.2; 1mM EDTA; 5% SDS). These 
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washes were repeated for three times. The membrane was then exposed for 
24 hours to a phosphoscreen, which was scanned later using a Fluorescent 
Image Analysis System (Fujifilm, FLA-5100). 
 
2.5 PCR genotyping  
 
2.5.1 Genomic DNA extraction for PCR Genotyping 
 
Tails or ear biopsies were digested with 400 µl TAIL digestion buffer supplied 
with fresh Proteinase K for 3 hours (or overnight), at 55 °C, 750 rpm. To 
remove the undigested coat, tubes were centrifuged at maximum speed for 5 
minutes and supernatants containing lysed cells were transferred into a new 
tube. To precipitate DNA out of solution, a 1:1 volume of isopropanol was 
added to each sample and tubes were vortexed before centrifuging them at 
maximum speed for at least 15 minutes. Supernatants were decanted and the 
DNA pellet were washed with 600 µl of 70% ETOH to remove residual salts. 
Sample were centrifuged as previously explained and supernatants decanted. 
Remaining Ethanol was removed by another centrifugation and by air-drying 
DNA pellets for approximately 10 minutes. DNA was resuspended in 40 µl of 
ddH20 and 1 µl was used as a template in a 25 µl PCR volume, for genotyping. 
 
2.5.2 Genotyping protocols 
 
All PCRs were resolved by electrophoresis in a 3% Agarose (A9339, Sigma) 
gel, containing 5% EtBr (09-0617 Sigma Aldrich), in 1X TAE buffer (40 mM 
Tris, 20 mM acetate, 1 mM EDTA), run at 200 Volts for 30-40 minutes.  
 
PCR mix: 
2.50 µl 10X DreamTaq Green Buffer (B71, Life technologies) 
0.25 µl 10 mM dNTPs (10319879, Thermo Scientific) 
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0.25 µl 20 µM primer mix 
0.40 µl Taq Polymerase (EMBL Heidelberg Facility) 
20.60 µl H2O 
 




“FW1_N2” : 5'- AACCTGGGGAATAACCTGCT-3' 
“FW2_N2” : 5'- TGCTGCTGAATAAAGCGTTG-3' 




Step TEMERATURE (°C) Time (s) CYCLES 
1. Denaturation 95 180  
1 X 
2. Denaturation 95 30  
 
34 X 
3. Annealing 63.3 30 
4. Extension 72 35 
5. Final 
extension 
72 300  
1 X 











Expected band’s length: 
 
Wt: 212 bp 









“DOC_FLP1” : 5'- CCCATTCCATGCGGGGTATCG -3' 




Step TEMERATURE (°C) Time (s) CYCLES 
1. Denaturation 90 240  
1 X 
2. Denaturation 90 60  
 
33 X 
3. Annealing 65 60 
4. Extension 72 60 
5. Final extension 72 600  
1 X 









Expected band’s length: 
 






Two-, four- and six-months old mice, from Nanos2CTL, Nanos2TAG alleles, were 
sacrificed and testes were dissected to examine the histology of seminiferous 
tubules. Four animals per genotype were analysed. Testes were fixed in 
Bouin’s solution (16045-1, Polysciences) and embedded in paraffin. Testes 
were sectioned with a Microtome to obtain 4-μm-thick slices, every ~300-400 
µm, to have ~15 sections for testis. Testes slices were obtained from the 
beginning, a quarter and half of the testis longitudinal length. Slices were 
placed on a glass slide and these were H&E stained, according to standard 
protocols. Images of tubules’ sections were acquired with Zeiss Axio Scan 
Slide Scanner and the presence of spermatogenic cells was evaluated by 












2.7 Whole-mount immunofluorescence of seminiferous tubules  
 
Adult mice were sacrificed, and testes were dissected. The genotype of each 
mouse was confirmed by taking a tail biopsy for DNA extraction and PCR 
genotyping. After weighing testes, their tunica albuginea was removed, and 
seminiferous tubules were gently spread with tweezers. Testis were rinsed in 
DMEM (41965039, Life technologies) medium enriched with 1 mM Na-
Pyruvate (11360070, Life technologies) and 1.5 mM Sodium DL-Lactate 
(L4263, Sigma). In order to release tubules from the connective tissue, testes 
were digested with 0.5 mg/ml Collagenase Type XI, (C7657, Sigma-Aldrich) in 
a water-bath at 32 °C for 7 mins, at 700 rpm. After removing the medium and 
washing them with PBS, tubules were fixed by covering them with 4% PFA 
and incubating for them 4 hours, on a rocker, at 4°C. PFA was washed away 
with PBS. Tubules were transferred into a 48-well plate and analysed under a 
stereomicroscope, in order to select the best tubules (long and intact). PFA 
was quenched with 1 M Glycine for 30 min at R.T., rocking. Tissue 
permeabilisation and blocking were performed by incubating tubules with 
PBS/0.5% TritonX-100 / 5% serum / 0.5% BSA (the serum used depended on 
the animal where secondary antibodies were made). Tubules were incubated 
with the appropriate primary antibody in 200 ul volume of 0.5% BSA, PBS, at 
R.T., over night. Primary antibodies used are: α-GFP, 1:500 (GFP-1010, 
Aves), α-GFRα1, 1:50 (GT15004, Neuromics), and α-c-kit, 1:250 (AF1356-SP, 
R&D Systems). Antibody excess was washed away with PBS, for three times. 
Tubules were stained by incubating with Alexafluor-488, or -546 conjugated 
secondary antibodies, in PBS, 0.5% BSA, 0.1% Triton X-100, at R.T., for 1 
hour. Tubules were washed for three times with PBS. Nuclei were 
counterstained with a solution of 1:1000 4’,6-diamidino-2-phenylindole (DAPI) 
(D1306, Life Technologies) (5 μg/ml) in PBS, for 10 minutes, at R.T. After 
washing the excess of DAPI with PBS, tubules were mounted in ~50 µl of 
ProLong Antifade Mountant (P36930, Life Technologies) on a glass slide 
(2800080, Leica). Twenty images per animals were acquired by using a 
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Confocal microscope, by taking Z-stacks, and with Z-stepsize set at 0.34 µm. 
Images were analysed with Fiji ImageJ.  
 
 
2.8 Adult spermatogonia preparation for FACS 
 
Adult mice were sacrificed, and testes were collected. After removing the 
tunica albuginea, testes were rinsed in DMEM, 1 mM sodium pyruvate, 1.5 mM 
sodium lactate and digested with 0.5 mg/ml Collagenase Type XI, for 7 
minutes, at 32 °C, at 700 rpm. Tubules were then digested with 0.05% Trypsin-
0.05 mg/ml DNase I (DN-25; Sigma-Aldrich), to obtain a single-cell 
suspension. Cells were filtered using a 70-μm strainer (14–959-49A; Falcon) 
and pelleted at 1,000 rpm, for 5 minutes. For each sample, approximately 5 
million cells were stained using the appropriate antibodies diluted in PBS 
3%/FBS/0.01% sodium azide in ice. Antibodies used were either fluorophore-
conjugated: CD117 (c-kit) (PE-Cy7 15360940), CD9-APC (Thermo Scientific, 
15360570), or primary antibodies: CD45 (eBioscience, clone A20), CD51 
(BioLegend, clone RMV-7). Cells were incubated with antibodies on ice and 
tubes were mixed every 5 minutes. For samples stained with CD45 and CD51, 
cells were washed with PBS-FCS and incubated with Qdot 605 Streptavidin 
Conjugate (Q10101MP, Life technologies) for 30 minutes, on ice. Cells were 
filtered, stained with SYTOX Blue (S34857, Thermo Scientific), and then 
analysed by FACS. 
 
2.9 Cells culture 
 
All cells were grown at 37 °C. HEK293t cells were grown in a 5% CO2 incubator 




2.9.1 HEK293t culture 
 
HEK293t cells were cultured in the following media: GMEM (12-739F, Lonza), 
10% fetal bovine serum (FCS) (Life technologies), 2 mM L-glutamine 
(Invitrogen), 100 units/100 µg Penicillin/Streptomycin (P4333, Sigma), 1X 
Non-essential amino acids (11140050, ThermoFisher Scientific), 0.1 mM 2-
Mercaptoethanol (31350-010, ThermoFisher Scientific). HEK293t cells were 
cultures in 10 cm (SIAL0599, Sigma) or 15 cm plates (430167, Corning) and 
passaged when they were 70-80% confluent, to a ratio of 1:10 (generally). 
Media was aspirated gently and cells were washed with PBS (D8537, Sigma). 
Cells were detached by resuspending them with pre-warmed HEK media and 
transferred into new plates.  
 
2.9.2 Transfection of HEK293t cells 
 
HEK293t cells were re-plated in 15 cm plates one day before transfection, in 
order to be 70% confluent on the day of transfection. Fresh medium was added 
to cells before transfection. Transfection was performed as described in the 
Lipofectamine manufacturer’s protocol. 15 µg of plasmid DNA and 
Lipofectamine 2000 (11668030, Invitrogen) were first diluted in Opti-MEM 
medium (31985062, ThermoFisher Scientific) and then mixed gently in one 
tube. DNA/lipofectamine complexes were added dropwise to cells and plates 
were placed back in the incubator and kept there for 24 hours. Transfected 
cells were visualised with a fluorescence microscope.  
 
2.9.3 Derivation and passaging of MEFs 
 
After setting-up matings, females were examined for the presence of vaginal 
plugs. Matings were separated after detection of plugs and females were 
sacrificed 13.5 days later (plug day counts as 0.5 day), in order to harvest 
embryos. Embryos were dissected, placed in a 10cm plate and covered with 
 
 67 
cold PBS. In order to isolate MEFs from embryos, desidua, placental and 
maternal tissues were removed. Embryos’ heads were cut away and all 
innards (blood tissues, liver etcetera) were removed by eviscerating the 
embryos’ body. To dissociate the remaining embryos’ tissues, these were 
collected in a 10 ml syringe. By adding 5 ml of MEF media into the syringe, 
embryos were passed through a 18-gauge needle for three times. This 
operation was repeated using a 21-gauge needle. The homogenized tissues 
were kept in the 10 cm plates and media was added to reach a volume of 10 
ml (this is passage 0, P0). Plates were placed in the incubator and cell were 
grown for three days to reach 70-80% confluency. Cells were passaged in the 
following way: first, they were rinsed with PBS, digested with 0.05% Trypsin 
(25300054, Life technologies) for three minutes at 37 °C and then they were 
collected in a tube. Clumps were removed by sedimentation. Cells in the 
supernatant were pelleted and resuspended in appropriate volume of MEF 
media. Each 10 cm plate was passaged into a 15 cm plate (passage 1, P1). 
Cells were grown for two days to reach 80-90% confluency and passaged as 
previously described (without the clumps’ sedimentation step) to a ratio of 1:3, 
in other 15 cm plates (passage 2, P2). Cells were grown for two days to reach 
80-90% confluency and they were either frozen or passaged again to a ratio 
of 1:3 (passage 3, P3). Once MEFs reached 80% of confluency, they were 
irradiated to induce DNA damage and subsequent cell cycle arrest. To irradiate 
MEFs, cells at P3 were trypsinised, resuspended in MEF media and collected 
in a 50 ml tube. Tubes were placed in a RS 2000 X-ray irradiator (Rad Source), 
and the X-ray dose was set at 20 Grays/minutes. Cells were placed back in 
the incubator for ~10 minutes, pelleted by centrifugation and resuspended in 
MEF media. Inactivated MEFs were used as feeders for SSCs culture. Thus, 
inactivated MEFs were plated in new plates and the following day SSCs were 
plated on top of them. Alternatively, when MEFs were not immediately used, 




MEF media composition: DMEM, 12.5% FCS, 2 mM L-glutamine, 1X non-
essential amino acids, 100 U/ml penicillin/streptomycin and 100 μM β- 
mercaptoethanol (Gibco).  
 
 
2.9.4 Derivation and maintenance of SSC lines 
 
SSCs derivation and maintenance protocol was adapted from (Kanatsu-
Shinohara et al., 2003).  
DBA/2 mice were bred with BL6N mice and F1 or F2 hybrid pups were used 
for SSCs derivation, when they were ~7 days old.  
After sacrificing the pups, a tail biopsy was taken to confirm the genotyping. 
To isolate testes, the abdomen of each pup was opened, and testes 
transferred into 1 drop of cold HBSS buffer (14170-088) on a plate. The tunica 
albuginea was removed, and testes were washed with HBSS buffer twice. To 
isolate germ cells, testes were digested with 600 µl of Collagenase (1mg/ml in 
HBSS) in a 15ml falcon and incubated for 10-12 minutes at 37°C in a water 
bath, by gently shaking every 5 minutes. Tubules were centrifuged at 800 rpm 
for 3 minutes. Sedimented tubules were washed in HBSS and resuspended in 
800 µl of 0.25% Trypsin (25200056, Life technologies), supplemented by 200 
µl of DNase (7 mg/ml in HBSS). Tubules were incubated for 10 minutes at 
37°C. Trypsin was blocked by adding 5 ml of MEF media and tubules were 
dissociated by pipetting 10 times with a p200 gilson pipette. The suspension 
was filtered with 0.45 µm filters and centrifuged at at 800 rpm for 5 minutes. 
Cells were resupended in 1 ml of SSCs media and counted with a Nexcelom 
(Bioscience) automated cell counter. SSCs were plated to have a final 
concentration of 3x105 cell/ml, in a well of gelatin coated 12 well-plates. Plates 
were incubated for 12 hours at 37°C. By collecting floating cells only, SSCs 
were transferred to new 12-well plates, thus depleting somatic cells. Media 
was changed every 3 days and after observing the first SSCs colonies (~6-10 
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days later), SSCs cultures were split 1:1 (Passage1). SSCs were cultured for 
additional 4-5 days, or until colonies of 10-20 cells became visible. At that 
stage SSCs were depleted from somatic cells.  
 
For the SSCs depletion from somatic cells, SSCs medium from SSCs cultures 
was collected in tubes. SSCs were washed twice with PBS and then they were 
trypsinised with 200 µl of 0.25% Trypsin for each well, for 3 minutes at 37°C. 
Trypsinisation was blocked with MEFs media and tubes were centrifuged. 
SSCs were resuspended in the SSCs media previously collected and plated 
on gelatin-coated plates. SSCs were left in the incubator for 30 minutes-1 hour, 
the time necessary to allow deposition of somatic cells on the bottom of the 
plates. Floating SSCs were collected and counted. 8 x 105 cells were plated in 
a well of a 6-well plate, which was previously seeded with 3-4 x 105 inactivated 
MEFs. This constituted passage number 2 of the derivation protocol.  
 
For SSCs maintenance, SSCs media was changed every 3 days and SSCs 
passaged every 7-8 days, 1:2 or 1:3. One day before passaging them, 
inactivated MEFs were thawed and plated in the appropriate plates.  
SSCs were washed twice with PBS and trypsinised as described before. As 
soon as MEFs media was added to block trypsinisation, MEFs clumps (white) 
were collected from the plates with a Gilson p1000 set to 1 ml and transferred 
to 15 ml tubes. The remaining cells, enriched for SSCs, were collected and 
added to the same tubes, without resuspending. Tubes were left at R.T. for 5 
minutes, to allow MEF sedimentation. Supernatants were transferred to new 
tubes and centrifuged. MEFs clumps in the bottom of the tubes were 
discarded. SSCs pellets were resuspended in the appropriate amount of pre-







Reagents for SSCs cultures:  
 
HBSS, Invitrogen (14170-088); DNAse, Sigma (DN25); Collagenase type I, 
Sigma (17100-017); Trypsin-EDTA 0.25%, Invitrogen (15050-065); Ultrapure 
water with 0.1% gelatin, Millipore (ES-006-B). 
 
Spermatogonial Stem Cell media:  
Stem Pro-34 SFM medium with 2,6 % Supplements, Invitrogen (10639-011); 
6 mg/ml D(+)Glucose, Sigma (G7021); 25 µg/ml Insulin, Sigma (I5500); 5 
ml/ml BSA, MP-Biomedicals (810661); 100 µg/ml Transferrin, Sigma (T1147); 
30 nM Sodium Selenite, Sigma (S5261); 1X MEM Vitamin solution, Invitrogen 
(11120-0370); 10 µg/ml D-Biotin, Sigma (B4501); 60 ng/ml Progesterone, 
Sigma (P8783); 30 ng/ml b-estradiol, Sigma (E2758); 1X Sodium Pyruvate, 
Sigma (P2256-5G); 60 µM Putrescine, Sigma (P7505); 1% L-Glutamine, 
Invitrogen (25030-024); 5.7 10-7 M b-mercaptoethanol, Sigma (M3148); 1 µl/ml 
Lactate, Sigma (L4263); 1% FBS, Millipore (ES-009-B); 20 ng/ml mEGF, B&D 
(354001); 10 ng/ml, hbFGF, B&D (354060); 10 ng/ml rat-GDNF, R&D System 
(512 GF); 20 ng/ml Recombinant LIF; 1% PenStrep, Invitrogen (15070-063). 
 
2.9.5 Cell freezing 
 
Cells were frozen when they reached at least 80% confluency. Cells from one 
6-wells plate or one 10 cm plate were frozen in 1 cryotube vial. Cells were 
trypsinised, collected by centrifugation and resuspended in freezing media, 
composed of 50% FCS (or 50% HyClone FBS (12379802, Fisher Scientific) 
for SSCs), 40% cell specific media (HEK, MEF or SSC media), 10% DMSO 
(D2650, Sigma). Vials were quickly moved into home-made freezing chambers 
to allow slow freezing. Chambers were made by a polystyrene rack, where 
cryotubes were placed, covered by paper towels and by another polystyrene 
rack, placed on top as a lid. The two racks were taped tightly and moved to the 
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-80C. After two days tubes were transferred to the liquid nitrogen, for long term 
storage.  
 
2.9.6 Cell thawing 
 
All cells types were thawed rapidly in a 37 °C water-bath and taken out when 
tubes were still cold. Each vial was resuspended in 10 ml of either HEK293t 
media (for HEK293t cells) or MEF media (for both MEFs and SSCs). Cells 
were pelleted by centrifuging tubes at 1000 rpm (for HEK293t and MEFs cells) 
or 2000 rpm (SSCs), for 5 minutes. Pellets were resuspended in the 
appropriate media, before plating cells in treated-plates.  
 
2.10 Immunoprecipitation followed by mass spectrometry (IP-MS) 
 
Samples for IP-MS were prepared as described in (Much et al., 2016). 
Samples were analysed by nanoscale liquid chromatography coupled to 
tandem mass spectrometry. Peptides were separated on an EasySpray 
(Thermo Fisher) 50 cm column coupled to an Orbitrap Fusion Lumos mass 
spectrometer (Thermo Fisher). Data were analysed by using MaxQuant 
version 1.6.1.0., and label-free quantitation (LFQ) was performed by using the 
MaxQuant LFQ algorithm (Cox et al., 2014). Peptides were analysed using the 
Uniprot database, and common contaminants (e.g. trypsin, keratins, etc.) 
were removed during the Perseus analysis (Cox et al., 2014; 
The UniProt Consortium, 2017; Tyanova et al., 2016; Hubner et al., 2010). For 
visualisation, LFQ intensities obtained from MaxQuant analysis were imported 
into Perseus version 1.6.0.2 (Tyanova et al., 2016) and processed as 






2.11 RNA isolation 
 
SSCs were MEFs-depleted and sorted by FACS according to size and shape. 
Approximately 1.5 x 106 SSCs were sorted for each sample and resuspended 
in cold PBS-2%FCS. These were pelleted by centrifuging at 2000 rpm, for 5 
minutes at 4 °C, by using a centrifuge with swinging-bucket rotor. Supernatants 
were gently discarded, and cellular pellets were resuspended in 1 ml of QIAzol 
Lysis Reagent (79306, Qiagen). Cell lysis was performed by incubating 
samples at R.T. for 5 minutes. 200 µl of Chloroform was added to each sample 
and mixed by pipetting. Tubes were incubated at R.T. for 2-10 minutes and 
centrifuged for 10 minutes at maximum speed, at 4 °C. Only the aqueous 
phase was transferred into new tubes, without dragging the white interphase. 
RNA was precipitated by adding 400 µl of Isopropanol and vortexing. Also, a 
nucleic acid carrier (1 µl of 5 µg/µl Linear acrylamide (AM9520, Life 
technologies)) was added in order to visualise the pellet. Samples were kept 
at R.T. for 10 minutes, and then centrifuged for 10 minutes or up to 1 hour. 
Supernatants were discarded, and the white pellet containing RNA was 
washed with 400 µl of 70% EtOH. Tubes were centrifuged at 7500 rpm for 5 
minutes and pellets were air-dried and then resuspended in 10-25 µl of DEPC 
nuclease free water (AM9916, Ambion).  
 
2.12 RNA quality controls 
 
The quality and integrity of RNA samples was assessed with the High 
Sensitivity RNA ScreenTape (5067- 5579, Agilent Technologies). RNA 







2.13 mRNA-seq  
 
1.2 µg of total RNA (isolated as previously described) was treated with DNAse 
I, in 10X Buffer (AMPD1, Sigma) for 30 minutes at 37 °C. RNA was purified 
from components of the DNAse I reaction using Rneasy MinElute columns 
(74204, Quiagen) suitable for the purification of mammalian mRNAs (longer 
than 200 nt). The elution was done in 20 µl of nuclease free water. All the 
purified RNA was used for Ribo-depletion with the RiboCop kit (see below) and 
RNA eluted in 12 µl of Elution Buffer. 9 µl of Ribo-depleted RNA was initially 
used to start Library generation with with SENSE Total RNA-Seq Library Prep 
Kit (include RiboCop), (SKU: 042.24, Lexogen). After reverse transcription and 
second strand synthesis, the double-stranded libraries were purified with 13 µl 
of Bead Diluent and 27 µl of Purification Solution, in order to select libraries 
with mean size of 386 bp and insert size of 264 nt. Libraries were amplified 
with 18 cycles of PCR.  
 
2.14 CRAC in HEK293t cells and SSC lines  
 
The pyCAG-Tag-Nanos2 plasmid for the generation of Nanos2OE 
HEK293t cells was cloned by using the pyCAG-vector (Chambers et al., 2003), 
which was a gift from the Chambers laboratory. 
The DNA corresponding to Tag-Nanos2 was amplified from genomic 





Primers for Sanger Sequencing: 
FW 941 Nos: 5'-AGGAGGGTGAGGTAGCTGAG-3' 
FW 586 GFP: 5'-ATCATGGCCGACAAGCAGAA-3' 
FW 77 N PreSci: 5'-ATCTGCTGGAGGTGCTGTTC-3' 
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UV-Cross-linking and cell lysate preparation 
 
HEK293t cells were grown in two 150 cm2 plates and were transiently 
transfected (as explained before) to obtain Nanos2OE cells. As a control, other 
two plates of cells were grown and Mock-transfected. Two days after 
transfection, cell media was discarded and cells were washed twice in PBS 
(14190094, Life technologies).  
Nanos2CTL and Nanos2TAG SSCs were grown on feeders in eight 150 cm2 
plates each genotype. Media was aspirated and cells were washed twice in 
PBS.  
At this stage, both HEK293t and SSCs were covered with a minimum amount 
of PBS (~ 3 ml) and plates were quickly placed on ice and irradiated at 254 nm 
(Bulbs, 400073, Agilent), with energy set at 400 mJ/cm2, by using a Stratagene 
Stratalinker 1800. By keeping plates on ice, cells were scraped off and lysed 
with 2 ml of Lysis Buffer (supplied with fresh complete EDTA-free) per plate. 
Lysates were pooled into low binding tubes and left on ice for additional 10 
minutes. Lysates were centrifuged for 20 minutes at maximum speed, at 4 °C. 
Clear supernatants (cytosolic fraction) were collected and nuclear pellets 
discarded. When clear lysates were not processed immediately for IP, they 
were snap-frozen in liquid Nitrogen and stored at – 80 °C. Inputs were also 
collected from the clear lysate for quality control / Western Blot (WB); they 
were boiled in Sample Buffer (NP0007, Life technologies) for 5 minutes and 
frozen.  
 
Purification of Protein-RNA complexes 
 
1st step: protein IP 
Anti-V5 (R960-CUS, Invitrogen) antibody was coupled with Dynabeads 
(11206D, Life technologies), for 15 minutes at R.T on a rotating wheel. Anti-
V5-Beads were isolated by using a magnetic rack and incubated with protein 
lysates for 2 hours, on a rotating wheel, at 4 °C. Beads were separated from 
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the flow-through (FT) on a magnetic rack. FT were collected for WB analysis. 
Beads were washed twice with 5 ml of TNM 600 buffer and once with 5 ml of 
TNM 100 buffer. Beads were resuspended in 1 ml of TNM 100 buffer without 
protease inhibitors.  
 
2nd step: protein cleavage 
Resuspended beads were incubated with 20 μl of 3C-GST Protease (2 mg/ml, 
EMBL) for 2 hours at 4 °C. Beads were separated from the supernatant on a 
magnetic rack and an aliquot from each fraction was saved for WB.  
Supernatants were incubated with 0.5 U of RNAce-It (400720, Agilent), for 5 
minutes at 25 °C. Subsequently, a mixture of 0.5 g guanidine-HCl, 300 mM 
NaCl, 10 mM imidazole was added to the samples and vortexed. 
 
3rd step: Ni-NTA binding and denaturing washes with GuHCl 
In the meanwhile, 50 µl of nickel agarose beads (30410, Qiagen) were washed 
twice with 1 ml Ni-WBI, (2000 g, 1 minute, at 4 °C). Beads were incubated with 
samples overnight on a rotating wheel, at 4 °C. Beads’ flow throughs (FT) were 
collected for protein precipitation and WB. 15 µl of FT was mixed with 185 µl 
PNK buffer and six volumes of pre cold acetone (32201, Fisher Scientific). The 
mixture was incubated on dry ice for few hours and then centrifuged at 
maximum speed for 20 minutes, at 4 °C. Supernatants were discarded, pellets 
were dried and processed for WB.  
Beads were washed three times with 1.5 ml Ni-WB I, incubated for 15 
minutes each wash at 4°C, with nutation. Afterwards, beads were washed 
twice with 1 ml of Ni-WB II and then three times with 0.75 ml of PNK buffer. 
The last wash was performed after transferring the beads onto microbio spin 
columns (69725, Sigma) For the phosphates treatment, the following 80 µl mix 
was added to the columns: 1X PNK buffer, 8 U TSAP (M9910, Promega), 80 
U RNasin (N2111, Promega), and samples were incubated for 30 minutes at 
37 °C. TSAP enzyme was inactivated by adding 400 µl of WB-I buffer to the 
columns and washed three times with 400 µl of PNK buffer to remove 
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guanidine-HCl. A pre-adenylated linker was ligated to the 3' end of RNAs by 
adding 80 µl of 1X PNK buffer, 10 µM miRCat-33linker 
(/5rApp/NAGATCGGAAGAGCACACGTCTG/3ddC/), T4 RNA ligase II 
truncated (M0242L, NEB), 40 U of RNasin, 10% PEG. Samples were 
incubated at 22 °C, for 4 hours, at 300 rpm and subsequently washed once 
with 0.5 ml of Ni-WBI, twice with 0.75 ml of Ni-WBII and twice with 0.75 ml of 
PNK buffer. RNA was radiolabeled by applying to samples 80 µl of the 
following labeling mixture: 40 µCi 32P-γATP (NEG502Z250UC, Perkin Elmer), 
1X PNK buffer, 32P -γ-ATP (NEG502Z250UC, Perkin Elmer), 20 U of T4 
polynucleotide kinase PNK (M0201S, NEB), 40 U of RNasin and incubating 
columns for 30 minutes at 37 °C. The labeling reaction was stopped by adding 
1 mM of cold rATP (E6011, Promega) and incubating samples for 15 minutes 
at 37 °C. 5' linkers were ligated to RNA by incubating samples with 10 pmol of 
5' linkers and 40 U of T4 RNA ligase I (M0294L, NEB), at 16 °C overnight. 
Samples were washed once with 1 ml of Ni-WBI and three times with 1 ml of 
PNK buffer. RNPs were eluted from the columns with 300 µl of Elution Buffer, 
for 5 minutes at 23 °C, 500 rpm and precipitated by adding 2 µg of BSA, 1.5 
ml of cold acetone and incubating over night at -20 °C. Radiolabeled RNPs 
were resolved on a 4-12% Bis-Tris NuPAGE gel (NP0335BOX, Invitrogen), 
using NuPAGE Running Buffer (NP0001, Life technologies) and transferred 
with NuPAGE Transfer Buffer (NP00061) to a nitrocellulose membrane at 70 
Volts, for 1.5 hours, on ice. RNPs were detected by autoradiography and their 
correct molecular size was identified by overlapping the film with the 
membrane showing the protein ladder (Kaleidoscope, 1610375, Bio-Rad). 
RNPs were extracted by cutting the membrane and incubating the slices with 
100 ug of proteinase K in WB-II supplied with 1% SDS and 5 mM EDTA, for 2 
hours at 55 °C. RNA was extracted by adding sodium acetate (AM9740, Life 
technologies) and PCI (15865408, Fisher Scientific). Tubes were vortexed, 
centrifuged for 5 minutes, 20000 g, at 4 °C. The aqueous phase was collected, 
and RNA was precipitated overnight at -20 °C, by adding 1 µl GlycoBlue 
(AM9515, Thermo fisher) and 1.1 ml of EtOH. The RNA pellet was washed 
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with 70 % EtOH, centrifuged and air-dried. RNA was resuspended in 13 µl of 
the Reverse transcription mixture containing the mirCat-33 primer and dNTPs 
and incubated for 3 minutes at 80 °C. Samples were snap-chilled on ice and 
kept there for 5 minutes. Subsequently, First-strand buffer, DTT and RNasin 
were added and incubated at 50 °C for 3 minutes. 1 ul of Superscript III 
(18080044, Life technologies) was added and incubated for 1 hour at 50 °C. 
The enzyme was inactivated by incubation at 65 °C for 15 minutes. To release 
the cDNA, samples were incubated with RNaseH and incubated for 30 minutes 
at 37 °C. The reverse transcription product was aliquoted and used for PCR. 
5 ul of cDNA was used for 50 ul PCR containing TaKaRa LA Taq (RR002M). 
PCR were pooled and purified from PCR reaction components by precipitating 
DNA with sodium acetate, 100% EtOH and freezing at -80 C for 2 hours. 
Samples were centrifuged at max speed for 30 minutes at 4 °C. DNA pellets 
were washed with 70% EtOH and resuspended in dH20. PCR products were 
resuspended in Loading Dye and resolved in 3% MetaPhor agarose gel 
(Lonza, LZ50180) and PCR fragments with inserts size between 10-50 bp 
(total length 170-200 bp were extracted, gel purified with MinElute Gel 
















Lysis Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
0.1 M NaCl 1,67 ml 3M stock 
1 % NP-40 5 ml 10 % stock 
5 mM MgCl2 0.25 ml 1 M stock 
10% glycerol 10 ml 50% stock 
5 mM B-ME (2860 x) Added fresh 
 
TNM100 Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
0.1 M NaCl 1,67 ml 3M stock 
0.1 % NP-40 0.5 ml 10 % stock 
5 mM MgCl2 0.25 ml 1 M stock 
5 mM B-ME (2860 x) Added fresh 
 
TNM600 Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
0.6 M NaCl 10 ml 3M stock 
0.1 % NP-40 0.5 ml 10 % stock 
1.5 mM MgCl2 75 µl 1M stock 
5 mM B-ME (2860 x) Added fresh 
 
PNK buffer Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
50 mM NaCl 0.83 ml 3 M stock 
0.1 % NP-40 0.5 ml 10 % stock 
1.5 mM MgCl2 75 µl 1 M stock 
5 mM B-ME (2860 x) Added fresh 
 
WBI (wash buffer I for Ni-NTA) Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
300 mM NaCl 5 ml 3M stock 
0.1 % NP40 0.5 ml 10 % stock 
10 mM Imidazol 0.2 ml 2.5M stock 
1.5 mM MgCl2 75 µl 1 M stock 
6 M GuHCl 28.66 g 
5 mM B-ME (2860 x) Added fresh 
 
WBII (wash buffer II for Ni-NTA) Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
300 mM NaCl 5 ml 3M stock 
0.1 % NP40 0.5 ml 10 % stock 
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10 mM Imidazol 0.2 ml 2.5M stock 
1.5 mM MgCl2 75 µl 1 M stock 
5 mM B-ME (2860 x) Added fresh 
 
EB (Ni-NTA elution buffer) Per 50 ml 
50 mM Tris-HCl pH 7.8 2.5 ml 1M stock 
50 mM NaCl 0,87 ml 3M stock 
0.1 % NP40 0.5 ml 10 % stock 
150 mM Imidazol 3 ml 2.5M stock 
5 mM B-ME (2860 x) Added fresh 
 
PK digestion buffer (for RNA extraction) Per 10 ml 
50 mM Tris-HCl pH 7.8 1M stock 
50 mM NaCl 3M stock 
SDS 20% stock 
EDTA 3M stock 
0.1 % NP40 10 % stock 
150 mM Imidazol 2.5M stock 
5 mM B-ME (2860 x) 3,4 ul Added fresh 
 
 



























2.15 CRAC analysis 
 
CRAC analysis was performed by Dr. Turowski, by following the principles 
described in the PyCRAC software (https://bitbucket.org/sgrann/pycrac). 
Sequencing reads were pre-processed as follows: reads were demultiplexed 
removing in-line barcodes and random barcodes (using the pyBarcodeFilter.py 
script from pyCRAC package v3.0 (Webb et al., 2014)). Then, they were 
collapsed to remove PCR duplicates by using fastx_collapser v0.0.14 
(http://hannonlab.cshl.edu/fastx_toolkit/). The 3' adapter was removed by 
using flexbar v3.4.0 (Dodt et al., 2012), which was also used for quality filtering.  
Pre-processed reads were aligned to the mouse genomic database (mm10) 
using two different alignment programs, STAR v.2.5.3a (Dobin et al., 2013) 
and Salmon v.0.13.1 quasi-quantification (Patro et al., 2017). Reads were also 
aligned to the mouse transcriptome database (Biomart (Smedley et al., 2015)) 
by using Novoalign v2.07.00 (http://www.novocraft.com).  
Peaks were called using the SciPy python library (function argrelextrema) to 
find local extreme or by simply calling signal extrema to localise the top peak 
of each transcript (FDR < 0.001). Nanos2 targets were initially ranked 
according to their total peak score (in rpm, reads per million), which was 
calculated by summing the intensities of one or more unique peaks present in 
a given transcript. For each transcript, the total peak score was calculated from 
two CRAC replicates and the average value for used eventually to generate 
the final CRAC list. CRAC peaks were visualised with the IGV (Integrative 
Genomics Viewer) (Robinson et al., 2011). 
 









The bioinformatic analysis was performed by Dr. Louie van de 
Lagemaat. 
FPKM values obtained from mRNA-seq data were calculated as the 
mean between two biological replicates (Nanos2TAG/+ and 
Nanos2TAG/TAG). Only genes containing both CRAC peaks and 
detectable gene expression levels were considered for the analysis: 
non-expressed genes (FPKM = 0) were eliminated in this comparison. 
Normalisation was performed by dividing the FPKM mean value of 
each gene with the corresponding CRAC peak score. The resulting 
values were used to rank again the CRAC peaks in a new list, which 
was called ‘normalised CRAC list’. The correlation between CRAC 
peak scores and FPKM values was calculated with the “CORREL” 
function in Excel.  
 
2.15.2 Motif analysis 
 
De novo motif analysis was performed by using MEME-ChIP (Bailey et al., 
2009). As input for MEME-ChIP we used the normalised NANOS2-CRAC 
peaks, containing deletions (deletions were previously detected in CRAC 
peaks, as described in the PyCRAC software). Sequences of 100 bp were 
centered on the peak summit, and on deletions. We scanned only one strand 
of the CRAC sequences and looked for motifs with E-value < 0.05, between 6-
15 bp, with 0-1 or 1 occurrence per sequence. As a background, we shuffled 
the 3' UTRs of NANOS2 CRAC peaks by using MEME-ChIP. ATTRACT 








GO analysis was performed by using the g:Profiler software (Reimand et al., 
2019). The input for the GO analysis was a ranked list of normalised NANOS2-
CRAC peaks. Biological terms were ranked according to the adjusted P-value. 
 
2.15.4 Gene clusters analysis 
 
This analysis was performed by Dr. Louie van de Lagemaat. mRNA-seq data 
from ex-vivo sorted spermatogonia were used as input for the analysis. To 
detect changes in the gene expression levels across the three populations of 
spermatogonia, genes were clustered using the Markov clustering algorithm 
(MCL) (Freeman et al., 2007). Normalisation of the reads was performed by 
using DESeq2 (Love et al., 2014). To evaluate the enrichment of NANOS2 
CRAC targets across the different gene clusters, we used the hypergeometric 
test. 
 
2.16 SLAM-seq  
 
SLAM-seq was performed by following the manifacturers’ instructions in the 
SLAMseq Kinetics Kit – Catabolic Kinetics Module, 24 preps, SKU: 062.24, 
Lexogen.  
All experiments were performed in the dark, or in the presence of a red-light 
lamp. After determining the optimal concentration of s4U (100 µM) with the cell 
viability tritation assay, SSCs media containing s4U was used to label SSCs 
for 24 hours. s4U was supplied also three hours before time 0. At time 0, s4U-
media was replaced with fresh SSCs media containing an excess of unlabeled 
uridine. SSCs were collected at different time-points: 0, 30 minutes, 1 hour, 2 
hours, 9 hours, and 24 hours. SSCs were collected by trypsinisation, and 
MEFs depletion (as described in the SSCs culture section). Additionally, SSCs 
were FACS sorted to exclude dead cells and MEFs contaminants. Two 
biological replicates, constituted by Nanos2TAG/+ and Nanos2TAG/TAG SSC lines, 
were used for the experiments. 
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SLAM-seq libraries were prepared by following the manifacturers’ instructions 
in the QuantSeq 3′ mRNA-Seq Library Prep Kit FWD for Illumina, SKU: 
015.24, Lexogen.  
 
2.16.1 SLAM-seq analysis 
The SLAM-seq bioinformatic analysis was performed by Dr. Louie N. van de 
Lagemaat, as described in the SlamDunk pipeline (Herzog et al., 2017). T to 
C conversion rates obtained from different timepoints were normalised to ‘Time 
0’ for each transcript. These values were used to fit a first order decay reaction 
with the R stats package.  
2.16.2 Sylamer analysis 
Sylamer analysis was performed as described in (van Dongen et al., 2008). 
As input for the analysis, we used the 3' UTRs of mRNAs of known stability 
(calculated with SLAM-seq), ranked from short to long half-life. 3' UTRs were 
selected by choosing the average length of all possible 3' UTRs for a given 
transcript.  
2.17 DNA quality controls  
 
The quality of DNA libraries was assessed with the High Sensitivity D1000 
ScreenTape (5067-5584, Agilent Technologies). DNA samples concentration 




Libraries generated by RNA and SLAM-seq were sequenced with an Illumina 
HiSeq2500 on a 50 bp, Single-end run.  
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Libraries generated by CRAC were sequenced with an Illumina NextSeq500, 
high output (400 million reads), on a 75 bp, Single-end run. All sample were 




Chapter 3. Identification of NANOS2 occupancy on 
RNA in SSCs  
 
3.1 Introduction  
 
Nanos family genes exert essential functions during development. These vary 
from body pattern formation in Drosophila, to their evolutionary conserved 
roles in germ cells (De Keuckelaere et al., 2018). A common feature among 
NANOS proteins is their CCHC zinc finger motifs, located in the C-terminus. 
Structural studies have demonstrated that the zinc fingers mediate protein-
RNA interactions (Hashimoto et al., 2010b; Weidmann et al., 2016). 
Importantly, the zinc fingers are essential to support all known NANOS 
functions, in Drosophila (Arrizabalaga and Lehmann, 1999). It is generally 
assumed that also Nanos2 functions in mouse strictly depend on its ability to 
bind to RNA. Therefore, different attempts have been made to characterise 
NANOS2 targets, both in male gonads and post-natal SSCs, by using native 
RIP (RNA Immunoprecipitation) (Saba et al., 2014; Suzuki et al., 2010; Zhou 
et al., 2015). However, native RIP has several technical limitations (see 
Chapter 1), which did not allow to unequivocally assess the following aspects, 
regarding protein-RNA interaction: first, whether NANOS2 contacts directly 
RNA, or through other bridging proteins; second, the precise identity of 
NANOS2 targets at the transcriptomic level; lastly, whether NANOS2 binds to 
RNA with sequence specificity.  
Therefore, I sought to address the issues above, and to provide a rigorous and 
extensive characterisation of NANOS2-RNA interactions. To do so, I employed 
one of the most stringent method, called CRAC (Granneman et al., 2009b) 
(see Chapter 1), and I applied it to in vitro SSC lines. In this chapter, I describe 
how we generated a Nanos2TAG mouse model for CRAC. Then, I assessed 
that the presence of the TAG at NANOS2 N-terminus did not alter protein 
localisation and function, in mouse SSCs. I optimised CRAC in HEK293t cells 
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and then performed it in SSC lines. In this chapter, I also show extensive 
CRAC analysis, including de novo motif discovery, which provides 
unprecedented insight into NANOS2 transcriptomic occupancy in SSCs. 
Eventually, I illustrate the biological identity of NANOS2 RNA targets, by 
performing gene ontology analysis, and by using Markov clustering algorithm.  
 
3.2 Generation of the Nanos2TAG mouse allele for CRAC 
 
Nanos2 locus is composed of a single exon and spans 1.563 Kb on 
chromosome 7. The locus consists of a 5' UTR, followed by a short coding 
sequence (411 bases), and a 3' UTR (Figure 3.1 A). Therefore, introns are not 
present in this gene. 
In order to perform CRAC, we engineered a Nanos2TAG mouse allele by gene 
targeting in mouse embryonic stem cells (ESCs). A Tag cassette was inserted 
into the endogenous Nanos2 locus, after the starting codon of Nanos2, to 
produce an N-terminal fusion protein (TAG-NANOS2). We designed a variant 
of the original CRAC Tag, to allow both complex biochemistry and also in vivo 
localisation studies. Thus, the Tag consisted of five moieties: V5-cMyc-
PreScission-6xHis-eGFP. The first four components comprised a set of 
epitopes to enable multiple biochemical purifications of NANOS2-RNA 
complexes, by CRAC. These included the V5 and c-Myc epitope tags, useful 
to perform endogenous NANOS2 immunoprecipitation; the PreScission 
cleavage site, which was used for protein cleavage; and the stretch of 
polyhistidine residues (6xHis), used for protein purification with nickel beads. 
Following these tags, an eGFP was also inserted to assess the in vivo 
localisation of the protein, by FACS and immunofluorescence.  
First of all, the Tag was inserted into a targeting vector (pDTA-Tag-Frt-Neo-
Frt), which carried homology arms to the Nanos2 locus, to allow precise 
insertion of the cassette into the desired genomic location. After the Tag, the 
vector contained a neomycin (neo) resistance gene (white rectangular), which 
was used to select recombinant ESC clones in culture. Additionally, the neo 
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cassette was flanked on both sides by flippase recognition target sites (FRT) 
(green triangles), to enable subsequent excision of the neo cassette, by a 
flippase (FLP).  
The targeting vector described above was electroporated into A9 ESCs, which 
were derived from a F1 hybrid, with mixed Bl6N and 129 genetic background. 
Homologous recombinant clones were enriched by addition of the G418 
antibiotic in the culture media. Surviving clones were picked and screened for 
the presence of the transgene by Southern blot, which was performed by Dr. 
Ivanova. Genomic DNA was extracted and digested with a NheI restriction 
enzyme. The Nanos2WT locus contains two NheI restriction sites, spanning a 
region of 6.6 Kb. However, the recombinant Nanos2TAG-neo locus, contains 
three NheI sites, since the integration of the Tag-neo cassette introduced an 
additional one (in brown) after the last Frt sequence. The sequence enclosed 
between the last two NheI sites in Nanos2TAG-neo spans 3.8 Kb. Therefore, 
different DNA digestion patterns are expected from Nanos2WT and Nanos2TAG-
neo clones. Southern blot revealed the presence of two clones with two bands 
of 6.6 and 3.8 Kb, representing the Nanos2WT and the Nanos2TAG-neo/+ alleles, 
respectively (Figure 3.1 B). 
After confirming the incorporation of the Tag-neo cassette by Southern Blot, 
Nanos2TAG-neo/+ clones were expanded and injected into embryos, to generate 
chimeric mice. These were crossed with BL6N mice to generate founder mice, 
which were examined for the presence of the transgene. Founder mice were 
crossed with BL6N to assess the germ-line transmission of the allele to the F1 
generation. Afterwards, Nanos2TAG-neo/+ F1 mice were crossed with mice 
expressing Flp (FLPeR, (Farley et al., 2000)), to induce the FLP-FRT 
recombination and thus the excision of the neo cassette. These matings 





Figure 3.1 Targeting strategy used for the generation of the Nanos2TAG mouse 
allele.  
A. Schematic representation of the Wild-type NANOS2 protein, with the two zinc 
finger domains (CCHC) in red. Amino acid sequence length (aa) is also shown. The 
Nanos2WT locus is composed of a protein-coding region (CDS) (black box) and a 5' 
and a 3' UTRs (white boxes). In the targeting vector the multi-coloured boxes 















































































The white box neo is the is the Neomycin gene and green triangles represent the FRT 
sites. The resulting N-terminal TAG-NANOS2 fusion protein is also showed and 
represented in scale. Wild-type NheI restriction sites are in black, whereas the NheI 
site introduced with the targeting vector is in brown. Also, the 3’ probe used for 
Southern blot is shown as a black box. B. Example of Southern blot performed on 
genomic DNA from two ESCs clones. C. Nanos2 PCR-genotyping using biopsies from 
Nanos2WT and Nanos2TAG/+ mice. The molecular size of the PCR products is 
expressed in base pair (bp).  
 
3.3 Functional validation of the Nanos2TAG mouse line 
 
Fusion proteins are useful tools to investigate proteins function. However, they 
can also negatively affect cells, since they have a modified amino acid 
sequence (and probably folding) compared to their wild-type counterparts. 
I have previously shown how we engineered a Nanos2TAG allele (Figure 3.1), 
which is supposed to generate an N-terminal fusion protein, called TAG-
NANOS2. Since this protein is three times bigger than its wild-type counterpart 
(~47 kDa and ~14 kDa, respectively), we verified whether TAG-NANOS2 was 
functional. NANOS2 is required for the maintenance of male gonocytes and 
also it is essential to sustain male fertility over time (see Chapter 1); therefore, 
I assessed whether TAG-NANOS2 could also do so. To this end, I evaluated 
male fertility in detail by assessing whether TAG-NANOS2 could support all 
stages of spermatogenesis. To this end, I collected testes from Nanos2TAG/+ 
and Nanos2TAG/TAG mice, measured their weight, and performed histological 
analysis of testes cross-sections. Since Nanos2-/- mice lose germ cells 
progressively over time (Tsuda et al., 2003), I also analysed testes from six 
months old mice, to detect any detrimental effect in the long-term. Importantly, 
Nanos2TAG/TAG mice had normal testicular weight, compared to the control 
Nanos2TAG/+ (Figure 3.2 B). Moreover, the histological evaluation of testicular 
cross-sections showed that Nanos2TAG/TAG mice also had a healthy tubular 
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morphology (Figure 3.2 C). Indeed, I could not detect empty tubules and 
importantly, I could observe all spermatogenic stages within the seminiferous 
tubules. Therefore, TAG-NANOS2 protein was able to sustain 
spermatogenesis fully, also in the long term. 
Next, we assessed whether Nanos2TAG/TAG mice had normal litter size. Thus, 
we paired adult homozygous Nanos2TAG/TAG males with wild-type females for 
three months and counted the number of litters they generated. Control mice 
were represented by Nanos2TAG/+ males, which were bred with wild-type 
females. In the graph shown in Figure 3.2 D, each black dot represents the 
average litter size per adult male, whereas red lines are the variance, 
calculated with a T-test. Importantly, homozygous males displayed standard 
litter size, when compared to controls.  






Figure 3.2 Assessment of fertility and spermatogenesis of the Nanos2TAG mouse 
allele.  
A. Schematic representation of the wild type NANOS2 and TAG-NANOS2 proteins. 
Lengths of amino acid sequences are also shown (aa). B. Dot plot showing the 
testicular weight (in mg) of Nanos2TAG/+ and Nanos2TAG/TAG mice, where Nanos2TAG/+ 
represents the control. Mice were six months old. C. Representative images of testes 
cross-sections, from six months old mice. Testes are stained with Hematoxylin and 
Eosin and scale bar is 100 µm. D. Dot plot showing the average litter size of 























































Two tailed Student’s t-tests were used to compare differences between Nanos2TAG/+ 
and Nanos2TAG/TAG, assuming equal variance. 
 
Afterwards, I assessed whether the presence of the TAG affected NANOS2 
localisation in vivo. To this end, I performed whole-mount immunofluorescence 
of seminiferous tubules, isolated from adult Nanos2TAG/TAG mice. Images of 
these samples were acquired with a confocal microscope and further 
analysed. 
First of all, I examined the intracellular localisation of TAG-NANOS2, which is 
known to be cytoplasmic. To detect TAG-NANOS2 expression, I stained 
tubules with an Anti-GFP antibody, and to visualise nuclei, I also stained them 
with Dapi. As shown in Figure 3.3 A, TAG-NANOS2 (GFP signal in green), is 
expressed only in the cytoplasm, and no signal is found in the nucleus. Thus, 
the presence of the TAG did not disturb NANOS2 intracellular localisation, in 
vivo. 
Moreover, I examined TAG-NANOS2 localisation within the SSC 
compartment, which is constituted by a tiny subset of the undifferentiated 
spermatogonia (see Chapter 1). Thus, I analysed TAG-NANOS2 expression 
in relation to GFRα1, a specific marker for self-renewing SSCs (see Chapter 
1), by using Anti-GFP and Anti-GFRα1 antibodies (Figure 3.3 B). Importantly, 
the majority of NANOS2-positive SSCs (in green) also expressed GFRα1 (in 
red), and they were mainly represented by single (Asingle, As) and short chains 
of cells, such as Apaired (Apr) and Aaligned4 (Aal4). Importantly, these cells are 
thought to contain most of the self-renewing SSCs pool (see Chapter 1). These 
observations were also confirmed by quantifying the number of SSCs which 
expressed GFP (Gfra1Neg; Nanos2Pos), GFRα1 (Gfra1Pos; Nanos2Neg) or both 
of them (Gfra1Pos; Nanos2Pos) (Figure 3.3 C). These cells were also classified 
according to their topology, as As, Apr, Aal4, Aal8, Aal12. I also normalised SSC 
counts by the number of Sertoli cells, which were found in the same portions 
of tubule. Sertoli cells are the only somatic cell type present within 
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seminiferous tubules (see Chapter 1), and their number is constant along 
tubules’ length. Sertoli cells were identified by analysing nuclei morphology, 
stained by DAPI, as these display two characteristic heterochromatic masses 
near the nucleolus. Overall, SSCs quantification confirmed our previous 
observation that most of the Nanos2Pos cells overlapped with the GFRα1 pool. 
Importantly, these data are in accordance with previously published results 
about NANOS2 localisation in vivo (Suzuki et al., 2009). 
Moreover, I assessed whether TAG-NANOS2 was correctly confined to the 
undifferentiated spermatogonia compartment. Hence, I co-stained tubules with 
an Anti-GFP (for TAG-NANOS2) and an Anti-c-Kit antibody, which detected c-
Kit, a marker of differentiating spermatogonia. Importantly, as shown by Figure 
3.3 D, TAG-NANOS2 (in green) was never expressed in c-KIT-positive cells 
(in red), which were only represented by long chains of spermatogonia. This 
indicated that the TAG-NANOS2 fusion protein was not expressed in the 
differentiated spermatogonia.  
In summary, these analyses indicated that the presence of the TAG in the 
TAG-NANOS2 fusion protein did not impact fertility nor spermatogenesis, even 
in the long term. Importantly, NANOS2 protein localisation in vivo was not 
altered by the TAG, since TAG-NANOS2 maintained its typical cytoplasmic 
expression and it was correctly confined to the SSC compartment.   
Therefore, these data demonstrated that the Nanos2TAG/TAG mouse allele was 






Figure 3.3. Assessment of NANOS2 localisation by whole-mount 
immunofluorescence (IF) of seminiferous tubules, from Nanos2TAG/TAG mice. 
A. Representative IF image showing NANOS2 (Anti-GFP) intra-cellular localisation. 
Nuclei are stained with DAPI. B. Representative IF images of NANOS2 and GFRα1. 
As and Apr (Apaired) SSCs are shown. C. Bar graph showing number of GFP positive 
and GFRα1 positive SSCs per cluster (1=As, 2=Apr, 4=Aal4, 8=Al8, 12=Al12). SSCs 



















































images showing NANOS2 and c-KIT localisation in spermatogonia. NANOS2 is 
expressed in an As (Asingle) SSC. All images have been acquired with a confocal 
microscope. 
 
3.4 SSCs derivation for CRAC 
 
It is estimated that SSCs constitute only 0.03% of all germ cells, in the adult 
mouse testis (Tagelenbosch and de Rooij, 1993). Furthermore, only a tiny 
subset of SSCs express Nanos2, approximately three or four thousand cells 
per animal. However, CLIP methods, like CRAC, require at least 108-109 cells 
as starting material (Ramanathan et al., 2019). Therefore, the rarity of Nanos2 
positive SSCs in testis hinders their molecular and biochemical 
characterisation in ex vivo isolated cells, by CRAC. To circumvent this 
problem, I derived SSCs from neonatal mouse testis and expanded them in 
vitro, as initially described in 2003 (Kanatsu-Shinohara et al., 2003). SSC lines 
were derived from Nanos2WT, Nanos2TAG/+ and Nanos2TAG/TAG pups, at 
postnatal day 7. Since Nanos2WT lines were used as control for the all rest of 
the experiments, from now onwards, they will be called Nanos2CTL, whereas 
Nanos2TAG/TAG lines will be named Nanos2TAG.  
As shown in Figure 3.4 A, SSCs in culture grow as grape-shaped colonies, on 
MEF feeders, and they can be amplified almost indefinitely in vitro, without 
losing their self-renewal ability (see Chapter 1 and 2). 
To control NANOS2 expression in these cells, I prepared protein extracts from 
Nanos2CTL and Nanos2TAG lines and performed western blotting. By taking 
advantage of the GFP inserted into the TAG, I probed the membrane with an 
Anti-GFP antibody, to detect TAG-NANOS2. A band of approximately 47 kDa, 
corresponding to the expected TAG-NANOS2 molecular size, was observed 
in Nanos2TAG sample (Figure 3.4 B). Importantly, no GFP signal was detected 
in the control (Nanos2CTL), although both samples displayed comparable levels 
of Actin, which indicated that a similar amount of protein extracts were used. 
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Afterwards, I analysed TAG-NANOS2 expression at single-cell level, by 
looking at the GFP signal by flow cytometry. SSCs were purified from MEFs 
and selected according to size and shape. Only single and living cells were 
used for the analysis. Importantly, Nanos2TAG displayed a mono-modal GFP 
distribution (Figure 3.4 C), and an average GFP intensity higher than 
Nanos2CTL. However, a partial overlap was observed between Nanos2CTL and 
Nanos2TAG populations. This indicated that a small subset of Nanos2TAG SSCs 
did not express GFP (TAG-NANOS2), since its level was comparable to the 
autofluorescent signal in the negative control.  
In summary, TAG-NANOS2 was successfully expressed in the Nanos2TAG line 
and had the expected molecular size. Moreover, flow cytometry analysis 
confirmed the expression of TAG-NANOS2 at the single cell level, in the great 
majority of SSCs. Only a small subset of Nanos2TAG cells did not significantly 
express GFP. This could be explained by a certain degree of heterogeneity 






Figure 3.4 Derivation and characterisation of in vitro SSC lines.  
A. Representative bright field images of SSC lines derived from Nanos2CTL 
(Nanos2+/+) and Nanos2TAG (Nanos2TAG/TAG) juvenile testes. SSCs are the bright, 
grape-shaped colonies, grown on top of MEF feeders. B. Western-blot showing 
endogenous NANOS2 expression (GFP signal) in Nanos2TAG SSCs. Anti-Actin signal 
is also shown. C. Histogram from flow cytometry analysis, showing the normalised 

























































3.5 NANOS2 CRAC optimisation in HEK293t cells 
 
When performing CRAC, continuous supply of biological material might be 
required at the beginning, in order to identify the best experimental conditions 
for the RBP of interest. 
However, SSCs are slow-cycling cells (division rate of seven days), and they 
express endogenous levels of NANOS2. Therefore, in order to obtain sufficient 
amounts of cells in a reasonable amount of time, I decided first to optimise 
CRAC in HEK293t cells and, only afterwards, to apply it to SSC lines. 
To this end, I over-expressed TAG-NANOS2 in HEK293t cells (Nanos2OE), by 
cloning the Tag-eGFP-Nanos2 construct into a PyCAG vector (Chambers et 
al., 2003), between the NotI and XhoI restriction sites (Figure 3.5 A). Three 
150 cm2 plates were transiently transfected with the Tag-eGFP-Nanos2-
PyCAG vector, and the expression of TAG-NANOS2 protein was examined 
under a fluorescent microscope. As it is shown in Figure 3.5 B, upon 
transfection, HEK293t could successfully express TAG-NANOS2 (GFP signal, 
Nanos2OE). Afterwards, I tried to understand whether the TAG-NANOS2 fusion 
protein was suitable for CRAC, by testing the efficiency of the main protein 
purification steps: immunoprecipitation, cleavage, and affinity binding to Nickel 
beads (see Chapter 1). Therefore, I collected WT and Nanos2OE cells forty-
eight hours after transfection and prepared protein extracts. These were 
incubated with an Anti-V5 antibody, to immunoprecipitate TAG-NANOS2. 
Then, to remove the Anti-V5 antibody together with the V5 tag, I added the 3C 
Protease to the beads. After cleavage, I incubated samples with the Nickel-
agarose resin (Ni-NTA), performed the washes, and eluted proteins. Samples 
were subjected to SDS-PAGE and western blot, whose results are shown in 
Figure 3.5 C. In the Input (first lane), TAG-NANOS2 was expressed at the 
expected molecular size, ~47 kDa, and it was efficiently immunoprecipitated 
since no protein was left in the flow through (second lane, FT). Importantly, the 
immunopurified TAG-NANOS2 was successfully cleaved, since the removal of 
both V5 and PreScission tags reduced its molecular size to ~43 kDa (third 
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lane, Cleaved). Additionally, only minimal fractions of both full length and 
cleaved proteins were left on the beads (fourth lane). Moreover, cleaved TAG-
NANOS2 could efficiently bind the Ni-NTA resin, as no protein was detected 
in the flow through (FT) and the great majority was found in the eluted sample 
(second last lane, Cleaved). Only a minimal part of the sample was left on the 
beads (last lane). 
Overall, these data showed that TAG-NANOS2 could successfully undergo the 








Figure 3.5. Generation of Nanos2OE HEK293t and CRAC optimisation.  
A. Cloning strategy used to generate Nanos2OE HEK293t. The ‘Tag-eGFP-Nanos2’ 
construct was inserted into the pyCAG vector, between the XhoI and the NotI 
restriction sites. B. Transfection of the ‘Tag-eGFP-Nanos2’ vector into HEK293t cells. 
Mock is the control. Nanos2OE cells show GFP signal (in green), which indicates 
transfected cells. C. Western blot showing NANOS2 immunoprecipitation (IP), 
cleavage and binding to Nickel-NTA beads. ‘FT’ indicates flow through. ‘Marker’ is the 




























































Next, I performed the complete CRAC protocol with HEK293t cells. After 
transient transfection, I cross-linked control (Mock) and Nanos2OE cells with 
254-nm UV light, at 400 mJ/cm2, a medium-high dose. After protein 
immunoprecipitation and cleavage, I trimmed RNA by partial digestion with 
RNase A and T1. I coupled protein-RNA complexes to Nickel-NTA beads and 
immobilised them on spin columns. I applied denaturing washes, by using a 
buffer containing GuHCl. While still on the columns, RNA was subjected to 
phosphatase treatment, to remove phosphate groups previously left by the 
RNase. RNA was radiolabelled and 3' RNA adapters were ligated to RNA, to 
enable library generation afterwards. Each sample was also barcoded with a 
unique 5' adapter, to allow their univocal identification afterwards. After eluting 
the RNA-protein complexes from the columns by using an excess of Imidazole, 
I performed SDS-PAGE and transferred samples to a nitrocellulose 
membrane. The radioactive membrane was exposed for autoradiography, and 
the film analysed following 1 and 24 hours (Figure 3.6 A). Strikingly, the 
autoradiogram showed a very strong signal corresponding to TAG-NANOS2, 
already after 1 hour. Moreover, this signal was specifically associated with 
Nanos2OE sample, as the control did not show any band, even after 24 hours. 
Importantly, the signal was extended above NANOS2 molecular size (up to 
~75 kDa), showing that RNA was successfully trimmed by RNase. 
Furthermore, I did not detect other strong bands at different sizes, suggesting 
that I did not co-purify other RBPs together with TAG-NANOS2. This also 
suggested that the UV-cross-linking dose used was not too high. Therefore, 
these data indicated that NANOS2 had a strong and specific RNA-binding 
ability in HEK293t cells. 
Next, I extracted the RBP-RNA complexes from the membrane, by selecting 
only the area which had a radioactive signal on the film. To remove proteins, I 
treated samples with Proteinase K, and then I extracted and reverse 
transcribed RNA. To generate libraries, I amplified the cDNA with PCR primers 
complementary to the 5' and 3' adapters previously used. PCR were performed 
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from the Nanos2OE sample and from the untagged HEK293t line (WT), which 
was the CRAC negative control. Additionally, to verify that the PCR mixture 
had no contaminants, another control was included, by performing a PCR with 
water instead of the cDNA template (dH20). PCRs were performed by using 
only 22 cycles and the PCR products controlled in a high resolution 3% 
MetaPhor agarose gel. As shown by Figure 3.6 B, libraries were successfully 
amplified only from the Nanos2OE sample and not from the negative controls. 
Indeed, I could detect a DNA smear (in grey, dotted red rectangular) which had 
the expected library size (between ~130 and ~190 bp). Below the smear, it is 
also evident an intense black band (arrowhead) represented by adapter-
dimers (~130 bp), which did not contain an RNA insert. These were excluded 
by performing gel extraction. After quantification of the purified libraries, I could 
conclude that TAG-NANOS2 could indeed precipitate significant amount of 






Figure 3.6. NANOS2 CRAC in HEK293t cells.  
A. Autoradiogram showing the radioactive signal associated to NANOS2-RNA 
complexes in Nanos2OE cells. Two films are shown. The one on the left was exposed 
for 1 hour and the other one for 24 hours (right). Red dotted rectangles indicate the 
area from which protein-RNA complexes were extracted. B. cDNA libraries amplified 
by PCR, using 22 cycles, were run in a 3% MetaPhor Agarose gel. Red dotted 
rectangle indicates the area excised from the gel, to purify libraries from adapter-
dimers (arrowhead). ‘WT’ sample represents the untagged Nanos2 HEK293t (CRAC 
negative control), and ‘dH20’ sample represents a PCR amplified with water instead 
of the cDNA template (PCR negative control). ‘L’ is DNA ladder. 
 
 
















3.6 NANOS2 CRAC in SSC lines 
 
After optimising NANOS2 CRAC in HEK293t cells, I proceeded with CRAC in 
in vitro SSC lines. First of all, I tested the protein immunoprecipitation from a 
Nanos2TAG/TAG 10 cm2 plate, to estimate the amount of material that I would 
need for the experiment.  
After preparing protein extracts and performing SDS-PAGE, I ran a western 
blot and probed the membrane with an Anti-V5 antibody. As shown in Figure 
3.7 A, NANOS2 could be immunoprecipitated specifically from Nanos2TAG/TAG 
SSCs and not from the control. However, the efficiency of the IP was not high, 
since a fraction of NANOS2 was still found in the flow through (FT). 
Subsequently, Nanos2CTL and Nanos2TAG/TAG lines were grown in eight 150 
cm2 plates, and CRAC was performed with the same conditions used for 
HEK293t. Results from the autoradiography are shown in Figure 3.7 B. 
Strikingly, a faint band with the molecular size of TAG-NANOS2 was already 
visible on the film after a few hours, but became evident after 24 hours. 
Additionally, the smear above TAG-NANOS2 indicated a partial RNA 
digestion. Importantly, almost no background signal was observed in the 
Nanos2CTL, indicating that NANOS2 specifically bound to RNA, in mouse SSC 
lines. The absence of strong bands on the film, at other molecular sizes, 
suggested that TAG-NANOS2 did not co-purify other RBPs, as expected after 
using very stringent purification conditions.  
Therefore, this data indicated that NANOS2 bound directly to RNA in SSCs.  
To prepare libraries, RNA was purified and reverse transcribed. First of all, I 
tried to amplify the cDNA by PCR with 22 cycles, as previously done for the 
CRAC in HEK293t. However, after running the PCR product in a MetaPhor 
agarose gel, I could detect only a weak DNA signal (Figure 3.7 C, black dotted 
rectangle), although this present only in the Nanos2TAG sample. Additionally, 
after gel-purifying this library, I did not obtain enough material for sequencing. 
Thus, I repeated the PCR using 28 cycles, and the same was done for the 
negative control. This time I could detect a clear DNA smear, which was 
 
 105 
present only in the Nanos2TAG sample (Figure 3.7 D). This result indicated that 
although I greatly increased the number of PCR cycles, I did not amplify non-
specific DNA from the negative control. These libraries were gel-purified in 
order to exclude adapter-dimers and sent for sequencing. 
Afterwards, I repeated the experiment another time from the same cell lines 
(technical replicate) and importantly, I could confirm the same autoradiogram 
and PCR results. Moreover, I also performed CRAC from other two SSC lines, 
Nanos2CTL and Nanos2TAG/+ (biological replicate). Strikingly, also this 
experiment validated previous results, reinforcing the fact that NANOS2 binds 









Figure 3.7. NANOS2 CRAC in SSC lines.  
A. Endogenous NANOS2 immunoprecipitation (IP) from Nanos2CTL (Nanos2+/+) and 
Nanos2TAG (Nanos2TAG/TAG) SSC lines. Input, flow through (FT) and IP samples are 
shown in the blot. The same membrane was also stained with Ponceau as a quality 
control for IP-western-blot. B. Autoradiogram showing the radioactive signal 
associated to NANOS2-RNA complexes in Nanos2TAG. Red dotted rectangles indicate 
the area from which protein-RNA complexes were extracted and purified from the 
membrane. The film was exposed for 24 hours. C. PCR optimisation to amplify CRAC 
libraries from cDNA. The PCR product amplified with 22 cycles was analysed in an 
agarose gel. Black dotted rectangle indicates the library (faint smear) which was gel-
purified. D. cDNA was amplified again by using 28 cycles of PCR. Red dotted 



























































3.7 NANOS2 CRAC analysis 
 
3.7.1 Reads filtering and quality controls  
Four CRAC libraries were subjected to high-throughput sequencing using an 
Illumina NextSeq500, on a single-end run. Libraries included two independent 
replicates (technical replicates) from a Nanos2TAG SSC line, as well as two 
negative controls from a Nanos2CTL line. High-depth sequencing generated a 
total of 427 million reads, ranging from 0.76 million and 209.8 million reads, 
depending on the sample (Table 3.1).  
 













Nanos2CTL 1 0.77 0.08 4.2 - 
Nanos2CTL 2 82 7.3 3.5 - 
Nanos2TAG 1 134 12.6 4.8 158 
Nanos2TAG 2 210 28.5 7.7 3.9 
 
Table 3.1. Number of sequencing reads obtained from CRAC. The table shows 
numbers (No) of raw and collapsed reads, generated by FastQC Report. Ratio 
between Nanos2TAG and Nanos2CTL reads are also reported in the last column of the 
table. 
 
Dr. Turowski performed the initial reads processing and the bioinformatic 
analysis. First of all, in-line barcodes, which are specific for each sample, were 
removed from raw reads. Additionally, in order to remove PCR duplicates, 
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reads with the same UMI were collapsed to single reads. These reads were 
also subjected to quality-filtering, before aligning them to the mouse genome. 
Importantly, Nanos2TAG replicates had more reads than Nanos2CTL. Moreover, 
the ratio of Nanos2TAG to Nanos2CTL reads showed a 158-fold and 3.9-fold 
enrichment for the first and the second replicate, respectively (last column, 
Table 3.1). Overall, this indicated a successful enrichment of RNA in 
Nanos2TAG samples compared to controls. 
Pre-processed reads were aligned to the mouse genome (mm10), by using 
different alignment programs. First of all, we assessed the degree of similarity 
among replicates by measuring the Spearman correlation coefficients (r). In 
Figure 3.8, correlation is displayed as a heatmap, and r values are provided 
on the right, with r=1 meaning perfect correlation and r=0 no correlation (anti-
correlation is not shown). Strikingly, Nanos2TAG replicates (1 and 2) were 
highly correlated between each other (r~0.8). Moreover, Nanos2TAG samples 
showed no correlation with Nanos2CTL, indicating the high specificity of the 
CRAC experiments. Eventually, Nanos2CTL replicates poorly correlated with 
each other (r~0.3), suggesting that only non-specific RNAs were purified from 





Figure 3.8 Heatmap showing Spearman correlation coefficients (r) for CRAC 
samples. 
Heatmap showing the level of correlation among Nanos2CTL and Nanos2TAG reads 
and among different replicates (1 and 2). Spearman correlation coefficients (r) are 
shown on the right. r=1 means perfect positive correlation and it is in faint pink; r=0 
means no correlation and is shown in black.  
 
 
3.7.2 Analysis of the genomic distribution of CRAC reads 
 
After evaluating the similarity among different CRAC samples, we sought to 
determine the identity of the RNAs bound by NANOS2. To do so, we analysed 
the genomic distribution of CRAC reads among different classes of RNA (eg. 
rRNA, mRNA, snRNA, etcetera) (Figure 3.9). Strikingly, both Nanos2TAG 
replicates showed that the vast majority of NANOS2 targets were constituted 























Figure 3.9 Genomic distribution of NANOS2 CRAC reads among different 
classes of RNA.  
Bar graph showing the distribution of CRAC mapped reads among various RNA 
classes, listed on the right. Reads come from Nanos2CTL and Nanos2TAG samples. 
Both replicates (1 and 2) are shown. Reads have not been normalised.  
 
 
This class was followed by miRNA (3.06%), rRNA (1.885%), lincRNA (1.8%), 
snRNA (0.965%), antisense (0.475%), and others (2.98%). The class ‘others’ 
included mainly processed pseudogenes, but also: transcribed processed 
pseudogenes, miscRNA, processed transcripts, sense intronic, Mt rRNA, 
unprocessed pseudogenes, snoRNA, transcribed unprocessed pseudogenes 
(see the Ensembl database for the exact definition of each category). 
Thus, these data revealed for the first time that NANOS2 also binds to non-
coding RNAs (ncRNA), and not only to mRNAs, although to a small extent.  
 
Importantly, Nanos2CTL and Nanos2TAG displayed distinct genomic distribution 


























such as rRNA and snRNA, in both replicates. Overall, this highlighted again 
the high specificity of the CRAC experiments. 
 
Furthermore, by analysing the list of NANOS2 CRAC targets (ranked 
according to the number of mapped reads), I noticed that miRNAs were often 
found among the highest positions. In Table 3.2, I listed the majority of miRNA 
targets and annotated their CRAC ranking position. Additionally, while 
examining this list I noticed that many miRNAs were located on the X-
chromosome (highlighted in red in Table 3.2). Then, I analysed the NANOS2 
CRAC signal associated to these X-linked miRNAs, by using the IGV 
(Integrative Genomics Viewer) (Robinson et al., 2011), and I noticed that many 
were located in the same genomic region (Figure 3.10). Interestingly, this 
miRNA-rich locus has also been described by other authors (Zhang et al., 
2019), who performed small RNA sequencing from different spermatogenic 
populations of adult mouse testis. The expression of these miRNAs was shown 
to be testis-specific, and the locus was found to be highly conserved across 
mammals, including human. Therefore, these miRNAs have been called 
‘spermatogenesis-related miRNAs’ or ‘spermiRs’. Figure 3.10 shows a 
snapshot of this X-linked locus with the spermiRs and their associated 
NANOS2 CRAC signal.  
In summary, these data suggest that miRNAs constitute a novel class of 
NANOS2 targets, which also includes a highly conserved X-linked miRNA 






Table 3.2 List of miRNAs present among NANOS2 CRAC targets.  
miRNAs in the NANOS2 CRAC list are ranked according to their average number of 
mapped reads, obtained from two CRAC. MiRNA targets which are on the X-
chromosome are highlighted in red, whereas miRNAs complementary to Mcm7 on 









Figure 3.10 Snapshot of an X-linked locus, showing NANOS2 CRAC signal.  
NANOS2 binds to specific miRNAs (also known as spermiRs), shown in blue. Peaks 
come from Nanos2CTL and Nanos2TAG samples, replicates 1 and 2 (Rep). The genomic 
strand (Fw or Rv) for each sample is also shown on the right. Specific miRNA names 
are shown on the bottom (eg. Mir743, Mir742 etcetera). NANOS2 CRAC signal 
(number of mapped reads) was visualised with IGV. 
 
 
Moreover, by analysing the same list of miRNA targets, I noticed another 
interesting group of miRNAs. This included miRNA 25, 106b and 93 
(highlighted in green in Table 3.2), which come from the same genomic locus, 
on chromosome 5. Interestingly, they all overlap the same gene, Mcm7, which 
is the mini-chromosome maintenance complex component 7. This gene is 
highly conserved across eukaryotes, and it is involved in the initiation of DNA 
replication, cell cycle regulation, and it is over-expressed in many cancers 
(Blow and Dutta, 2005; Hua et al., 2014; Tian et al., 2017). Importantly, these 
three miRNAs (25, 106b and 93) are conserved in human, where they also 
overlap the Mcm7 gene, on chromosome 7. Overall, these data suggest that 
NANOS2 binds to another group of conserved miRNAs, whose biological 

































3.7.3 Analysis of NANOS2 peaks and normalisation of CRAC signal to 
mRNA abundance in SSCs 
 
Since mRNA represented by far the most abundant class of NANOS2 targets, 
we followed up on this category of transcripts. Since NANOS2 is localised in 
the cytoplasm, we assumed that it bound mainly to mature mRNAs, without 
introns. Therefore, we decided to align CRAC reads to the mouse 
transcriptome, and to use this alignment for the rest of the analysis. CRAC 
reads contained a certain number of deletions, which were induced by the UV 
cross-linking and reverse transcriptase, during the CRAC protocol (see 
Chapter 1 and also afterwards). Since these deletions could be useful to detect 
NANOS2 binding site on RNA, we used them for the motif enrichment analysis.  
In order to precisely map reads with deletions to the transcriptome, we used 
an alignment program that had a certain tolerance for gaps (see Material and 
methods). The resulting alignment showed that approximately 5000 genes had 
a CRAC signal, expressed as reads per million (rpm). In order to identify the 
exact genomic location of NANOS2 binding sites, peaks were called for both 
Nanos2TAG replicates. Since Nanos2CTL samples had previously shown no 
positive correlation with Nanos2TAG, we did not call peaks for Nanos2CTL, as 
they would not even be useful to control the background noise. 
Peak calling for Nanos2TAG samples identified a list of genes ranked according 
to the ‘peak score’, defined as the number of reads (rpm) associated with all 
peaks in that gene. Although ‘peak scores’ for both replicates were very 
similar, we decided to use their average rpm values. Eventually, ~2000 genes 
were identified as containing confident NANOS2 CRAC peaks.  
 
So far, NANOS2 binding intensity on RNA was expressed as ‘peak score’ 
(rpm). However, the binding intensity between an RBP and its targets depends 
on at least three factors. First, the structural and chemical properties at the 
amino acids-ribonucleotides interface; second, the physiological levels of the 
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RBP in cells; third, the physiological levels of the interacting RNAs, in the same 
cellular compartment of the RBP.  
CRAC signal or ‘peak score’ can be considered as a measure directly 
proportional to the first factor, although it does not completely take into account 
the third one, that is RNA abundance in cells.  
Therefore, to obtain a more precise estimation of NANOS2 binding intensity to 
its targets, we also decided to quantify mRNA abundance in SSCs. To this 
end, we performed RNA-seq from two biological replicates, constituted by 
Nanos2TAG/TAG and Nanos2TAG/+ SSC lines. SSCs were grown until confluency 
and purified from MEF co-culture, as explained in Material and methods. 
mRNA-seq libraries were prepared and subjected to high-throughput 
sequencing. Eleven million reads were mapped to the mouse genome for each 
replicate, and fpkm (fragments per kilobase million) values for both replicates 
were calculated. Only average fpkm values from both replicates were 
considered for further analysis. 
Importantly, the correlation between CRAC ‘peak scores’ (rpm) and signal from 
RNA-seq (fpkm) was shown to be weak, although positive (0.042). This 
suggested that CRAC signal was mainly affected by NANOS2 binding 
intensity, rather than by transcript abundance.  
Then, we proceeded with the normalisation of CRAC signal over mRNA levels 
in SSCs, by dividing ‘peak scores’ (rpm) by the average fpkm. Values obtained 
from this ratio were used to rank again CRAC peaks, which generated a new 
list of normalised NANOS2 CRAC targets. This new list, called “normalised 
CRAC list” from now onwards, was used for all the remaining analysis.  
After this normalisation, the number of NANOS2 peaks was reduced from 
~2000 to 1428 genes. This decrease was due to the exclusion of many genes, 






3.7.4 Transcriptomic features of the normalised NANOS2 peaks 
 
To explore NANOS2 binding pattern across its targets, we examined how 
many times NANOS2 bound each transcript. Strikingly, we found that the 
majority of NANOS2 targets had a single peak, whereas smaller proportions 




Figure 3.11 Number of NANOS2 CRAC peaks per transcript.  
The bar graph shows the distribution of NANOS2 peaks among its targets. In 
particular, it shows the number of targets which has only 1 or more (2, 3, 4, or 5) 
peaks per transcript (peak count). 
 
 
Furthermore, we inspected the shape of NANOS2 peaks in the IGV 
(Integrative Genomics Viewer). Representative examples of NANOS2 peaks 
are shown in Figure 3.12. Interestingly, the highest peaks present in these 
genes are always located in the last exon, which includes the 3' UTR.  
Although sometimes multiple peaks per gene are present, these have 
















Therefore, this suggested that the majority of transcripts with multiple peaks 




Figure 3.12 Representative examples of NANOS2 CRAC peaks in three targets.  
The number of mapped reads from Nanos2CTL and Nanos2TAG CRAC samples 












































































































representative targets are displayed in the picture: Dmrt1 (A), Taf7l (B), and Zfand6 
(C). The genomic strand (Fw or Rv) for each sample is shown on the right. Peaks’ 
positions are also shown in relation to exons and introns.  
 
 
Moreover, to better understand how NANOS2 regulated its targets, we 
mapped peaks according to different regions of protein-coding transcripts: 5' 
UTR, CDS (coding sequence) and 3' UTR. These regions are known to be 
functionally different, and they associate to distinct RBPs and regulatory small 
RNAs which, in turn, determine the fate of that transcript (see Chapter 1). 
Remarkably, the vast majority of NANOS2 peaks mapped to 3' UTR, (81.1%), 
whereas only a small portion mapped to CDS (17.9%), and almost none of 
them was found in 5' UTR (1.1%) (Figure 3.13). Therefore, NANOS2 binding 
mainly occurred in the 3' UTR of protein-coding genes, which is a critical region 
for the regulation of mRNA stability and translation. Overall, these data 
suggest that NANOS2 might exert a key role in the post-transcriptional 








Figure 3.13 Metaprofile of NANOS2 binding sites along the 5' UTR, CDS, and 3' 
UTR of mRNA targets. 
A. The graph shows NANOS2 binding profile along the three regulatory regions of 
mRNA: 5' UTR, CDS, and 3' UTR. In the x-axis the lengths of each region correspond 
to the average lengths of all 5' UTRs, CDSs, 3' UTRs used in the analysis. B. Relative 
proportions (percentages) of NANOS2 peaks within the three regions are also 
reported in the pie chart.  
 
 
3.7.5 Characterisation of NANOS2 direct binding site using reads with 
deletions and de novo motif analysis 
 
To gain insight into how NANOS2 selects its targets in SSCs, we sought to 
determine whether it bound RNA with sequence specificity. 
To that end, we performed de novo motif analysis by using MEME-ChIP 
(Bailey et al., 2009). As input for the analysis, we used both normalised and 
non-normalised NANOS2 peaks (see the previous part) and compared the 
results. Moreover, we also took advantage of sequencing reads containing 
deletions. Indeed, deletions can be used to precisely map the binding site of 
























Therefore, NANOS2 CRAC reads were filtered in order to select the ones with 
deletions. These reads were centred on deletions, and only one hundred or 
twenty nucleotides in the proximity of deletions were further analysed. 
We used reads with and without deletions to perform motif enrichment 
analysis. We also used either all NANOS2 peaks or the highest peak per gene. 
Additionally, we selected different subsets of genes from both the normalised 
and non-normalised CRAC lists and compared the results. Interestingly, a 
common motif appeared to be enriched in CRAC targets, in almost all the 
cases described above. 
Here, I show only one example of the various analyses performed.  
In this case, we selected the first half of the normalised CRAC peaks (714 out 
of 1428 peaks), which corresponded to 5530 deletions. Also, we selected only 
twenty nucleotides around deletions. As a negative control, we used the same 
sequences, but shuffled. Interestingly, MEME-ChIP showed that an AU-rich 
heptamer, ‘AUNAANU’, was enriched with high confidence (P-value =1.5 e-067) 
in 970 deletions, one-fifth of the total (Figure 3.14 A). Since we considered only 
twenty nucleotides around deletions, we estimated that actually more reads 
were likely to contain this motif, downstream from the cross-linked nucleotides.  
Visual inspection of these reads revealed that one or more uridine residues 
(U) were often present in the centre, at positions corresponding to the cross-
linked nucleotides or deletions. Remarkably, a uridine residue stood out in the 
centre of the motif  
Overall, this suggested that uridine residues were the most probable 
ribonucleotides directly interacting with NANOS2.  
 
Examples of NANOS2 targets containing the motif adjacent to deletions 
(uridines) are shown in Figure 3.14 B.  
As mentioned before, the ‘AUNAANU’ motif was repeatedly found in many of 
the analyses performed. However, when analysing the top two or three 
hundred targets, from the normalised CRAC list, the motif became even more 
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U-rich, with the third nucleotide changing from N to U, ‘AUUAANU’ (data not 
shown). 
 
Strikingly, this motif was not found in the ATtRACT database (Giudice et al., 
2016), which contains all known RBP motifs. Therefore, the RNA heptamer 
‘AUNAANU’ represented a novel motif, exclusively bound by NANOS2. 
Interestingly, MEME-ChIP did not detect additional motifs with comparable P 
values, following this one. This suggested that NANOS2 targets did not contain 
other known RBPs motifs, in the proximity of NANOS2 binding site. 
Importantly, the enrichment of the ‘AUNAANU’ motif among CRAC targets did 
not correlate with CRAC signal intensity. This suggested that additional 
factors, other than sequence specificity, could also influence targets’ selection 
and determine the intensity of NANOS2 binding to RNA.  
 
In summary, these data indicated that NANOS2 binds RNAs enriched for the 
novel ‘AUNAANU’ motif, and therefore this RBP displays sequence specificity 




Figure 3.14. De novo motif analysis using NANOS2 CRAC targets.  
A. CRAC reads containing deletions (cross-linking sites) were analysed by performing 
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shown as a logo in the figure, with the corresponding P-value. B. Sequence alignment 
of a subset of NANOS2 reads containing the ‘AUNAANU’ motif (in red). Reads were 
centered on deletions (central ‘U’, in bold red), which correspond to the most probable 
cross-linking sites (and direct NANOS2 binding site).  
 
 
3.7.6 In silico prediction of the secondary structure of the NANOS2 motif 
sequence, using Taf7l 3' UTR 
 
So far, I have shown that NANOS2 specifically binds the 3' UTRs of mRNAs, 
enriched in the novel ‘AUNAANU’ motif. Additionally, this motif was often 
located near some uridine bases, which represented most likely the direct sites 
of interaction between NANOS2 and RNA. 
It is reasonable to speculate, that the ‘AUNAANU’ sequence need to be 
located in an accessible region of the RNA, in order to allow NANOS2 binding.  
To address this hypothesis, I sought to understand the spatial conformation of 
NANOS2 binding sites, by taking into account also regions in the proximity of 
the motif. Thus, I choose one of the NANOS2 targets containing the motif, 
Taf7l, and selected its 3' UTR sequence. Then, I performed a preliminary 
analysis of its secondary structure by using the ‘RNAfold web server’ (Gruber 
et al., 2008; Hofacker, 2003). As shown in Figure 3.15, two possible secondary 
structures are predicted for this 3' UTR. In ‘A.’ it is shown the minimum free 
energy structure (MFE), and in ‘B.’ the centroid structure (Ding et al., 2005), 
which is an alternative way to model RNA structures. Apart from the central 
region, both algorithms show a similar conformation for Taf7l 3' UTR, which 
makes the overall prediction more reliable. Then, to assess the local 
conformation in the close proximity of NANOS2 motif, I first identified the 
‘AUNAANU’ sequence within both structures, (arrows in Figure 3.15). It is 
worth noting that in the drawing, each base has a colour that reflects the 
probability of base-pairing, with blue representing the minimum base-pair 
probability (0), and red the maximum one (1). Strikingly, in both structures, 
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most of the nucleotides included in the NANOS2 motif are not engaged in 
strong base pairing (they are coloured in green or light blue). Indeed, these 
bases reside within one or two loops, depending on the MFE or centroid 
structure. Overall, this suggested that the RNA bases of the NANOS2 motif 
are in a relatively open conformation, which is not highly structured. 
Importantly, this might increase the chances of NANOS2 binding to the 
‘AUNAANU’ sequence.  
However, further analysis will be necessary to confirm that this type of 
secondary structure is also present in the rest of NANOS2 motifs, from the 




Figure 3.15. Prediction of Taf7l 3' UTR secondary structure, using the ‘RNAfold 
web server’.  
A. MFE (minimum free energy) secondary structure of Taf7l 3' UTR. On the right, 
zoom-in of the region containing the NANOS2 motif (arrow). B. Centroid secondary 








3.7.7 Identity of NANOS2 targets and Gene ontology analysis 
 
In order to better understand how NANOS2 maintains SSCs, we sought to 
relate NANOS2 CRAC targets to their biological function. Thus, I searched for 
the biological processes enriched in NANOS2 targets, by using the g:Profiler 
software (Reimand et al., 2019). The normalised list of CRAC targets, including 
1428 genes, was provided to the software, and results were subsequently 
analysed. As shown in Figure 3.16 A, NANOS2 targets were mainly enriched 
in cellular metabolic processes which concerned “cellular macromolecules”, 
“nitrogen compounds”, “proteins”, “organic substances”, “nucleic acids”, 
“nucleobase-containing compounds”, “RNA”, “heterocycle”, “cellular aromatic 
compounds” as well as “regulation of metabolism”. Besides these metabolic 
processes, also “organelle organisation” and “gene expression” were found to 
be enriched.  
I noticed that the majority of these processes belonged to broad biological 
categories, and additionally, they were closely related to each other, 
suggesting a certain degree of redundancy.  
In order to simplify the interpretation of GO results, and to potentially discover 
more specific biological functions, I reduced the GO term size from 10000 to 
1000. Results are shown in Figure 3.16 B. Interestingly, this analysis revealed 
enrichment for additional processes, such as “protein modification by small 
protein conjugation”, “translation”, “chromatin organisation”, “protein 
ubiquitination”, and “regulation of translation”. However, they also confirmed a 






Figure 3.16. Gene ontology (GO) analysis performed on ranked NANOS2 CRAC 
targets. GO performed with term size of 10,000 (A.), or 1,000, (B.).  
Term size = 10,000
A
B
Term size = 1,000
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Therefore, NANOS2 mainly binds to transcripts involved in macromolecules 
metabolism, including nucleic acids and proteins, and more specifically 
nitrogen and aromatic compounds. Additionally, NANOS2 binds to regulators 
of cellular metabolism, probably to ensure a more robust control on this cellular 
process.  
However, NANOS2 targets are also involved in gene expression at multiple 
levels, including chromatin organisation, translation, and its regulation, as well 
as post-translational modifications, such as ubiquitination.  
Overall, these results indicate that NANOS2 might have an important role in 
controlling SSC growth, through the regulation of major biosynthetic 
processes. Furthermore, by binding to mRNAs which regulate gene 
expression at multiple layers, NANOS2 could shape SSC identity and thus 
pave the way for either self-renewal or differentiation.  
  
Tight regulation of cellular metabolism is known to be essential for SSCs. In 
particular, the repression of the mTOR pathway is critical to maintain the self-
renewing SSC pool over time (Hobbs et al., 2010; Wang et al., 2016). NANOS2 
was related to mTORC1 by virtue of their physical protein-protein interaction, 
which leads to mTORC1 trapping in stress granules and reduces translation 
levels in SSC lines. This mechanism is also thought to contribute to the 
repression of NANOS2 targets (Zhou et al., 2015). To further explore the 
relation between NANOS2 and the mTOR pathway, I assessed whether 
NANOS2 interacted with mTorc1 mRNA and mTOR regulators (defined as in 
MGI informatics, GO terms database). Although I did not detect mTorc1 among 
CRAC targets, strikingly, I could identify eleven positive mTOR regulators out 
of thirty-nine, in our CRAC list. Interestingly, only three negative mTOR 
regulators out of forty-six were recruited by NANOS2, and they were bound 
only with a moderate intensity (none of them was found within the first 500 
CRAC targets). In contrast, five positive mTOR regulators out of eleven were 
present among the top 500 CRAC targets, and they were: Lamtor3, Rheb, 
Xbp1, Rictor and Mios. Overall, these findings suggest that NANOS2 might 
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regulate mTOR signalling through direct binding of its positive regulators. This 
could potentially constitute an additional mechanism through which NANOS2 
keeps under control mTOR pathway in SSCs, in order to preserve their self-
renewal. 
 
Afterwards, I assessed whether known NANOS2 targets, previously 
determined by RIP in SSCs (Zhou et al., 2015) and embryonic gonads (Saba 
et al., 2014), were also identified by CRAC. Among the most confident RIP 
candidates, there were Taf7l, Sohlh2, Dmrt1, and Dazl, all involved in germ 
cell differentiation (see Chapter 1). Interestingly, I found that only Taf7l and 
Dmrt1 were confirmed by CRAC, indicating that Sohlh2 and Dazl are not 
directly bound by NANOS2 in SSC lines. 
 
In summary, I have shown that NANOS2 targets are enriched for cellular 
metabolic processes and that they also include positive mTOR regulators.  
Therefore, these data suggest that upon direct recruitment of various 
metabolism-related transcripts, NANOS2 might control SSC growth and thus 
preserve the self-renewing SSC pool for a long time. 
 
3.8 Analysis of the transcriptional changes through spermatogonia 
development and comparison with NANOS2 CRAC targets 
 
In order to better understand the biological function of NANOS2 targets in 
SSCs, we sought to analyse their expression across SSC development, in the 
adult testis. Therefore, we characterised the transcriptomic profile of three 
different stages of spermatogonia by performing RNA-seq. The first stage we 
analysed was the self-renewing SSC pool, marked by Gfrα1. The second 
population of spermatogonia was represented by transit-amplifying cells, 
which express Miwi2 (Carrieri et al., 2017). The third stage was constituted by 
differentiated spermatogonia, marked by both Miwi2 and c-kit. Importantly, 
most of the Nanos2 positive cells also express Gfrα1, as determined by 
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previous studies and also our IF data. Therefore, the first stage of 
spermatogonia that we analysed, was also the one closest to Nanos2 
expressing cells. 
In order to isolate these three populations from adult mouse testes, we 
employed two different transcriptional reporter alleles, available in our 
laboratory: a Gfrα1GFP allele (Hara et al., 2014), where the gene encoding the 
GFP protein was inserted into the Gfrα1 locus, and a Miwi2TOM allele (Carrieri 
et al., 2017), where the gene encoding the Tomato protein was inserted into  
the first exon of Miwi2. These two alleles have been crossed to generate a 
Gfrα1GFP/+; Miwi2TOM/+ line, which was used for FACS. Spermatogonia have 
been isolated from testes of Gfrα1GFP/+; Miwi2TOM/+ mice by FACS, whose 
gating strategy is shown in Figure 3.17. The first two stages of spermatogonia 
were selected by gating the single and live cells. Somatic cells were gated out 
by using the CD45 and CD51 markers (CD45neg CD51neg, live cells). Then, to 
select only undifferentiated spermatogonia, we sorted cells positive for the 
surface marker CD9, and we gated out c-kit-positive cells (c-kitneg; CD9pos 
cells). Next, we analysed the GFP fluorescent signal, which indicated the 
expression of Gfrα1+ SSCs, and the Tomato fluorescence, for the Miwi2-Tom+ 
cells. Thus, we isolated the GFPpos, TOMneg cells, which represented the 
Gfrα1+ cells and, at the same time, we sorted the GFPneg, TOMpos cells, which 
are the Miwi2-Tom+ cells (Figure 3.17 A). Additionally, by using other mice, we 
also sorted the third stage of spermatogonia, by gating the live, CD45neg 
CD51neg cells, and selecting the Miwi2-Tom+ c-kit+ cells (Figure 3.17 B).  
RNA was isolated from these populations in order to generate mRNA libraries 
for sequencing. FACS and RNA isolation have been performed by Dr. Ivanova, 
whereas the subsequent bioinformatic analysis was performed by Dr. Enright 
and his group.  
First of all, we analysed the similarity among the four biological replicates 
(Figure 3.18). Importantly, principal component analysis (PCA) showed that 
our samples clustered only according to the spermatogonial stage, which was 
either Gfrα1+ (green circles), or Miwi2-Tom+ (red triangles), or Miwi-Tom+ c-kit+ 
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(blue squares). Therefore, the four replicates displayed very low biological 
variability. 
Then, we characterised gene expression patterns across the three populations 
of spermatogonia. To this end, we used the Markov clustering algorithm 
(Freeman et al., 2007), which identifies clusters of genes whose expression 
profile varies across different developmental stages .  
This analysis revealed that twenty-two clusters of genes had different profiles 
across spermatogonia development. The full list of clusters, with the 
corresponding number of genes per cluster, is shown in Table 3.3, whereas 
the expression dynamics of the first ten clusters are shown in Figure 3.19.  
Cluster 1 was the most remarkable group of genes undergoing transcriptional 
changes across the three developmental stages and included more than six 
thousand genes. Interestingly, this cluster represented genes which were 
expressed at a moderate level in Gfrα1+ SSCs, and which were acutely up-
regulated during the transition from self-renewing SSCs (Gfrα1+), to transit-
amplifying cells (Miwi2-Tom+). Moreover, upon differentiation (Miwi2-Tom+ c-
kit+ cells), the same group of genes underwent a significant down-regulation. 
Similarly, clusters 5, 7, and 10, displayed analogue dynamics across 
development. Overall, these four clusters represented the great majority of 
transcripts identified by the Markov algorithm.  
Cluster 2 contained the second largest group of genes, over four thousand. 
This cluster included genes which were sharply down-regulated from the first 
to the second stage of spermatogonia, and which continued to decrease their 
expression level until differentiation (third stage).  
 
Next, we sought to determine whether NANOS2 targets were significantly 
enriched or depleted in any of the clusters identified. This analysis was 
performed by Dr. van der Lagemaat. 
NANOS2 targets were selected from the normalised CRAC list, which included 
1428 genes. Surprisingly, NANOS2 targets were slightly enriched or over-
represented only in cluster 1 (P-value < 0.05). Moreover, they were depleted, 
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or under-represented, only in cluster 2 (P-value < 0.01) (see P-values in red in 
Figure 3.19). Given the expression profiles of these two clusters, these data 
indicated that most likely NANOS2 bound to many transcripts which were up-
regulated during the transition from Gfrα1+ to Miwi2-Tom+ cells. 
 
In summary, this analysis suggested that most of the transcriptional changes 
occurring through the three developmental stages analysed, were represented 
by cluster 1. This group included transcripts whose expression increases from 
self-renewing SSCs to transit-amplifying cells.  
Importantly, NANOS2 targets showed a modest overrepresentation among 
genes in cluster 1.  
 
Nanos2 expression decreases along the three stages analysed. Thus, these 
data suggested that NANOS2, upon binding to a group of genes in cluster 1, 
might repress them in Gfrα1+ cells. Then, once SSCs start to lose NANOS2 
(Miwi2-Tom+ cells), these genes would be released from its repression and 
become up-regulated.  
Since these genes are involved in the metabolism of nucleic acids and 
proteins, these data indicate that NANOS2 might control SSCs growth in 
Gfrα1+ cells, by preventing excessive proliferation and thus preserving the self-





Figure 3.17. Gating strategy used to sort ex-vivo three distinct populations of 
spermatogonia from adult testes, by FACS.  
A. Spermatogonia have been sorted according to size and shape (SSC-A, FCS-A) 
and cell debris were excluded. Single cells (singlets) were selected according to FSC-
H and FSC-A (and also to SSC-H and SSC-A). Somatic cells were gated out by 
selecting CD45neg; CD51neg cells. Dead cells were also excluded by using a living dye 
(Sytox Blue). Undifferentiated spermatogonia were selected by gating for c-kitneg; 
CD9pos cells. SSCs were selected by gating the GFPpos, TOMneg cells (Gfrα1+). Transit-
amplifying spermatogonia were selected by gating the GFPneg, TOMpos cells (Miwi2-
Tom+). B. Representative FACS analysis of Miwi2pos, c-Kitpos cells (Miwi2-Tom+ c-kit+), 
which represent differentiating spermatogonia. These cells are live, CD45neg, 
CD51neg. The populations used for mRNA-seq and Markov clustering analysis are 
































Table 3.3. List of clusters identified across three stages of adult spermatogonia. 





Figure 3.18. Principal component analysis (PCA) of RNA-seq samples from 
adult spermatogonia.  
RNA-seq was performed on three populations of spermatogonia, Gfrα1+, Miwi2-Tom+, 
and Miwi2-Tom+ c-kit+, and four different mice have been used to sort each 
population. PCA shows the variability among the four biological replicates, and in 
relation to the spermatogonia stage. PC1, which explained most of the variance of the 




























Figure 3.19. Results of Markov clustering analysis performed on three 
developmental stages of spermatogonia.  
The graphs show the expression profile of ten gene clusters, across three populations 
of spermatogonia: Gfrα1pos (1), Miwi2-Tompos (2), and Miwi2-Tompos c-kitpos (3). The 
number of genes present in each cluster is reported. Additionally, we have 
investigated whether NANOS2 CRAC targets were significantly over- or under-
represented among any of these clusters. The P-values, for both enrichment and 
depletion, were calculated from the hypergeometric test. Statistically significant P-
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3.9.1 NANOS2 binds directly to RNA both in HEK293t cells and in SSC 
lines 
 
In this chapter, I have shown how we developed a Nanos2TAG mouse allele, 
by gene targeting in mouse. Nanos2TAG expresses a TAG-NANOS2 fusion 
protein, whose complex tag allowed performing both biochemical experiments 
(CRAC) and in vivo localisation studies. Importantly, I have shown that the tag 
did not impair NANOS2 function in male germ cells. Histological analyses of 
testicular sections from Nanos2TAG mice revealed that TAG-NANOS2 could 
sustain spermatogenesis fully, even in the long term. Moreover, NANOS2 
localisation in vivo is not disrupted by the tag, as assessed by 
immunofluorescence of whole-mount seminiferous tubules. Indeed, NANOS2 
is correctly expressed in the self-renewing SSCs pool, marked by Gfrα1, and 
it does not co-localise with c-kit, a marker of differentiated spermatogonia.  
 
To perform CRAC in SSCs, I derived SSC lines from Nanos2TAG pups, 
assessed NANOS2 expression both by WB and by FACS, and expanded 
SSCs in vitro. However, NANOS2 is low abundant in SSC lines, and 
additionally, these cells divide very slowly. Since CRAC requires high amounts 
of material, applying it to SSC lines constituted a major challenge. Thus, I first 
optimised it by over-expressing TAG-NANOS2 in HEK293t cells (NANOS2OE), 
and only later, I performed CRAC in SSC lines.  
 
By using NANOS2OE HEK293t cells, I optimised the main steps of the CRAC 
protocol, which revealed that TAG-NANOS2 was suitable for CRAC. 
Moreover, by performing the entire CRAC protocol, we discovered that 
NANOS2 binds directly to RNA in human cell lines. Hence, I used exactly the 
same conditions to perform CRAC in SSC lines and, importantly, I could 
confirm that NANOS2 binds directly to RNA also there.  
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Remarkably, the fact that NANOS2 can bind to RNA in both cell types, strongly 
suggests that it does not require additional SSCs-specific factors (e.g., RBPs) 
to bind to RNA. In contrast, NANOS ortholog in Drosophila (dNANOS) needs 
PUMILIO in order to shift RNA, as shown by EMSA (Sonoda and Wharton, 
1999; Weidmann et al., 2016). Thus, although the RNA-binding ability of 
dNANOS was tested only by EMSA and not by CRAC, it seems that the mode 
of RNA-binding of NANOS orthologs is not fully conserved among different 
organisms.  
 
Moreover, the strong radioactive signal on the CRAC films indicated that 
NANOS2 cross-links well to RNA, using the UV light. Indeed, by examining the 
amino acid sequence of NANOS2 zinc fingers and its proximity, I observed 
many amino acids which are known to have high cross-linking potential 
(Shchepachev et al., 2019). These include three aromatic residues, F, Y, H as 
well as three positively charged, H, R, K and two aliphatic, P and G. Since 
these amino acids are present in the most conserved region of NANOS2, this 
suggests that also other NANOS proteins could cross-link well and may be 
suitable for CRAC. Thus, studying the RNA occupancy of NANOS paralogs 
and orthologs by CRAC (or CLIP) is potentially possible, in mouse and in 
different organisms.  
 
3.9.2 NANOS2 binds to the 3’ UTR of mRNAs with sequence specificity, 
in mouse SSC lines  
 
Strikingly, CRAC analysis showed that ~90% of NANOS2 binding occurs on 
mRNA, in SSC lines. Moreover, after normalising CRAC signal with mRNA 
abundance, we discovered that NANOS2 binds to ~1400 transcripts, which are 
almost exclusively constituted by novel targets. 
In mouse SSC lines, NANOS2 was already shown to bind to a handful of 
mRNAs, by native RIP (Suzuki et al., 2010; Zhou et al., 2015). Therefore, our 
data corroborate the fact that NANOS2 associates with mRNAs and reveal for 
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the first time that this interaction is direct, and that occurs at the transcriptomic 
level, in mouse SSC lines.  
Moreover, also other NANOS orthologs associated with mRNAs, and these 
interactions are essential for NANOS functions (see Chapter 1). Thus, not only 
mRNAs constitute a conserved class of targets for different NANOS, but they 
could also be the means through which NANOS2 exerts its critical functions, 
in mouse SSCs. 
 
Furthermore, CRAC analysis showed that the vast majority of NANOS2 
binding (~81%) occurs in the 3’ UTR of mRNAs, in SSC lines.  
NANOS2 was already shown to associate with the 3’ UTR of Dazl in male 
gonocytes (Kato et al., 2016), and to the 3’ UTR of Sohlh2, in SSC lines (Zhou 
et al., 2015). However, our work determined for the first time that NANOS2 has 
a substantial bias towards the 3’ UTR of its bona fide targets.  
Given that post-transcriptional gene regulation extensively exploits the 3’ UTR 
of mRNAs (Mayya and Duchaine, 2019), our findings suggest that NANOS2 
might directly regulate the expression of many protein-coding genes, at the 
post-transcriptional level, and through their 3’ UTR.  
Moreover, previous studies in Drosophila have reported that dNANOS binds 
to the 3’ UTR of different mRNAs (Kadyrova et al., 2007; Sonoda and Wharton, 
1999; Wharton and Struhl, 1991). Hence, the 3’ UTR bias might be a 
conserved and critical feature of NANOS targets, also among different 
organisms.  
 
Next, we mapped NANOS2-RNA interactions at the single-nucleotide 
resolution, by using CRAC reads with deletions, which reflect the cross-linking 
sites. Strikingly this analysis revealed that NANOS2 targets are enriched in the 
novel ‘AUNAANU’ motif. Additionally, this motif is often found adjacent to or in 
the proximity of the direct binding site, which is constituted by uridine residues 
(U). Thus, NANOS2 binds to RNA with sequence specificity in mouse SSC 
lines. Interestingly, the ‘AUNAANU’ motif is seven nucleotides long, which is 
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the typical length of the RNA-motifs identified so far, in both human and 
Drosophila (Giudice et al., 2016). It is also likely that this nucleotide length 
corresponds to the space necessary to accommodate two zinc finger motifs, 
present in NANOS2 C-terminus. Indeed, it was shown that one zinc finger 
generally binds to three nucleotides (Choo and Klug, 1994). The fact that we 
found a heptameric motif instead of a perfect hexamer, it might be explained 
by the unique structure adopted by NANOS2 zinc fingers. Since these are 
separated by a particular spacing, not shared with any other known zinc fingers 
(see Chapter 1), this could justify why NANOS2 binds to seven ribonucleotides 
instead of six. 
 
So far, nobody had investigated whether NANOS2 bound to RNA with 
sequence specificity in mouse SSC lines. In Drosophila, NANOS is generally 
thought to bind to RNA without sequence-specificity (Curtis et al., 1997; 
Hashimoto et al., 2010b). Moreover, its RNA-binding ability depends on 
PUMILIO, which recruits dNANOS to RNA (Sonoda and Wharton, 1999). 
However, once dNANOS joins the PUMILIO-RNA complex, it alters PUMILIO 
sequence specificity, which becomes more AU-rich (Weidmann et al., 2016). 
Since also the novel NANOS2 motif (‘AUNAANU’) is AU-rich, this might 
implicate a certain degree of conservation in the RNA-protein interactions 
between NANOS proteins and their targets.  
 
As previously mentioned, CRAC analysis revealed that NANOS2 directly binds 
to uridine residues (U). Interestingly, the crystal structure of PUMILIO-
dNANOS-RNA showed that dNANOS mediates base-specific contacts with 
the last uridine in the ‘AUU’ sequence (Nanos binding site) (Weidmann et al., 
2016). Moreover, the three hydrophobic amino acids, present in dNANOS zinc 
fingers, which interact with that uridine, are essential to repress hunchback 
mRNA (Weidmann et al., 2016). Therefore, dNANOS-uridine interaction is 
essential for NANOS function in Drosophila. Given the similarity among 
NANOS proteins, and in particular among their zinc fingers, it is possible that 
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also the interaction between NANOS2 and the uridine residues detected by 
CRAC is critical for NANOS2 function, in mouse SSC lines. 
However, we cannot exclude that the identification of uridine residues could 
also be linked to the intrinsic bias of pyrimidines to cross-link (Hockensmith et 
al., 1986; Meisenheimer and Koch, 1997). Also, analysis of CLIP and iCLIP 
experiments of different RBPs revealed that the ‘UUU’ motif is often enriched 
at the cross-linking sites (Sugimoto et al., 2012). Additionally, some types of 
reverse transcriptases have been shown to have a very high rate of single-
base deletion error, in homopolymeric nucleotides (Hamburgh et al., 2006).  
Thus, in order to have an additional proof that uridine residues are directly 
contacted by NANOS2, it would be interesting to analyse the crystal structure 
of NANOS2 zinc fingers in complex with an RNA containing the ‘AUNAANU’ 
motif. The crystal structure could also reveal whether uridine residues are 
contacted by the same hydrophobic amino acids found in Drosophila. 
However, this issue could also be addressed by using a different method, 
which would determine the exact NANOS2 amino acids bound to the RNA 
targets, by using UV-cross-linking coupled to mass spectrometry (Kramer et 
al., 2014; Shchepachev et al., 2019).  
 
Further CRAC analyses revealed that the motif enrichment did not correlate 
with CRAC signal intensity, which is associated with NANOS2 targets. This 
suggested that NANOS2 motif could be necessary but not sufficient to 
determine NANOS2 binding intensity to RNA. Indeed, many factors can 
contribute to achieving target selectivity. For instance, the 3' UTR structure 
(see Chapter 1), can affect the accessibility of RBPs to certain sequences, 
thus controlling their binding along the RNA. I have shown that the NANOS2 
motif present in Taf7l 3' UTR is predicted to be in a low energy region, which 
spans one or two loops. This preliminary finding suggests that NANOS2 might 
prefer binding to very accessible regions and that it might be a ssRNA binding 
protein, like other NANOS proteins (Hashimoto et al., 2010b). However, it 
would be interesting to assess at a global level whether NANOS2 targets adopt 
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a conformation similar to the one in Taf7l 3' UTR, in the proximity of the motif. 
This could be addressed in the future by analysing transcriptome-wide the 
secondary structure of 3' UTRs (Bevilacqua et al., 2016; Jacobs et al., 2012; 
Kwok et al., 2015), in SSC lines. This analysis could also reveal whether 
certain structural elements are more enriched in those targets with higher 
CRAC signal and thus explain how NANOS2 binding intensity is achieved in 
vivo. 
Moreover, complex secondary structures could bring closer sequences which 
are normally far away. This could explain why not all NANOS2 targets had the 
motif adjacent to the direct binding site. 
 
Importantly, the fact that NANOS2 binds to RNA with sequence specificity 
allows predicting NANOS2 targets also in other cells of interest.  
The molecular mechanisms through which NANOS2 maintains mitotic 
quiescence and suppresses meiosis in male gonocytes is not fully understood. 
However, we could address this by sorting gonocytes from E13.5-15.5 and 
performing RNA-seq. Subsequently, we could determine which mRNAs 
contain the NANOS2 motif within the 3' UTRs. This might lead to the 
identification of direct NANOS2 targets in male gonocytes and help to gain 
insight into NANOS2 functions during early male germ cells development.  
Additionally, NANOS2 has an overlapping expression with NANOS3, from 
E13.5 to E14.5, and it was also shown that they have partially redundant 
functions during early germ cell development (Suzuki et al., 2007). Their 
redundancy might be due to the presence of the same zinc fingers in both 
proteins. This could lead them to associate with a very similar pool of mRNAs 
and thus regulate analogous biological processes. To address this, we could 
also identify NANOS3 targets by CRAC. To circumvent the scarcity of male 
gonocytes in vivo, we could engineer Nanos3TAG ESCs lines and then 
differentiate them into PGC-like cells in vitro (Hayashi et al., 2011). 
Furthermore, NANOS3 is also present in the adult testis, where it has a broad 
expression, from the undifferentiated spermatogonia to the c-kit-differentiating 
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cells. Given the expression profile of NANOS2 and NANOS3 in relation to 
GFRα1 (Suzuki et al., 2009), it is likely that a small proportion of the GFRα1-
positive Apaired and Aaligned(4) SSCs co-express both NANOS2 and 
NANOS3. Thus, we could assess whether they exert partially redundant 
functions in this fraction of the self-renewing SSCs pool. To address this, we 
could verify whether they share some of the mRNA targets in post-natal SSCs, 
by engineering a Nanos3TAG mouse allele, deriving SSCs and by performing 
CRAC.  
 
Moreover, NANOS genes have been associated with infertility as well as 
multiple cancers in human (De Keuckelaere et al., 2018). In order to 
investigate the molecular functions of the human NANOS proteins, it could be 
useful to predict NANOS targets, in both healthy and pathological human 
tissues.  This could be addressed by analysing the transcriptomic profiles of 
human samples, and by looking for mRNAs which contain the ‘AUNAANU’ 
motif.  
Since NANOS1 was shown to be associated with human infertility (Kusz-
Zamelczyk et al., 2013), it would also be interesting to investigate the 
molecular role of NANOS1 during human germ cell development. This could 
be addressed by engineering NANOSTAG human induced pluripotent stem 
cells (hiPSCs) lines, which would be differentiated into human primordial germ 
cell-like cells (hPGCLCs) in vitro (Sasaki et al., 2015), and used to perform 
CRAC.  
 
3.9.3 Non-coding RNAs constitute a minor but novel class of targets 
bound by NANOS2 in SSC lines 
 
mRNA is by far the most enriched class of transcripts bound by NANOS2, in 
SSC lines. Additionally, our data reveal for the first time that NANOS2 can also 
bind to non-coding RNAs (ncRNAs), although to a small extent.  
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Notably, miRNA was the most enriched class of ncRNAs bound by NANOS2 
(~3% of all targets). Other RBPs, such as Lin28, were shown to associate with 
a tiny fraction of miRNAs, by performing CLIP in mouse ESCs (0.07% of all 
Lin28 targets) (Cho et al., 2012). However, the consequences of Lin28-miRNA 
interactions are known to be functionally relevant for development, from C. 
elegans to human cells (Tsialikas and Romer-Seibert, 2015). Similarly, part of 
the miRNAs bound by NANOS2 could have a critical role in SSCs 
maintenance, although they comprise only a small proportion of all its targets. 
To assess whether NANOS2 could regulate gene expression through 
miRNAs, we could verify the presence of bona fide miRNAs-mRNAs hybrids 
in SSC lines, by performing CLASH (Helwak and Tollervey, 2014), which is a 
variant of the CRAC. Moreover, by considering only the miRNAs with tissue-
specific expression pattern as well as the ones evolutionary conserved, we 
could select a few candidate miRNAs for functional validation.  
Overall, these analyses would allow clarifying whether there are indeed 
miRNA-mRNA in SSCs and whether these interactions have a biological 
relevance for mouse germ cell development. 
Furthermore, CRAC analysis showed that many miRNAs bound by NANOS2 
are located on the X-chromosome. Part of these are also transcribed from the 
same genomic region, and interestingly, this group of miRNAs has been 
recently shown to be testis-specific and highly conserved in mammals, and 
thus was named SpermiR (Zhang et al., 2019). The genetic deletion of single 
miRNAs from this locus did not cause major phenotypes in mice due to their 
possible redundancy. Thus, it would be interesting to delete the entire family 
of SpermiRs in mouse and to assess the consequences on spermatogenesis, 
as also suggested by Zhang and colleagues.  
Moreover, SpermiRs are positioned between two highly conserved genes, 
Slitrk2 and Fmr1, present both in mouse and human. Fmr1 is the Fragile X 
mental retardation syndrome-related 1, and its loss was also associated with 
primary ovarian insufficiency (Wittenberger et al., 2007). Since also human 
NANOS3 was related to primary ovarian insufficiency (Santos et al., 2014; Wu 
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et al., 2013), it might exist a molecular relationship among hNANOS3, 
SpermiRs, and FMR1, in human ovaries.  
I also reported that NANOS2 binds to another conserved group of miRNAs 
(miRNA25, miRNA106b, miRNA93), which overlaps to the Mcm7 locus and 
that is involved in cell proliferation and apoptosis (Mehlich et al., 2018). Thus, 
if we confirmed that these miRNAs formed hybrids with mRNAs in SSC lines 
by CLASH, we could also investigate their functional relevance for 
spermatogenesis, by deleting the locus from the mouse genome. Moreover, 
this locus is also involved in a variety of cancers in human (Mehlich et al., 
2018). Given that also human NANOS proteins are dysregulated in cancer (De 
Keuckelaere et al., 2018), we could investigate the molecular interaction 
between these miRNAs and human NANOS, by doing CRAC from human cell 
lines. Overall, this could reveal novel mechanisms underlying tumour 
progression. 
 
In the future, to gain insight into NANOS2 binding intensity to miRNAs, we 
could normalise CRAC signal with miRNAs abundance, by performing small-
RNA-seq from SSC lines, as already done for the mRNA targets. This might 
change the ranking of the miRNA-CRAC list which was analysed so far and 
could highlight different miRNAs in the top of the CRAC list. 
 
Overall, the fact that NANOS2 can bind to a small fraction of ncRNAs in mouse 
SSC lines, it might suggest that also other NANOS proteins could do so, in 
other cells and organisms. Thus, further investigations are needed to verify 
whether ncRNAs contribute to the intricate network of post-transcriptional 






3.9.4 NANOS2 binds to mRNAs involved in cellular metabolism and 
include mTORC regulators 
 
In order to investigate the identity of the ~1400 transcripts identified by CRAC, 
we performed GO analysis. Interestingly, this revealed that NANOS2 targets 
are enriched in a variety of metabolic processes, including biosynthesis of 
nucleic acids, proteins, organic, and aromatic compounds. Moreover, protein 
modification, ubiquitination, translation, and chromatin organisation were also 
found to be moderately enriched in NANOS2 targets.  
NANOS2 is generally thought to preserve SSCs self-renewal by repressing 
mRNAs involved in spermatogonia differentiation. However, GO analysis did 
not identify specific processes related to the differentiation of male germ cells, 
such as meiosis. NANOS2 was previously shown to bind to Sohlh2, Dazl, 
Taf7l, and Dmrt1 mRNAs, by native RIP in SSC lines (Zhou et al., 2015). All 
these mRNAs are important for SSCs differentiation (Cheng et al., 2007; 
Kimmins et al., 2004; Pointud, 2003; Zhang and Zarkower, 2017). However, 
we could confirm only Taf7l, and Dmrt1 as bona fide targets, by CRAC. This 
indicated that NANOS2 could directly repress these two differentiation-related 
targets in SSC lines, as previously hypothesised (Zhou et al., 2015).  
It is possible that Sohlh2 and Dazl were identified by RIP because of their 
abundance in SSC lines. Since native RIP does not stabilise RBP-RNA 
complexes before cell lysis, many post-lysis interactions can occur in vitro (Mili 
and Steitz, 2004), although they are not physiological. Therefore, although 
Sohlh2 and Dazl mRNAs are important during later stages of spermatogenesis 
(Phillips et al., 2010; Suzuki et al., 2012b), my data suggests that most likely 
NANOS2 is not the direct link between these mRNAs and SSCs differentiation.  
Thus, Dazl may be directly bound by NANOS2 only in male gonocytes, as 
suggested by RIP (Kato et al., 2016), but not in post-natal SSCs. However, to 
address whether this interaction is indeed direct, we could perform NANOS2 
CRAC from in vitro differentiated PGC-like cells (as previously explained). 
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Interestingly, many targets bound by NANOS2 with high intensity (top positions 
in CRAC list) have their highest expression in the central nervous system. 
Among others, there were Wdr89, Snrpb2, Fbxo45, Epc2, and Fbxo33 genes. 
Moreover, Ddx3y, the first CRAC target, is also involved in neuron 
development (Vakilian et al., 2015). NANOS1 in mouse is expressed in the 
central nervous system (Haraguchi et al., 2003). Similarly, dNANOS is also 
expressed in dendrites, where it regulates their morphogenesis (Ye et al., 
2004). Additionally, dNANOS also regulates sodium current in motoneurons 
by repressing Para mRNA, in concert with PUMILIO (Muraro et al., 2008). 
Given the importance of post-transcriptional gene regulation in the brain 
(Kiebler et al., 2013), it is possible the RBP NANOS2, or its paralogs could 
have a critical role in this organ, also in mouse and not only in Drosophila. It 
would be interesting to explore NANOS2 localisation in the central nervous 
system by performing immunofluorescent staining of mouse brains. To do so, 
we could take advantage of the Nanos2TAG allele, that has a GFP tag. Thus, 
by investigating NANOS expression in the brain, we might expand our 
knowledge on these proteins and potentially discover novel functions. 
 
Overall, the GO analysis revealed clearly that NANOS2 targets are mainly 
involved in cellular metabolism. In general, metabolism is highly regulated 
during spermatogenesis, where each stage is adapted to particular metabolic 
needs, also with the support of Sertoli cells (Rato et al., 2012). This is in part 
due to the compartmentalised environment inside the seminiferous tubules, 
which partially limits the availability of metabolites, as, for instance, oxygen 
(Rato et al., 2012). Recently, single-cell RNA-seq of human SSCs (hSSCs) 
revealed that upon differentiation, hSSCs undergo four developmental states, 
one of which is characterised by a major metabolic transition (Guo et al., 2017). 
Additionally, human spermatogonia are known to rely on glucose to produce 
ATP, and this might be provided by blood components (Rato et al., 2012). 
Importantly, the regulation of glycolysis via Myc is essential for SSCs self-
renewal in mouse (Kanatsu-Shinohara et al., 2016). 
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One of the most critical regulators of cellular metabolism is mTOR signaling. 
By sensing the availability of nutrients and growth factors, this pathway 
controls major processes such as glucose metabolism, lipids and nucleotides 
biosynthesis, but also protein translation. Overall, this allows mTOR 
coordinating cellular growth and proliferation (Saxton and Sabatini, 2017).  
Different stem cells populations have been shown to balance their self-renewal 
and differentiation by controlling cellular growth via the mTORC pathway 
(Castilho et al., 2009; Gan and DePinho, 2009). Among other stem cells, also 
mouse SSCs were shown repress mTORC hyper-activation, in order to 
maintain their self-renewal ability. This is also achieved by regulating the 
expression of Redd1, a mTORC1 inhibitor, which is induced by the 
transcription factor PLZF (Hobbs et al., 2010). Importantly, the deletion of only 
one mTORC1 inhibitor, Tsc1, causes subfertility in mice. This phenotype is 
due to premature SSCs differentiation and germ cell depletion, which are 
caused by the hyper-activation of the mTORC1 pathway (Wang et al., 2016).  
Interestingly, NANOS2 was shown to control SSCs metabolism by repressing 
mTORC1 in SSC lines (Zhou et al., 2015). Notably, NANOS2 interacts with 
mTOR and confines it to stress granules, which results in general translation 
repression and inhibition of the mTORC1 pathway.  
Although our GO analysis did not specifically detect the mTORC1 pathway, I 
could identify different positive regulators of the mTOR signaling, among the 
first 500 NANOS2 CRAC targets.  
Therefore, we speculate that NANOS2 could post-transcriptionally control the 
expression of many metabolic genes, including five key mTORC regulators 
(Lamtor3, Rheb, Xbp1, Rictor, and Mios). Importantly, their potential 
repression mediated by NANOS2 could slow down metabolism and cellular 





3.9.5 One-third of NANOS2 targets takes part in the transition from self-
renewing to transit-amplifying spermatogonia 
 
After determining the identity of NANOS2 targets by GO, we sought to 
determine their expression profile throughout adult spermatogonia 
development. To this end, we sorted three populations of spermatogonia ex-
vivo, from adult testes, which represented three different stages: the self-
renewing SSCs pool, marked by Gfrα1, the transit-amplifying spermatogonia 
marked by Miwi2-Tom, and the differentiating spermatogonia, which express 
both Miwi2-Tom and c-kit. Then, we performed mRNA-seq from these three 
populations, and we applied the Markov clustering algorithm to define mRNA 
expression profiles. This analysis revealed that the majority of genes whose 
expression changes during the stages considered is characterised by a sharp 
upregulation from Gfrα1+ to Miwi2-Tom+ cells (Cluster1, ~6000 genes). 
Importantly, we discovered that approximately one-third of NANOS2 targets 
(469 transcripts) were also present in this cluster. Moreover, also another 
important group of genes (cluster 2, ~4000 genes) underwent significant 
changes throughout spermatogonia development. This was constituted by 
genes down-regulated from the self-renewing to the transit-amplifying 
population (expression profile opposite to cluster 1). Interestingly, NANOS2 
targets were under-represented in this cluster. Thus, given the expression 
profiles of cluster 1 and 2, the over-representation of NANOS2 targets in 
cluster 1 is in accordance with their under-representation in cluster 2.  
Overall, our analysis suggests that once Gfrα1+ SSCs (which are all Nanos2+) 
start to undergo differentiation (Miwi2-Tom+ cells), one-third of NANOS2 
targets is upregulated. Importantly, NANOS2 targets are enriched in 
processes such as cellular metabolism and include mTORC positive 
regulators. Therefore, we speculate that NANOS2 could repress cellular 
growth in Gfrα1+ spermatogonia. This mechanism would safe-guard SSCs 
quiescence, and protect them from excessive proliferation, thus inhibiting 








Figure 3.20. Possible working model for NANOS2 in SSCs.  
CRAC showed that NANOS2 directly binds to the 3' UTR of mRNAs, enriched for a 
novel motif. These mRNAs are involved in metabolism, and they also include positive 
regulators of mTORC. Metabolic genes and the mTORC pathway are strictly related 
to cellular growth and proliferation (Ma and Blenis, 2009). One-third of NANOS2 
targets are upregulated during the transition from self-renewing SSCs (GFrα1+) to 
transit-amplifying spermatogonia (Miwi2+). Thus, we speculate that NANOS2 could 
preserve SSCs self-renewal through the post-transcriptional repression of metabolic 

























However, it is worth noting that NANOS2 targets were only slightly enriched in 
cluster 1 (P-value < 0.05) and moderately depleted in cluster 2 (P-value <0.01). 
This weak statistical significance might be due to a number of reasons. First 
of all, we compared two datasets generated from the high-throughput 
sequencing of cells isolated from two different sources. Indeed, CRAC was 
performed in SSC lines, and RNA-seq for Markov clustering from ex-vivo 
sorted spermatogonia. This discrepancy might implicate a certain degree of 
background noise in the comparative analysis. The extent of this variability 
could be addressed by comparing the transcriptional profile of SSC lines and 
Gfrα1-positive cells. To do so, we could perform a PCA analysis between the 
RNA-seq from SSC lines and the one from ex-vivo sorted Gfrα1+ cells. 
 
Moreover, although all Gfrα1+ cells are also Nanos2+, and ~70% of Nanos2+ 
cells express Gfrα1 (Suzuki et al., 2009), the two populations do not overlap 
completely. Since we isolated only Gfrα1+ cells, these SSCs do not take into 
account 30% of Nanos2+ spermatogonia. Thus, in order to comprehensively 
characterise the Nanos2+ population, in the future, we could employ a Nanos2-
reporter allele, sort the Nanos2+ cells, and integrate our analysis with these 
additional data. This might reveal that more than one-third of NANOS2 targets 
participate in the transition from self-renewing to transit-amplifying 
spermatogonia. 
 
However, it is also possible that genes in cluster 1 are not controlled 
exclusively by NANOS2. For instance, these genes could also be rapidly 
upregulated by NANOS2 targets, both at the transcriptional and post-
transcriptional level.  
Moreover, we cannot exclude the collaboration of more SSCs intrinsic factors 
present in Gfrα1+ cells, such as NANOS2, PLZF, and ID4. This might 
contribute to the massive changes in gene expression (~6000 genes) 
observed during the transition from self-renewing SSCs to transit-amplifying 
spermatogonia. Overall, this hypothetical cooperation could constitute a robust 
 
 150 








Chapter 4. Characterisation of NANOS2 protein 




In the previous chapter, I have explored NANOS2 RNA-binding transcriptome-
wide in SSC lines by using CRAC. NANOS proteins mediate RNA-binding by 
the conserved zinc finger motifs within their C-terminus (Hashimoto et al., 
2010b; Weidmann et al., 2016). In Drosophila, the genetic analysis of several 
nanos mutants lacking selective amino acids in the zinc fingers, proved that 
the zinc fingers were essential for all NANOS functions (Arrizabalaga and 
Lehmann, 1999). Moreover, NANOS2 zinc fingers were also shown to mediate 
protein-protein interactions by recruiting DND1 (Suzuki et al., 2016). Although 
the C-terminus is assumed to be necessary for NANOS2 function, it is not 
sufficient in mouse. Indeed, a NANOS2 mutant lacking the first ten amino acids 
in the N-terminus does not rescue defects in a Nanos2-/- mouse (Suzuki et al., 
2012a). This N-terminal portion is essential for the direct interaction between 
NANOS2 and NOT1. The discovery of this important interaction raised the 
possibility that additional proteins could be recruited by NANOS2, through the 
same or different regions. Co-immunoprecipitation (co-IP) experiments have 
previously identified different NANOS2-interacting proteins, both in male 
gonads and in SSCs (Suzuki et al., 2010; Zhou et al., 2015). More recently, 
two proteomic approaches have been used to characterise NANOS2 
interactome in embryonic male gonads (Suzuki et al., 2016; Zhou et al., 2017), 
revealing novel protein partners. 
In this chapter, I have further investigated NANOS2 molecular function by 
determining its interactome in post-natal SSCs. To do so, we performed 
immunoprecipitation followed by mass spectrometry (IP-MS) from 
Nanos2TAG/TAG in vitro SSC lines.  
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Subsequently, we followed-up on the main molecular pathway revealed by the 
interactome, which was RNA decay. Therefore, I illustrate how we analysed 
transcripts stability in SSCs, by using a novel metabolic approach, called 
SLAM-seq (Herzog et al., 2017). 
 
4.2 Endogenous NANOS2 protein interactome in SSC lines 
 
To identify NANOS2 protein interactome in mouse SSCs, we performed 
immunoprecipitation followed by mass spectrometry (IP-MS), in collaboration 
with Dr. Much and Dr. Auchynnikava. For this purpose, we used the previously 
described Nanos2TAG/TAG SSC line, here called Nanos2TAG, and, as a negative 
control, the untagged Nanos2WT line, called Nanos2CTL. A schematic in Figure 





Figure 4.1. Schematic of the procedure used to determine NANOS2-protein 
interactome in SSC lines.  
Two different SSC lines were used for Immunoprecipitation (IP) coupled to mass-
spectrometry (MS). The first one (in red), Nanos2CTL, expresses an untagged 
NANOS2 protein, and thus served as a control. The second SSCs line (in green), 
Nanos2TAG/TAG, expresses TAG-NANOS2, whose tag contains the epitopes used for 
IP (V5 and eGFP). After immunoprecipitating NANOS2 from both SSC lines with 
either Anti-V5 or Anti-GFP antibodies, samples were subjected to MS. NANOS2 
interactors (in green) were identified as proteins significantly enriched (four-fold 
enrichment and p-value < 0.05) in the Nanos2TAG/TAG IP, compared to the control 
IP (Nanos2CTL). For more details see Figure 4.3. 
 
 



















SSCs cultures were expanded in 10 cm2 plates, and each confluent plate was 
used for one experimental replicate. We prepared protein extracts by using a 
lysis buffer containing an intermediate salt concentration and non-ionic 
detergents, in order to preserve protein-protein interactions. In order to obtain 
more robust IP-MS results, we performed two immunoprecipitations in parallel, 
by taking advantage of the multiple tags in TAG-NANOS2. Thus, we incubated 
protein extracts with beads coupled to either Anti-V5 or Anti-GFP antibodies. 
Samples were washed with a mild buffer without salts. Half of the samples 
were also washed in the presence of RNase to assess whether protein-protein 
interactions depended on RNA. The remaining samples washed without 
RNase, also served as negative controls. Proteins were eluted from beads, 
and 20% of the eluate was used for quality controls. 10% of the eluate was 
separated by SDS-PAGE and transferred to a nitrocellulose membrane. First, 
to exclude an antibody’s contamination, we stained the membrane with 
Ponceau (Figure 4.2 A). Importantly, we could not detect any band 
corresponding to the heavy and light chains of antibodies, suggesting that 
these were not co-purified in the eluates.  
Then, to assess TAG-NANOS2 immunopurification, we probed the membrane 
with an anti-V5 antibody. As shown in Figure 4.2 A, NANOS2 was present in 
the input of Nanos2TAG (second lane), and it ran at the expected molecular size 
(~47 kDa). A very faint band was detected only in the lane corresponding to 
the GFP-IP and not in the V5-IP, indicating that the protein was not efficiently 
immunoprecipitated (this was already observed when optimising IP for CRAC 
in SSCs). Another 10% of the eluate was used for SDS-PAGE and silver 
staining, which however did not show any clear NANOS2 band (Figure 4.2 B). 
Anyway, since only a small fraction of the IP was loaded into both gels (A and 
B), we assumed that a sufficient amount of protein could still be present in the 
remaining part of the IP (80%). Therefore, we continued with samples’ 
preparation for MS.  
After protein precipitation and digestion, processed samples were loaded onto 




Figure 4.2. Endogenous NANOS2 immunoprecipitation (IP) and silver staining 
of protein gel.  
A. Immunoblot probed with an Anti-V5 antibody showing two endogenous NANOS2 
IP (with V5 and GFP beads), from Nanos2CTL and Nanos2TAG SSCs. The predicted 
molecular size of TAG-NANOS2 is ~47 kDa. Samples have been treated with 
(+RNase) or without RNase (-RNase). Ponceau staining of the same membrane is 
also shown below the blot. B. Silver staining of a protein gel loaded with 10% of the 
NANOS2 IP.  
 
 
Proteins which were significantly enriched in the Nanos2TAG IP compared to 
the control IP (Nanos2CTL), were identified as NANOS2-interactors (see 
schematic in Figure 4.1). Notably, only interactors enriched with high 
confidence (four-fold enrichment and p-value < 0.05) were considered 
confident NANOS2-interactors and these are represented as labelled dots in 
the volcano plots (Figure 4.3). In these graphs, the x-axis represents the level 
of enrichment of precipitated protein, and the y-axis represents the level of 
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and B. represent MS results from anti-V5 IP and plots in (C) and (D) from anti-
GFP IP. Results shown in (A) and (C) represents IP-samples not treated with 
RNase, whereas (B) and (D) were treated. Each graph shows results obtained 
from three replicates (N = 3), for each SSC line. 
Importantly, NANOS2 was enriched in all conditions, although it was not 
previously detected by Western blot and silver staining in the IP. Overall, this 
suggested that NANOS2 was successfully immunopurified, for all the MS 
experiments.  
Remarkably, a set of common interactors were found among the four MS. 
These included the CNOT1, 2 and 9 proteins, part of the CCR4-NOT 
deadenylase complex (CNOT), as well as TRIM21, an E3 ubiquitin protein 
ligase. Interestingly, these four proteins were found to interact with NANOS2 
independently of RNA. Importantly, CNOT1 was the most enriched protein in 
all MS and experimental conditions tested. CNOT1 is the structural component 
of the CNOT complex, which also mediates protein-protein interactions with 
RBPs (see Chapter 1). Moreover, NANOS2-CNOT1 interaction was already 
described to occur in mouse male gonads by Co-IP, and it is also essential for 
Nanos2 function (Suzuki et al., 2010).  
Therefore, our results show that the NANOS2-CNOT1 interaction is conserved 
also in post-natal SSCs, and that it could exert a critical role also in these cells. 
Moreover, almost all members of the CCR4-NOT complex were identified 
among the four MS. These included CNOT1, 2, 3, 9 and 10 as well as two 
catalytic subunits, CNOT7 and 8.  
Additionally, TNKS1BP1, tankyrase1-binding protein, was detected in three 
out of four MS experiments. This protein is associated with TNKS1, 
Tankyrase1, which is a poly-ADP-ribosyl transferase involved in the post-
translational modifications of proteins (Gibson and Kraus, 2012).  
  
Collectively, our IP-MS results suggested that CNOT1, 2, 9, and TRIM21 
proteins were the most robust NANOS2 interactors, as they were found with 
high confidence in all the MS performed. Given the essential role of the CNOT 
 
 158 
deadenylase complex in RNA turnover (Collart and Panasenko, 2012), we 
speculated that NANOS2-CNOT interaction might have important implications 










Figure 4.3. Volcano plots showing NANOS2-interactors identified by IP-MS, 
from SSC lines.  
The endogenous NANOS2 was immunoprecipitated from Nanos2TAG and from 
Nanos2CTL (control) SSC lines. Immunoprecipitations (IP) were performed with Anti-
V5 and Anti-GFP antibodies, and IP were treated with or without RNase. Plots in A. 
and B. display results from Anti-V5 IPs and plots in C. and D. show results from Anti-
GFP IPs. IPs performed in A. and C. were not treated with RNase (- RNase), whereas 
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enrichment of interactors in each IP-MS, defined as 
(log2(LFQ(Nanos2TAG)/LFQ(Nanos2WT))), which is the logarithmised ratio of the 
average LFQ intensities for proteins detected in the Nanos2TAG-IP over LFQ values of 
the same proteins in the Nanos2WT-IP. The x-axis shows the confidence of the 
enrichment, defined as (-log10(p-value)), which is the negative logarithmised p-value 
obtained from a t-test. Proteins with at least four-fold enrichment and p-value < 0.05 
are shown as labelled dots and are considered as interactors. NANOS2 is displayed 
in D. as a labelled dot, although it is enriched with slightly lower confidence than 
specified above. CNOT proteins are highlighted in red, as they are part of the same 
complex, (CCR4-NOT). Each graph shows results from three independent IP-MS 
replicates (N = 3).  
 
 
4.3 Analysis of NANOS2 mRNA targets’ stability by SLAM-seq in SSC 
lines 
 
4.3.1 SLAM-seq: a metabolic approach to measure mRNA half-life 
 
The characterisation of NANOS2 interactome in SSC lines showed that 
CNOT1 was the most enriched interactor, followed by other subunits of the 
CNOT deadenylase complex. Given the prominent role of the CNOT complex 
in RNA stability, we speculated that NANOS2-CNOT interaction might have 
important consequences on the half-life of NANOS2 RNA targets. In order to 
test this hypothesis, we sought to determine general mRNA stability in SSCs 
and to address whether NANOS2 mRNA targets were more unstable than the 
rest of mRNAs. To measure global mRNA stability in SSCs, I employed a 
pulse-chase labelling method, recently developed by Herzog and colleagues, 
called SLAM-seq (thiol(SH)-linked alkylation for the metabolic sequencing of 
RNA) (Herzog et al., 2017). This method allows tracing mRNA over time in 
cells and, importantly, it does not require high input of biological material, 
which made it suitable for in vitro SSC lines. Moreover, it allows transcriptome-
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wide identification of mRNA stability, which is ideal in order to identify the half-
life of NANOS2 CRAC targets globally.  
Critical steps of the SLAM-seq method are shown in Figure 4.4 A and B. In 
brief, a nucleotide-analog, 4-thiouridine (s4U), is supplied to cell media for a 
certain period of time, to allow its uptake by cells and its incorporation into 
newly synthetised RNAs. A critical step is to determine s4U labelling time, 
which may vary across different cell types, depending on their specific RNA 
turnover rate. At the end of the labelling time, it is essential to stop s4U 
incorporation into nascent transcripts, in order to allow discrimination between 
old (s4U labelled) and new (unlabelled) RNA. This is achieved by supplying an 
excess of uridine to cell media, which is exchanged with s4U. This results in 
the incorporation of uridine in place of s4U into newly synthetised RNAs, from 
that moment onwards (t0). RNA is isolated at different timepoints (tx), in order 
to chase s4U-containing RNA over time. After retrieving cells and extracting 
total RNA, s4U is covalently modified (s4U*) through alkylation, by using 
iodoacetamide (IAA). IAA reacts with the thiol (S) group of s4U, by nucleophilic 
substitution. This reaction converts s4U to s4U*, which is much more stable 
than s4U. It is worth to notice that the stabilization of s4U by IAA-alkylation 
greatly enhances the efficiency of this method compared to other metabolic 
labelling protocols (Herzog et al., 2017). Since s4U*is chemically more similar 
to cytosine than uridine, s4U* is recognised as if it were a cytosine by the 
reverse transcriptase. Therefore, after reverse transcription (RT), guanosines 
are incorporated at s4U* positions. Adapters in RT primers allow subsequent 
PCR amplification of the cDNA. During PCR, guanosines are converted into 
cytosines, resulting in the thymidine-to-cytosine-conversion (T > C) of original 
s4U. T > C conversions are further identified by high-throughput sequencing 
and used for the bioinformatic analyses of SLAM-seq data. Overall, these 
conversions allow discrimination between labelled (s4U*; T > C) and unlabelled 
(U; T) transcripts, and thus to retrace their fate over time. Therefore, transcripts 
which have high rate of T > C conversions in late time points are considered 
as the most stable ones.  
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In Figure 4.4 C, the expected RNA degradation kinetics are shown, after s4U 
labelling. After reaching the steady-state level of s4U incorporation, s4U levels 
drop due to dilution with unlabelled uridine (green lines). By following the s4U 
levels in mRNA over time, it is possible to obtain specific decay curves for each 







Figure 4.4. SLAM-seq work-flow and RNA degradation kinetics, adapted from 
(Herzog et al., 2017).  
A. The diagram shows key steps of the SLAM-seq method. After adding s4U, total 
RNA is isolated, and s4U is stabilised by chemical modification. RNA is reverse 
transcribed using primers with adapters and guanosines are incorporated at s4U 

















scheme highlights other critical steps of SLAM-seq. RNA is labelled with s4U for a 
given time, Dt, until the reaction is stopped by diluting S4U with uridine, t0. Cells are 
retrieved at different time points, tx, and s4U is stabilised by the addition of IAA 
(iodoacetamide), which modifies s4U through an alkylation reaction (s4U*). 
Discrimination between existing and nascent RNA is achieved by detecting T>C 
mutations in sequencing reads. C. Kinetics of RNA degradation after s4U labelling. 
Both slow and fast degradation kinetics can be detected by monitoring levels of s4U 
labelled RNA over time (tx).  
 
 
4.3.2 SLAM-seq in SSC lines 
 
In order to perform SLAM-seq in SSCs, first of all, I optimised the s4U labelling 
in this cell type (see scheme in Figure 4.5 A). As previously explained, s4U can 
exert cytotoxic effects, to the extent that may vary across different cell types. 
In order to minimise its cytotoxicity, I determined the optimal s4U working 
concentration, which had a minimum impact on SSC viability, also called the 
inhibitory concentration, IC10. In particular, this was defined as the s4U 
concentration that would inhibit (kill) a maximum of 10% of SSCs, during a 
certain time (as described in (Herzog et al., 2017)). To do so, I tested a range 
of s4U concentrations varying from 0 µM to 4000 µM in SSC lines. After 
culturing SSCs until they reached 70% confluency, I added s4U to the cell 
media. Since SSCs are slow-dividing cells, we thought that they might also 
have a slow RNA turnover rate. Therefore, we opted for a relatively long 
labelling time (24 hours), and tested cell viability for twice the labelling period, 
for a total of 48 hours. SSC viability was assessed by counting cells’ number 
at the longest time point (t48). It is worth to notice that in the original SLAM-seq 
protocol, numbers of live cells are used for the cell viability assay, rather than 
just cell numbers. Although I tried to do so, this strategy did not allow me to 
determine the s4U cytotoxic effect in SSCs successfully. In general, SSC death 
in culture occurs through cell detachment from colonies, so the only SSCs 
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suitable for experimental analysis are the ones which remain attached. When 
I analysed cell death, following s4U incubation, the great majority of SSCs were 
found alive. Indeed, they displayed very low cell death rates (~1-4%), even at 
the maximum s4U concentration (data not shown). Since cell death rates below 
10% were not useful to determine s4U working concentration, I concluded that 
measuring live cells was not the most appropriate way to detect s4U toxic effect 
in SSC lines. Hence, I assumed that SSCs number would be more informative 
than live cells, and thus, I simply used this measure for the cell viability assay. 
After counting the number of SSCs retrieved from s4U-treated samples, I 
compared them to SSCs number from the untreated ones (negative control). 
Their relative percentage was plotted over s4U concentrations, as shown in the 
graph in Figure 4.5 B. Two technical replicates were performed for the cell 
viability assay (rep1 and rep2), using the Nanos2TAG SSC line. Average values 
between the two replicates (red curve) were used to calculate IC10. This 
analysis revealed that the optimal s4U concentration that killed a maximum of 






Figure 4.5. Cell viability assay in SSC lines used to determine s4U cytotoxicity.  
A. A range of s4U concentrations, [s4U], were tested on SSCs for a labelling time of 
24 hours. After an additional 24 hours (t48), SSCs were retrieved and counted to 
assess cell viability. B. The graph shows the numbers of SSCs retrieved when 
cultured with s4U. The x-axis indicates [s4U] used. The y-axis indicates the percentage 
of s4U-treated SSCs over the untreated ones. The optimal working concentration of 
s4U (IC10) is shown in blue (100 µM). Two replicates (rep1 and rep2) were used for 
this assay, and their average values (curve in red) were used to calculate the IC10. 
 
 








































































After determining the s4U working concentration, I performed the SLAM-seq 
experiment by using the Nanos2TAG/+ and Nanos2TAG/TAG SSC lines. The 





Figure 4.6. SLAM-seq work-flow in SSC lines.  
RNA in SSCs was labelled with [s4U] = 100 µM for 24 hours until the addition of 
unlabelled uridine stopped its uptake (t0). To monitor RNA decay through s4U chase, 
samples were collected at different time points (t = 30, 60, 120, 540, 1440 minutes). 
RNA was isolated, and libraries were prepared for sequencing.  
 
 
In order to obtain sufficient material for RNA extraction, I cultured SSCs on 10 
cm2 plates and added s4U in the cell media to a final concentration of 100 µM. 
I incubated SSCs with s4U for 24 hours and stopped the labelling by adding an 
excess of unlabelled uridine (t0). To follow RNA decay over time, SSCs were 
isolated at different time points (t = 30, 60, 120, 540, 1440 minutes), with the 
longest one set at 24 hours (or 1440 minutes). Each 10 cm2 plate represented 
[S4U] = 100 µM
1. SSCs culture
2. Labelling
(△t) = 24 hrs
3. Labelling stop (t0)
4. Chase
5. SSCs retrieved for RNA isolation
and library preparation
(△t) = 24 hrs
+ Uridine






an experimental time point, for a specific SSC line. SSCs were purified from 
MEFs co-culture by doing MEF depletion (see Chapter 2) and FACS. SSCs 
sorting strategy in shown in Figure 4.7 A. SSCs were first selected according 
to cell shape and size (FSC and SSC) and only living cells (negative to the 
DRAQ7 dye) were isolated. Approximately one million of SSCs was sorted for 
each experimental time point. Total RNA was extracted, and s4U stabilised by 
IAA treatment (as previously explained). Purified SLAM-seq libraries had an 
average peak size of ~250 bp, as shown by the representative 







Figure 4.7. SLAM-seq in SSC lines: FACS strategy used to purify SSCs from 
MEFs and mRNA library.  
A. Gating strategy used to purify SSCs from MEFs co-cultures. SSCs were sorted 
according to cell size (FSC-A, SSC-A) (P1). Single SSCs were isolated according to 
FSC-H, SSC-A, and SSC-H, FSC-A, respectively (P2, P3). Live SSCs were sorted by 





















(events) for each population (P1, P2, P3, P4) and their percentage with respect to the 
previous population (%Parent) and the original one (%Total). B. Example of an 
electropherogram, showing a typical SLAM-seq library obtained after cDNA 
amplification by PCR. The peak size of the mRNA library is ~ 250 bp. 
 
 
Libraries were subjected to high-throughput sequencing, and the subsequent 
bioinformatic analysis was performed by Dr. van de Lagemaat.  
By counting the T to C conversion rate within reads (see previous explanation), 
we determined the original s4U levels in transcripts and thus their stability.  
First of all, we assessed the degree of correlation between the two biological 
replicates (rep1, rep2). By analysing half-life values of individual genes in a 
scatter plot (Figure 4.8 A), we concluded that the two samples correlated very 
well with each other, as shown by the red line in the graph. Afterwards, we 
calculated global mRNA half-life in SSCs by using the T to C conversion rate 
from each experimental time point (Figure 4.8 B). When half-life for a given 
gene failed to be calculated in one of the two replicates, we excluded that gene 
from the analysis. Eventually, mRNA stability was determined for a total of 
5806 genes. Overall, this analysis revealed that the average mRNA stability in 
SSCs was ~3.73 hours (or 224.5 minutes). Importantly, this value was 
extremely similar between the two replicates (224 and 225 minutes). 
Interestingly, although SSCs are slow-dividing cells, they displayed even a 
slightly faster RNA turnover than ESCs, which have an average mRNA half-
life of ~3.9 hours (Herzog et al., 2017).  
 
Additionally, we examined the decay kinetics of few individual transcripts, 
Taf7l, Sycp1, Dmrt1, and Zfand6, previously identified by CRAC (Figure 4.8 
C). These showed different degradation dynamics, with Sycp1 having the 






Figure 4.8. Analysis of mRNA stability in SSC lines measured by SLAM-seq.  
A. In the scatter plot shown, each dot represents the half-life of an mRNA. The graph 
shows the correlation of half-life values expressed in minutes (logarithmic scale), 
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SSC line). B. The graph shows global mRNA stability in SSCs. RNA half-life (t1/2) was 
calculated by counting the T to C conversion rate in sequencing reads (y-axis), over 
time (minutes, on the x-axis). Half-life was determined for 5806 mRNAs, from two 
replicates (rep1 and rep2). C. Example of RNA decay curves for four distinct genes 
(Taf7l, Sycp1, Dmrt1, Zfand6), which are also NANOS2 CRAC targets. 
 
 
However, in order to understand whether NANOS2 binding could affect mRNA 
stability at a global level, we analysed the cumulative distribution of NANOS2 
targets’ half-life. These targets were previously ranked according to CRAC 
signal intensity, normalised with mRNA abundance (see Chapter 3). 
Importantly, this list included 1428 genes, which we subdivided into two 
categories, depending on CRAC intensity. The first group included the top 500 
genes, which had the highest CRAC signal (Figure 4.9, ‘high’ targets, in red). 
The second category of genes included the remaining targets, with lower 
CRAC signal, as well as non-targets (‘other’, in black).  
First of all, transcripts with low or no CRAC signal (‘other’) had similar stability 
to the global one in SSCs, (~224 minutes). However, targets strongly bound 
by NANOS2 (‘high’) displayed a significantly shorter half-life, with an average 
of ~180 minutes (~3 hours), which is 44 minutes less than the global stability 
in SSCs. Importantly, these data were consistent between replicates (rep1, p-
value < 10-15; rep2, p-value < 10-10). Furthermore, these data were really 
indicative of the majority of NANOS2 CRAC targets, since they were based on 
half-life values calculated for 74% of the ‘high’ targets (370 genes out of 500). 
Additionally, CRAC signal intensity positively correlated with transcript 
instability. Indeed, when smaller subsets of NANOS2 ‘high’ targets were 
analysed (top 400, 300, 200), these revealed a continuous and increasing 
mRNA instability (data not shown).  
 
Overall, these data indicated that the direct interaction between NANOS2 and 
mRNAs resulted in a significant reduction of their half-life in SSC lines. 
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Additionally, this effect increased for targets with very high CRAC signal. 
Importantly, these data constitute the first molecular proof that NANOS2 





Figure 4.9. Analysis of NANOS2 targets stability in SSC lines.  
S-curves show cumulative frequency of mRNA half-life for two distinct categories of 
transcripts. NANOS2 ‘high’ targets represent the top 500 mRNAs from the CRAC list 
and are shown in red. NANOS2 ‘other’ targets groups mRNAs with low CRAC signal 
and not bound by NANOS2, (in black). Results from two replicates are shown (rep1, 
rep2). P-values were calculated by using the Mann-Whitney U test. 
 
 
So far, I characterised global mRNA stability for NANOS2 targets in SSCs and 
I also showed the correlation between CRAC signal and short half-life. 
Subsequently, I investigated the stability of Taf7l and Dmrt1 mRNAs, two 
targets identified both by CRAC and RIP (Zhou et al., 2015). Importantly, they 
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by NANOS2 in SSCs (see Chapters 1 and 3). Interestingly, both of them 
displayed remarkable mRNA stability. In particular, Taf7l had a half-life of 
403.5 minutes and Dmrt1 of 310 minutes, which are much higher values than 
the average half-life in SSCs. These data indicated that, although NANOS2 
directly binds to these transcripts, its binding does not seem to trigger RNA 
instability.  
 
I previously showed that NANOS2 could directly bind to mTOR regulators 
(Chapter 3), and potentially regulate the fate of these transcripts. Therefore, I 
evaluated whether also these mRNAs had a short half-life, similar to other 
NANOS2 targets. Interestingly, among the positive mTOR regulators which 
had a high CRAC signal (first 500 targets), I found that four out of five of them 
were more unstable compared to the average. These were represented by 
Lamtor3, Rheb, Xbp1, and Rictor, which had a half-life of 118.5, 197, 69.5, 
122.5 minutes respectively (Figure 4.10). It is worth noting that Xbp1 displayed 
a half-life of only 69 minutes; this value is significantly lower than the average 
for NANOS2 CRAC targets (~180 minutes) and even lower than the half-life of 
the very top targets (~100 minutes).  
Overall, these data indicated that upon binding to specific mTOR regulators, 
NANOS2 triggered their decay. This mechanism might constitute a novel way 
through which NANOS2 represses the mTORC1 pathway in SSCs, in order to 











Figure 4.10. Decay curves representing four mTORC positive regulators (black) 
and the rest of mRNAs (grey).  
The decay curve in black represents the combined half-life of the four mTORC 
positive regulators (Lamtor3, Rheb, Rictor, and Xbp1 mRNAs). Black vertical lines are 
the standard deviations, for each timepoint. The decay curve in grey represents the 
combined half-life of all mRNAs analysed in SLAM-seq. Values from two biological 
replicates are reported in the graph.  
 
 
4.4 Motif analysis in transcripts ranked according to their half-life 
 
In the previous chapter, I have described that NANOS2 binds to mRNAs, which 
are specifically enriched in the novel ‘AUNAANU’ motif. In this chapter, I 
showed that NANOS2-mRNA targets have a short half-life. In order to further 
investigate the relation between transcript instability and NANOS2-RNA 
binding in SSCs, we sought to understand whether unstable transcripts also 
bore NANOS2 motif. To this end, we performed a motif enrichment analysis 
using the 3' UTR of mRNAs, whose half-life was determined by SLAM-seq.  
 
We decided to use the Sylamer software (van Dongen et al., 2008), which 






















according to a certain parameter of interest, which in our case, was half-life. 
The Sylamer bioinformatic analysis was performed by Dr. van der Lagemaat. 
It is worth to notice that we did not provide the software with the NANOS2 motif 
sequence, as we wanted to assess its presence in an unbiased way. As input 
for the analysis, we used the 3' UTRs of mRNAs ordered according to 
increasing values of half-life, previously calculated from two biological 
replicates (Nanos2TAG/+ and Nanos2TAG/TAG). Results of the Sylamer analysis 
are shown in Figure 4.11. In the graphs, the x-axis represents the 3' UTR of 
mRNAs, sorted according to half-life, and the y-axis shows the significance of 
each motif found. Dotted lines represent E-values thresholds. Coloured lines 
represent the landscape of enriched motifs across the ordered list of 3' UTRs. 
In particular, each coloured line is associated with a different motif, whose 
sequence is shown on the right. Grey lines represent motifs not linked to those 
3' UTRs.  
The first graph (Figure 4.11 A), shows results from the Nanos2TAG/+ SSC line. 
Interestingly, Sylamer analysis identified three motifs as being moderately 
enriched in the 3' UTRs provided. Surprisingly, two motifs (the light blue, 
‘AUGAAAU’, and the blue one ‘AUGAAUU’) were also compatible with the 
NANOS2 motif (‘AUNAANU’). Importantly, these two motifs were enriched in 
the 3' UTRs having a short half-life (left part of the x-axis). 
Figure 4.11 B shows results from the Nanos2TAG/TAG SSC line. Three motifs 
were found to be enriched in this analysis and, importantly, one of them 
matched the NANOS2 motif (in light blue, ‘AUGAAUU’). Similar to the other 
replicate, also this motif seemed to be moderately enriched in transcripts with 
a short half-life. Interestingly, the ‘AUGAAUU’ motif, was already observed 
among NANOS2 targets, such as in Otud4 mRNA (Chapter 3, Figure 3.14 B). 
Additionally, a different motif displayed a steep slope at the beginning of the x-
axis, indicating an enrichment in 3' UTRs with an extremely short half-life (the 
one in purple, ‘ACGCACG’). On the contrary, the third motif had a steep slope 
towards the end of the graph, indicating its enrichment in RNAs with a very 
long half-life (the blue one, ‘UAAAUAU’).  
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In summary, we identified NANOS2 motif in the 3' UTR of transcripts which 
displayed short half-life, from two biological replicates. 
Overall, these data suggested that NANOS2 induced mRNA instability in SSCs 











Figure 4.11. Motif enrichment analysis in 3' UTRs of transcripts ranked 
according to their half-life.  
Sylamer plots show the landscape of motifs enriched in the 3' UTRs of mRNAs, which 
are sorted according to their half-life. 6,000 3' UTRs are displayed on the x-axis. The 
vertical dotted line in each graph is positioned in the middle of the x-axis (at 3,000 3' 
UTRs). The analysis was performed from Nanos2TAG/+ (A.) and Nanos2TAG/TAG SSC 
lines (B.) Horizontal dotted lines are E-values threshold of 0.01. Each coloured line 
represents an enriched motif. The significance of the enrichment was calculated by 
using hypergeometric P-values. The sequence of the enriched motifs is shown on the 
right. Black rectangular boxes highlight sequences compatible with NANOS2 motif 
(‘AUNAANU’).  
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4.5 Discussion  
 
4.5.1 NANOS2 mainly interacts with the CCR4-NOT deadenylase 
complex, in mouse SSC lines 
 
By using the previously characterised Nanos2CTL and Nanos2TAG/TAG SSC lines 
(Chapter 3), we could immunoprecipitate (IP) NANOS2 and identify the 
interacting proteins by mass spectrometry (MS). Thus, we determined the first 
NANOS2 protein interactome in SSC lines, which revealed some known 
partners as well as novel ones.  
We discovered that members of the CCR4-NOT (CNOT) complex, notably 
CNOT1, 2 and 9, as well as TRIM21, constituted the most robust and confident 
interactors, as they were identified in all IP-MS performed. Moreover, their 
interactions with NANOS2 was independent of RNA, suggesting that they 
might interact directly in SSC lines. 
Interestingly, CNOT1 was, by far, the protein enriched with the highest 
confidence. CNOT1-NANOS2 interaction was previously detected in male 
gonadal extracts (Suzuki et al., 2010, 2012a). Additionally, by using 
recombinant NANOS2 produced in bacteria, NANOS2 was shown to interact 
directly with CNOT1, through the NIM region (N-terminus, first 10 aa), which 
contacts the C-terminal part of CNOT1 (Suzuki et al., 2012a). CNOT1 was also 
shown to be the strongest interactors by performing IP-MS from male gonads 
(Suzuki et al., 2016). Moreover, the CNOT1, 3, 6L, 7, and 9 subunits were co-
immunoprecipitated (co-IP) by NANOS2 from male gonads (Suzuki et al., 
2010) and CNOT9 was co-IP by NANOS2 also from SSC lines (Zhou et al., 
2015).  
Thus, except for CNOT6L, we confirmed all these CNOT-NANOS2 interactions 
by IP-MS in mouse SSC lines, and we also found that additional subunits, such 
as CNOT2, 8, and 10 were associated with NANOS2. 
Importantly, we determined that NANOS2 interacts with two out of four 
catalytic subunits of the CNOT complex, which are CNOT7 and CNOT8, in 
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SSC lines. Although CNOT6L was previously found to interact with NANOS2 
both in gonads and post-natal testis (Suzuki et al., 2010), I could not identify it 
in our IP-MS. Thus, our data suggest that the CNOT6/6L might not be part of 
the NANOS2-CNOT complex in SSC lines. This would be compatible with the 
heterogeneity of the CNOT complex, which is thought to be composed of both 
integral and optional subunits (Lau et al., 2009; Winkler and Balacco, 2013).  
Moreover, Cnot6-6l mRNAs are only moderately expressed in SSCs (Gfra1+ 
Nanos2+ cells) but are highly upregulated during the transition from 
undifferentiated (Miwi2+ cells) to differentiating spermatogonia (c-kit+ cells) 
(from our mRNA-seq data). On the contrary, Cnot7 mRNA has an opposite 
expression pattern of Cnot6/6l and the same expression profile of Nanos2. 
Thus, these data suggest that the composition of the CNOT complex might 
change during adult spermatogonia development.  
Moreover, Cnot6 mRNA is expressed at a very low level in SSC lines (our 
mRNA-seq data, ~7 fpkm). Interestingly, Cnot6 mRNA is also one of the 
strongest NANOS2 targets (our CRAC data, ranking position ~100) and, in sea 
urchin, Cnot6 mRNA is also found amongst NANOS targets (Swartz et al., 
2014). Therefore, these findings suggest that NANOS2 could regulate the 
dosage of some Cnot mRNAs (e.g., Cnot6) at the post-transcriptional level, 
thereby controlling the composition of the CNOT complex in SSCs. However, 
to confirm that the levels of the Cnot transcripts reflect their protein expression 
levels, we should perform western blotting using specific antibodies against 
the CNOT6/6L and CNOT7/8 subunits, in SSC lines. 
Moreover, it is known that some RBPs preferentially bind to certain CNOT 
catalytic subunits rather than others. For instance, ZFP36L2 preferentially 
interacts with CNOT6L, rather than CNOT7, in Hela cells (Sha et al., 2018). 
Similarly, NANOS2 could prefer to bind to CNOT7 compared to CNOT6/6L, 
even if these subunits were equally expressed at the protein level, in SSC 
lines. 
Furthermore, in yeast and human cells, CAF1 (CNOT7/8) takes part in one of 
the two specific phases of the deadenylation process, since it preferentially 
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shortens poly(A) tails not covered by PABP (Bresson and Tollervey, 2018)  . 
Thus, NANOS2 in complex with CNOT7/8 could also be associated with this 
particular deadenylation stage, if this process really occurred on NANOS2 
targets. 
 
We also identified with high confidence two novel NANOS2 interactors. As 
previously mentioned, the E3 ubiquitin ligase TRIM21 was bound by NANOS2 
in each condition tested, also independently of RNA. Since it was already 
shown that another E3 ubiquitin ligase, NEDD4, ubiquitylates NANOS2 in post-
natal SSCs (Zhou et al., 2017), it is possible that also TRIM21 could do so, in 
order to modulate NANOS2 expression level or RNA-binding ability. To assess 
this, we could test whether NANOS2 directly interacts with TRIM21, by 
performing co-IP experiments in bacteria, after overexpressing a GST-
NANOS2 and a tagged TRIM21. Moreover, it could be interesting to assess 
whether NANOS2 is ubiquitylated by TRIM21 by using an in vitro ubiquitylation 
assay.  
Alternatively, it is also possible that TRIM21 directly interacts with CNOT to 
modulate the activity of the complex. For instance, it was shown that CNOT7 
can be ubiquitylated by the E3 ubiquitin ligase, MEX-3C, and this results in the 
regulation of its deadenylase activity, in human cell lines (Cano et al., 2015a). 
Moreover, since we did not detect the E3 ubiquitin ligase CNOT4 in our IP-MS, 
it is also possible that TRIM21 could replace CNOT4 in the NANOS2-CNOT 
complexes, in SSC lines.  
 
Additionally, also the tankyrase1-binding protein (TNKS1BP1) was identified 
as one of the most confident NANOS2 interactors. Interestingly, this protein 
was previously shown to associate with CNOT (Wahle and Winkler, 2013), 
although its role in the complex is not known. However, this suggests that 
TNKS1BP1 might not associate directly with NANOS2, but that it is part of the 
CNOT complex in SSC lines. TNKS1 mediates protein parsylation through its 
poly-ADP-ribosyl transferase domain (Gibson and Kraus, 2012), and this 
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activity is involved in a variety of cellular processes, which include DNA repair, 
transcription, regulation of ubiquitylation (Gibson and Kraus, 2012), RNA 
metabolism, and modulation of RNA stability (Ke et al., 2019). Interestingly, 
the human TNKS1 seems to have its highest expression in the adult testicular 
tissues (NCBI database), indicating its potential involvement in 
spermatogenesis. Thus, it could be interesting to investigate the relevance of 
TNKSBP1 during spermatogenesis, by deleting the Tnks1bp1 gene in mouse. 
Moreover, we could also assess whether components of the CNOT complex 
or NANOS2, are subjected to parsylation in SSC lines. 
Overall, both parsylation and ubiquitylation have been related to RNA 
metabolism and, in particular, to RNA decay (Cano et al., 2010, 2015b; 
Hildebrandt et al., 2017; Ke et al., 2019). Therefore, the presence of TRIM21 
and TNKS1BP in the NANOS2 interactome indicates that they could edit 
CNOT or NANOS2 with post-translational modifications. This, in turn, could 
modulate the putative repressive activity of the CNOT-NANOS2 complex and 
eventually affect the expression of NANOS2 targets in SSCs. 
 
In summary, besides TRIM21 and TNKS1BP, CNOT subunits are the main 
NANOS2 interactors in mouse SSC lines. Importantly, since the NANOS2-
CNOT1 interaction is essential for NANOS2 functions during early male germ 
cell development (Suzuki et al., 2012a), CNOT could also be critical for 
NANOS2 in SSC lines.  
 
4.5.2 NANOS2-mRNA targets have a short half-life in SSC lines 
 
After proving by IP-MS that NANOS2 mainly engages the CNOT complex in 
SSC lines, we hypothesised that this interaction could result in the degradation 
of NANOS2 targets. To address this, we measured mRNA stability in mouse 
SSCs by employing SLAM-seq. This is a novel metabolic labelling method, 
that quantifies mRNA half-life transcriptome-wide in live cells, also from low 
input material (Herzog et al., 2017).  
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Thus, I set-up SLAM-seq in SSC lines, and chased mRNA decay for 24 hours. 
Interestingly, SLAM-seq analysis revealed that the general mRNA half-life in 
SSCs is similar to the one in ESCs (224 and 229 minutes, respectively), 
despite the great difference in their doubling time (~5.6 days for SSCs (Kubota 
et al., 2004), and ~10-14 hours for ESCs (Pauklin et al., 2011)). Hence, these 
data suggest that mRNA turnover in SSCs is actively used and it is employed 
as much as rapidly dividing cells. 
Next, we investigated the relationship between NANOS2 CRAC occupancy 
and mRNA half-life in SSCs. Strikingly, we discovered that the half-life of 
NANOS2 mRNA targets was significantly shorter (~180 minutes) compared to 
the average mRNA half-life in SSC lines (~224 minutes). Importantly, NANOS2 
binding intensity correlated with higher mRNA instability.  
Overall, these data strongly suggested that NANOS2 binding promotes the 








Figure 4.12. Model for NANOS2 molecular function in SSC lines.  
The CNOT complex is the major NANOS2 interactor in SSC lines, as we determined 
by IP-MS. Since NANOS2 binds directly to the 3' UTR of mRNAs, it is likely that it 
recruits the CNOT complex to these transcripts and promote their decay. Indeed, 
NANOS2 binding triggers fast mRNA turn-over, as we assessed by performing SLAM-
seq in SSC lines. We believe that the mechanism underlying mRNA decay is most 
likely deadenylation, with subsequent 5’ decapping and 5’-3’ degradation. However, 
we cannot exclude that also other types of deadenylation-independent repressions, 
mediated by CNOT, might occur. 
 
 
It is worth noting that although we could calculate mRNA half-life for the 
majority of NANOS2 mRNA targets (~74%), our analysis does not take into 
account 26% of the NANOS2 CRAC targets. This is probably due to intrinsic 
limitations of SLAM-seq, such as the RNA labelling efficiency. Indeed, also in 
the original SLAM-seq protocol the authors reported the half-life of only ~8400 



















of NANOS2 in RNA decay are partially limited by the sensitivity of the SLAM-
seq technique. 
 
In general, attempts to investigate whether NANOS2 could induce RNA decay 
were made in different systems. For instance, NANOS2 was shown to 
deadenylate artificial poly(A)-RNAs in vitro, in the presence of CNOT, from 
Nanos2-overexpressing testes extracts (Suzuki et al., 2010). Similarly, also 
human NANOS proteins were shown to degrade mRNA reporters in vitro 
(Bhandari et al., 2014).  
In SSC lines, NANOS2 was suggested to repress its targets through storage 
of ‘dormant’ mRNAs, promoted by condensation of mRNPs, or by their 
degradation (Zhou et al., 2015). However, our data showed that NANOS2 
targets undergo fast RNA turnover, and thus, they are not dormant. Moreover, 
Zhou and colleagues assessed mRNAs repression by evaluating the 
upregulation of few putative NANOS2 targets (determined by native RIP) by 
RT-qPCR, in Nanos2-/- SSC lines (Zhou et al., 2015). However, when I 
analysed the half-life of the only two NANOS2 targets confirmed by CRAC 
(Taf7l and Dmrt1), I observed that they were significantly more stable than the 
average stability in SSC lines. Thus, although Taf7l and Dmrt1 are important 
for SSCs differentiation and they are upregulated upon Nanos2 loss, my data 
suggest that, in steady-state conditions, they do not undergo rapid turnover as 
a consequence of NANOS2 binding. 
 
In the previous chapter, I described that NANOS2 bona fide targets identified 
by CRAC are mainly involved in cellular metabolism and include mTORC 
positive regulators. Strikingly, we found that the half-life of these mTORC 
regulators was significantly shorter than the average stability in SSC lines. 
Importantly, these data point to a role of NANOS2 in the negative regulation of 
the mTORC pathway. This could ensure mTORC repression in the self-
renewing SSCs, thus protecting them from aberrant proliferation and stem cell 
depletion. At the same time, as soon as Nanos2 expression decreases in the 
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Miwi2+ and c-kit+ spermatogonia, NANOS2 targets would be released from its 
repression. Thus, following Nanos2 downregulation in differentiating 
spermatogonia, hundreds of metabolic mRNAs could be rapidly stabilised and 
possibly translated, in order to accelerate proliferation and promote a fast 
switch towards differentiation. Importantly, this post-transcriptional mechanism 
could provide a flexible means to ensure from one side maintenance of the 
self-renewal ability, and, from the other side, rapid differentiation. Although we 
already observed an upregulation of NANOS2 targets in differentiating 
spermatogonia (see Chapter 3), it would be interesting to assess whether they 
are also upregulated in Nanos2cKO SSC lines. 
 
Thus, NANOS2 binding induces rapid RNA turnover by shortening mRNA half-
life in SSC lines. We showed that in the same cells, NANOS2 mainly interacts 
with the CNOT complex, which is involved in mRNAs deadenylation, the most 
rate-limiting step of RNA degradation. Thus, it is likely that NANOS2 mRNAs 
targets undergo CNOT-mediated deadenylation, which could be followed by 5’ 
decapping and subsequent 5’-3’ degradation. However, it is known that CNOT 
can destabilise mRNAs also via deadenylation-independent mechanisms 
(Collart and Panasenko, 2012; Cooke et al., 2010). Moreover, NANOS 
proteins were also shown to mediate translational repression of mRNAs which 
lack poly(A) tails, both in Drosophila and Xenopus (Chagnovich and Lehmann, 
2001; Lai et al., 2011). 
In mouse, attempts to investigate whether NANOS2 was responsible for the 
deadenylation of its targets, in complex with CNOT, were made by 
immunoprecipitating NANOS2 from Nanos2-overexpressing testes, and 
assessing the poly(A) length of artificial mRNAs in vitro (Suzuki et al., 2010). 
The investigation of mRNAs poly(A) length in vivo was impaired due to the low 
sensitivity of the technique used, in Nanos2-/- male gonocytes (Suzuki et al., 
2010). Thus, it is currently unclear whether NANOS2, in complex with CNOT, 
would promote mRNA decay through deadenylation. To address this long-
standing issue, we could measure the precise length of mRNAs poly(A) tails 
 
 187 
in SSC lines and assess whether NANOS2 targets have indeed shorter tails. 
To do so, we could employ a high-throughput method called TAIL-seq (Chang 
et al., 2014), which now can also be applied to a low amount of material, such 
as a few hundred of mouse oocytes (Morgan et al., 2017).  
 
It is also known that the CNOT complex can repress mRNAs through miRNAs 
(Inada and Makino, 2014; Shirai et al., 2014) and we determined that NANOS2 
can also bind to miRNAs, although to a minor extent (see Chapter 3). Since 
one miRNA is thought to regulate hundreds of mRNAs (Bartel, 2009; Friedman 
et al., 2009), it is possible that NANOS2-miRNAs-CNOT complexes could 
trigger the decay of hundreds of transcripts in SSCs. 
 
Moreover, the CNOT complex is involved in translational repression, also 
independently of deadenylation (Collart and Panasenko, 2012; Cooke et al., 
2010). The precise mechanisms underlying its translational repression activity 
are poorly understood. However, this might occur through the interaction 
between CNOT and Dhh1, which is part of the 5’ decapping complex (Collart 
and Panasenko, 2012; Maillet and Collart, 2002).  
Additionally, NANOS is considered a translational repressor in different 
organisms (Bhandari et al., 2014; De Keuckelaere et al., 2018). Notably, 
human NANOS proteins can repress the translation of a reporter gene without 
affecting its mRNA levels in vitro (Bhandari et al., 2014). Thus, it is possible 
that NANOS2 targets in SSCs could also undergo translational repression, 
besides mRNA instability. 
In mouse SSCs, sucrose gradient experiments determined that NANOS2 is 
mainly associated with the RNPs (ribonucleoproteins) and the light monosome 
fractions, suggesting that NANOS2 mRNAs targets should not be actively 
translated (Barrios et al., 2010; Zhou et al., 2015). Furthermore, upon Nanos2 
deletion in SSC lines, there is a general increase of polysome-associated 
RNAs, suggesting that NANOS2 is a translational repressor (Zhou et al., 
2015). However, this might also be an indirect effect of Nanos2 loss, and we 
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do not know whether NANOS2 really represses its bona fide targets at the 
translational level. Thus, to clearly define whether NANOS2 exclusively affects 
the RNA stability of its targets or also their translation, we could perform 
ribosome profiling (Reid et al., 2015) from Nanos2TAG SSC lines. By doing so, 
we could compare the translation efficiency (TE) of NANOS2 targets with the 
general TE in SSCs. 
 
In summary, it would be interesting to clarify whether NANOS2 targets are 
indeed degraded as a result of mRNA deadenylation, and also whether they 
undergo other types of post-transcriptional regulation, such as translational 
repression, besides mRNA decay.  
 
4.5.3 mRNAs with a short half-life are enriched in NANOS2 motif  
 
mRNA degradation is controlled by different factors, among which cis-
elements in their 3' UTR, such as the ‘ARE’ (see Chapter 1). Therefore, we 
assessed whether the instability of NANOS2 mRNA targets was also related 
to the presence of particular sequences in their 3' UTR. Strikingly, we 
discovered that mRNAs with short half-life contained few motifs compatible 
with the ‘AUNAANU’ NANOS2 motif, previously identified by CRAC in SSC 
lines. Thus, these data provided the NANOS2 motif with a functional effect, 
since they suggest that it induces mRNA instability.  
 
However, the motifs identified by Sylamer analysis were only moderately 
enriched in the 3' UTRs analysed. This could be explained by the relatively 
small size of the 3' UTRs analysed (~1000), which might reduce the statistical 
power of the enrichment analysis performed.  
Moreover, the motifs identified by Sylamer represent variants (e.g., 
‘AUGAAUU’) of the original NANOS2 motif (‘AUNAANU’). Since the 
‘AUNAANU’ did not correlate with NANOS2 binding intensity (see Chapter 3), 
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it is possible that, instead, these specific variants correlate better with high 
CRAC signal.  
Furthermore, NANOS2 affinity towards RNA might also change depending on 
the slight nucleotide differences present in these motifs. It would be interesting 
to measure this by employing EMSA in vitro and using these specific motifs as 
substrates. Moreover, to further demonstrate that the presence of these motifs 
induces higher mRNA instability, we could reconstitute NANOS2-CNOT 
complexes in vitro, and test whether the addition RNA substrates with these 
motifs affects their mRNA degradation rate, by using a deadenylation assay 
(Morita et al., 2007).  
Eventually, it would also be interesting to investigate whether NANOS2 targets 
with these motifs are enriched in specific biological processes, within the broad 
category of cellular metabolism. 
 
In summary, we demonstrated that NANOS2 RNA-binding is associated with 
mRNA instability and that this is true for the 74% of its bona fide targets, 
identified by CRAC. This instability most likely occurs as a result of the 
NANOS2-CNOT interaction, since CNOT is the major NANOS2 interactor in 
SSC lines and the most critical deadenylase in eukaryotes.  
Moreover, our data suggest that NANOS2 can select its targets and promote 






Chapter 5. Conclusions 
 
Undifferentiated spermatogonia have been studied for decades according to 
their morphology and topology in mouse testes (Phillips et al., 2010; Rooij, 
2017). Then, the development of spermatogonial transplantation assays 
allowed the functional evaluation of their self-renewal capacity (Brinster and 
Zimmermann, 1994; Helsel and Oatley, 2017). Later on, several genes were 
identified as being specifically expressed in sub-groups of undifferentiated 
spermatogonia, where SSCs were considered to be enriched (Buaas et al., 
2004; Costoya et al., 2004; Hofmann et al., 2005; Rooij, 2017; Sun et al., 2015; 
Suzuki et al., 2009; Yoshida et al., 2004). Some of these genes have been 
used as markers to follow the fate of SSCs, with lineage tracing experiments 
and live imaging, both under the steady-state and during regeneration 
(Nakagawa et al., 2007, 2010). These and other studies led scientists to 
conceive two different SSCs self-renewal models (Hara et al., 2014; Helsel et 
al., 2017; Nakagawa et al., 2010), which both challenged the classic ‘As model’ 
(Huckins, 1971; Oakberg, 1971) (see Chapter 1). Therefore, during the past 
ten years, much progress has been made in the field, which increased our 
understanding of SSCs’ behaviour in mouse. However, the molecular 
mechanisms underlying SSCs self-renewal are still poorly understood, since 
the scarcity of SSCs in vivo has hampered their molecular characterisation for 
decades. Importantly, the development of an in vitro SSCs culture system in 
2003 (Kanatsu-Shinohara et al., 2003) allowed expanding a large amount of 
cells, and thus provided an invaluable tool for molecular and biochemical 
studies in SSC lines (Takashima and Shinohara, 2018). By taking advantage 
of this SSCs culture system, in this work, I have investigated the molecular 
function of the RBP NANOS2, which is essential for mouse fertility and SSCs 
self-renewal (Sada et al., 2009; Tsuda et al., 2003). In particular, I employed 
a Nanos2TAG mouse model to derive SSC lines and expand them in vitro in 
order to perform biochemical and molecular analyses.  
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To determine the NANOS2-RNA interactome accurately, we decided to use 
CRAC, which is one of the most stringent CLIP methods (Chapter 1, section 
1.9). However, CRAC was originally designed for yeast cultures (Granneman 
et al., 2009a), which can provide grams of cells within hours. On the contrary, 
SSC lines proliferate slowly in culture and also express low levels of NANOS2, 
indicating that performing CRAC in these cells would have been a demanding 
task. However, I have successfully applied this technique to SSC lines, and 
this work is, to my knowledge, only the second one which employed CRAC in 
cells lines derived from adult mammalian tissues (Tebaldi et al., 2018). 
Importantly, CRAC analysis revealed unprecedented findings concerning 
NANOS2 molecular interaction with RNA. First of all, we determined that 
NANOS2 binds directly to RNA in mouse SSC lines, which had not been 
unambiguously demonstrated before (see Chapter 3). In Drosophila NANOS-
RNA binding is mediated by the RBP PUMILIO (De Keuckelaere et al., 2018), 
and in mouse male gonocytes NANOS2 is thought to act together with the RBP 
DND1 to repress specific RNAs (Suzuki et al., 2016). Thus, my data suggested 
that NANOS2 adopts a distinct mode of RNA-binding in mouse SSCs, which 
is independent of other RBPs. Additionally, this knowledge could be useful to 
better investigate the RNA-binding ability of other NANOS paralogs and 
orthologs. 
Moreover, CRAC analysis showed that NANOS2 binds to RNA with sequence 
specificity, which also constitutes a new finding. Furthermore, we determined 
that NANOS2 binds to the 3' UTR of mRNAs in SSC lines and that these 
transcripts are involved in cellular metabolism. So far, only a handful of 
putative mRNAs were described to associate with NANOS2 in SSC lines (Zhou 
et al., 2015), and these were all related to spermatogenesis, thus suggesting 
that NANOS2 maintained SSCs self-renewal through the repression of 
spermatogenesis-specific transcripts. However, my data indicate that 
NANOS2 would rather repress metabolic mRNAs in SSC lines. 
Among NANOS2 CRAC targets, I also identified a few positive mTORC 
regulators, which suggested that NANOS2 could repress the mTOR pathway 
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in SSC lines. Although the interplay between NANOS2 and mTOR was already 
shown in these cell lines (Zhou et al., 2015), this was demonstrated exclusively 
at the protein level, by virtue of their physical interaction.  
To clarify how NANOS2 could regulate the fate of these metabolic mRNAs, we 
sought to determine its protein interactome by performing IP-MS. Importantly, 
we discovered that the CNOT proteins were the most robust and confident 
NANOS2 interactors in mouse SSC lines. Thus, my data reinforced the notion 
that the CNOT complex is a conserved NANOS2 interactor (Bhandari et al., 
2014; Kadyrova et al., 2007; Suzuki et al., 2010), and also suggested that 
NANOS2-CNOT interaction could be essential for NANSO2 function in post-
natal SSCs, as it was shown for male gonocytes (Suzuki et al., 2012a).  
Hence, we hypothesised that NANOS2 could recruit CNOT to its mRNAs 
targets and promote their degradation. To address that, we employed SLAM-
seq (Herzog et al., 2017) and measured mRNA stability transcriptome-wide in 
SSC lines. Importantly, we discovered that NANOS2 targets are unstable, 
compared to the average stability in SSCs. Therefore, although it was already 
hypothesised that NANOS2 could repress transcripts through RNA decay in 
SSCs (Zhou et al., 2015), we addressed this speculation by providing accurate 
experimental evidence, in SSC lines.  
Overall, my data demonstrated a link between NANOS2 and the RNA decay 
pathway, in SSC lines, at least in two independent ways: first of all, by 
identifying CNOT by IP-MS and then, by proving a correlation between 
NANOS2 RNA-binding and higher mRNA instability, by SLAM-seq. 
Thus, these findings improved our comprehension of NANOS2 molecular 
function in SSC lines and supported a model where NANOS2 could act as a 
repressor of hundreds of mRNAs, by promoting their instability, at the post-
transcriptional level, in SSCs (Figure 5.1). Moreover, since unstable transcripts 
are generally associated with regulatory functions (Herzog et al., 2017; 
Schwanhäusser et al., 2011), NANOS2 targets could contribute to the 
regulation of critical processes, such as the transition from self-renewing SSCs 
to differentiating spermatogonia. If NANOS2 really repressed its targets in 
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SSCs, we would expect that this repression was released upon NANOS2 
downregulation in differentiating spermatogonia. To address this, we analysed 
the transcriptomic changes across adult spermatogonia development. 
Interestingly, we discovered that one-third of NANOS2 bona fide targets were 
moderately upregulated during the transition from self-renewing SSCs 
(GFRα1+, NANOS2+) to transit-amplifying spermatogonia (MIWI2+) (Figure 
5.1).  
Post-transcriptional regulation of gene expression is extensively employed by 
cells during critical development processes, as it provides a dynamic means 
to modify cellular programs (see Chapter 1). Our data support a model where 
the association between NANOS2 and CNOT could induce the degradation of 
hundreds of transcripts at the post-transcriptional level in SSCs. However, 
following the downregulation of NANOS2 in differentiating spermatogonia, this 
post-transcriptional mechanism could be switched off promptly, and NANOS2 
targets could be stabilised. Thus, NANOS2 could act in the GFRα1+ SSCs pool 
by suppressing a critical developmental decision, which is the first step 
towards differentiation. Since this process would occur by employing a flexible 
regulative mechanism, in the absence of NANOS2, there could be a rapid 
resumption of NANOS2 targets expression. This, in turn, would promote a 
faster metabolism and thus support the higher proliferation rates required by 
the MIWI2+ spermatogonia (Figure 5.1).  
Therefore, by doing so, NANOS2 could actively participate in the maintenance 
of cellular quiescence and self-renewal of GFrα1+ SSCs, and allow, at the 
same time, their rapid switch towards differentiation, as soon as NANOS2 
levels decrease. 
 
In conclusion, the results presented herein revealed unprecedented insight 
into NANOS2 mechanistic function in mouse SSCs.  
Moreover, they improved our knowledge about the possible molecular basis of 
SSCs maintenance, a crucial process which supplies an endless source of 




Figure 5.1. Possible working model for NANOS2 in SSCs.  
We showed that NANOS2 binds to the 3' UTR of mRNAs with sequence specificity in 
SSC lines. There, it also associates with the CCR4-NOT complex and promotes 
mRNA instability. The mRNAs bound by NANOS2 are enriched in cellular metabolic 
processes, including few positive mTORC regulators among the top targets. Self-
renewing SSCs control metabolism strictly in order to maintain the balance between 
cellular quiescence and proliferation. Since one-third of NANOS2 targets are 
upregulated during the transition from Gfrα1+ to Miwi2+ spermatogonia, we propose a 
model where NANOS2 represses these transcripts in the Gfrα1+ SSCs to preserve 
quiescence and the long-term self-renewing pool. Once NANOS2 is downregulated 


































transcripts would increase, thus allowing the resumption of their expression. This 
would result in the positive regulation of cellular growth, which, in turn, would support 
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